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Cell Fate Decisions in Early Embryonic Development 
 
Abstract 
 
The basis of developmental biology lies in the idea of when and how cells decide to divide or to 
differentiate. Previous studies have established several signaling pathways that determine cell 
fate  decisions,  including  Notch,  Wingless,  Hedgehog,  Bone  morphogenetic  protein,  and 
Fibroblast  growth  factor.  Signaling  converges  on  transcriptional  factors  that  regulate  gene 
expression. In mouse embryonic stem cells, I explored how pluripotency and differentiation are 
regulated  through  opposing  actions  of  β-catenin-mediated  canonical  Wnt  signaling,  and  the 
mechanisms underlying Sonic hedgehog signaling in generating progenitor cells in the ventral 
neural tube. 
In  the  first  study,  we  uncovered  a  repertoire  of  β-catenin-associated  cis-elements 
associated with the maintenance of pluripotency or early differentiation in mouse embryo stem 
cells.  Which  is  preferred  depends  on  transcription  factors  that  partner  with  β-catenin.  For 
pluripotency, β-catenin/Oct4/Tcf3 complex serves as an alternative to Oct4/Sox2 complex in 
maintaining self-renewal. For differentiation, β-catenin/Tcf/Lef complex acts through a more 
optimal Lef/Tcf motif to promote differentiation, which is blocked in the presence of an Erk 
inhibitor. These results point to a synergistic action of canonical Wnt signals with Fgf, or similar, 	 ﾠ iv	 ﾠ
receptor tyrosine kinase dependent signals that utilize Erk-directed, Ets-mediated, transcriptional 
programs. 
The second study focused on neural progenitors arising on differentiation of embryonic 
stem cells. We produced evidence supporting a central role for the general neural determinant 
Sox2 in establishing a neural-specific Sonic Hedgehog response. Their combined actions lead to 
the  regional  expression  of  distinct  transcriptional  regulators  that  determine  ventral  neural 
progenitor cell fates. Three of these are Nkx2.2, Nkx6.1 and Olig2: each has been shown to act 
as a repressor preventing premature differentiation and repressing alternative progenitor fates. A 
number  of  putative  shared  regulatory  elements  were  identified,  suggesting  common  sites  of 
action for many of their functions. In silico study of Olig2 sequence specificity, in comparison 
with  other  basic-helix-loop-helix  factors,  leads  to  a  model  in  which  switching  of  Olig2 
dimerization partners engages a distinct type of DNA binding motif. 
In summary, this dissertation utilizes genome scale analyses to provide new mechanistic 
insights into cell signal regulated transcriptional programs that influence key cell fate decisions 
in early embryonic development. 
   	 ﾠ v	 ﾠ
Acknowledgement 
 
I  would  like  first  to  sincerely  thank  my  advisor,  Dr.  Andrew  McMahon,  who  provides  me 
wonderful platform to work on exciting projects and support me throughout the past five years. 
Andy is an outstanding scientist, and is one of my most respected people. Andy has guided me to 
have a scientific way of thinking from experimental design to data interpretation to delivering 
presentation. I am proud of being part of the McMahon lab, and what I have learnt from Andy 
will continue to influence my life in the future. Thanks to my thesis committee, Drs. Catherine 
Dulac, Joshua Sanes, X. Shirley Liu, and Alex Meissner, for their helpful comments and critical 
inputs. Special thanks to Shirley, who kindly supervised me for over a year and provided me 
great opportunities to work with talented scientists and friends in her lab. 
I would also like to thank all the members of the McMahon Lab and Liu Lab, who have 
discussed  with  me  on  projects  and  on  life,  with  special  thanks  to  Yuichi  Nishi  and  Kevin 
Peterson, who patiently taught me experiments, as well as Shinsuke Ohba, from whom I learnt a 
lot on scientific rigorousness and excellence during our collaboration. Thanks also to Xinjun He, 
Ke Xu, Lori O’Brien, Jing Liu, Lick Lai, Bob Kao, Jingjing Guo, Jill McMahon, Joe Vanghan, 
and Celia Schneider from McMahon Lab, and Chongzhi Zang, Yiwen Chen, Su Wang, Sheng’en 
Hu, Cliff Meyer, Tao Liu, Wei Li, Han Xu, Hansen He, and Yin Liu from the Liu Lab. It has 
been a great pleasure working with such a wonderful group of people. 
I am fortunate to have a group of very talented classmates at Harvard. All twenty of them 
are great people to interact with. Special thanks to Jessica Liu and Vu Nyugen, who have been 
supporting me in study and in life throughout the years. I wish them all the best for the future 
lives, and have no doubt they will excel in their fields. Special thanks to my dear friend Qingqing 	 ﾠ vi	 ﾠ
Wang. During my most difficult times in Harvard, I was fortunate to have the friendship of her, 
who  was  always  willing  to  lend  me  support,  keep  my  spirits  up,  and  share  with  me  great 
moments. 
I  cannot  thank  enough  for  my  family,  who  have  always  been  alongside  me,  without 
whom I would certainly not be here. I thank my parents for their guidance throughout my life 
and especially for always cheering me up during my down time. Last but certainly not the least, I 
thank my husband, who has been accompanied me for my entire five years in the US. I thank 
him for his love, patience, dedication, and honesty. My family are the reason that supports me 
not to give up and I am excited to celebrate with them the end of this chapter of my life. 
 
April 2013 
Cambridge, MA 
   	 ﾠ vii	 ﾠ
Table of Contents 
 
Abstract .......................................................................................................................................... iii 
Acknowledgement .......................................................................................................................... v 
Table of Contents .......................................................................................................................... vii 
List of Figures and Tables  .............................................................................................................. xi 
List of Abbreviations .................................................................................................................... xii 
Chapter 1 ......................................................................................................................................... 1 
Genomic analysis of gene regulatory networks underlying development ...................................... 1 
Abstract ....................................................................................................................................... 2 
Introduction ................................................................................................................................. 3 
Biological system review ........................................................................................................ 5 
Early mouse embryonic development  ................................................................................. 5 
Embryonic stem cells, pluripotency & transcription factors .............................................. 8 
Morphogen and tissue patterning ...................................................................................... 13 
Early embryonic neural tube patterning and Shh signaling .............................................. 14 
In vitro differentiation from mouse embryonic stem cells to neural progenitors ............. 17 
Technology review  ................................................................................................................ 18 
Genome-wide TF binding, epigenetic change & gene regulation .................................... 18 
ChIP-seq overview ............................................................................................................ 21 
DNA binding specificity and cell-type specific gene regulation ...................................... 22 
TF regulation other than sequence specificity .................................................................. 24 	 ﾠ viii	 ﾠ
RNA-seq overview............................................................................................................ 26 
Summary ................................................................................................................................... 26 
References ................................................................................................................................. 28 
Chapter 2 ....................................................................................................................................... 43 
Gene regulatory networks mediating canonical Wnt signal directed control of pluripotency and 
differentiation in embryo stem cells ............................................................................................. 43 
Addendum ................................................................................................................................. 43 
Abstract ..................................................................................................................................... 44 
Introduction ............................................................................................................................... 45 
Results ....................................................................................................................................... 48 
Genome-wide profiling of the canonical Wnt regulatory network in mESCs ...................... 48 
Analysis of β-catenin, Tcf3, Sox2, Oct4, and Nanog interactions at target genes points to 
distinct enhancer modules mediating the actions of canonical Wnt signaling ..................... 57 
Activation of canonical Wnt signaling directs early mesoderm differentiation ................... 63 
Similarity of β-catenin chromatin binding between CM+CHIR and 2i ............................... 69 
Differentiation-associated genes fail to be up-regulated by CHIR in 2i medium  ................. 72 
β-catenin complexes with Oct4 and Tcf3 at Oct-Sox motifs in 2i cultured mESCs ............ 75 
Discussion ................................................................................................................................. 83 
Summary ................................................................................................................................... 87 
Materials and methods .............................................................................................................. 87 
Acknowledgements ................................................................................................................... 99 
References ............................................................................................................................... 100 
Chapter 3 ..................................................................................................................................... 107 	 ﾠ ix	 ﾠ
Genome-wide study of Shh-directed neural patterning in mouse ventral neural tube  ................ 107 
Addendum ............................................................................................................................... 107 
Abstract ................................................................................................................................... 108 
Introduction ............................................................................................................................. 109 
Pan-neural factor Sox2 and neural priming ........................................................................ 109 
bHLH Protein Olig2 and differentiation of pMN into motor neuron and oligodendrocytes 
progenitors .......................................................................................................................... 110 
Results ..................................................................................................................................... 114 
Gli1 and Sox2 chromatin co-binding in neural progenitors denote actively transcribed genes 
with Shh responsiveness ..................................................................................................... 114 
Sox2 priming might be necessary for Gli1 binding in Class II gene cis-element prior to Shh 
responsiveness  ..................................................................................................................... 122 
Nkx6.1, Nkx2.2 and Olig2 share a common set of target binding regions ......................... 123 
Active enhancer signature characterizing Olig2 NEB binding regions .............................. 128 
E-box motif variants are differentially preferred by Olig2 in NEB .................................... 131 
Olig2 peaks with different E-box variants are associated with genes of distinct expression 
patterns and biological processes ........................................................................................ 139 
Discussion ............................................................................................................................... 145 
Shh neural-specific response by integration of Gli1-defined neural CRMs with Sox2 input
............................................................................................................................................. 145 
Common cis-regulatory elements for VNT repressor TFs ................................................. 146 
bHLH TF DNA recognition site preferences for MN versus OLP fate choices ................. 147 
Materials and methods ............................................................................................................ 148 	 ﾠ x	 ﾠ
References ............................................................................................................................... 152 
Chapter 4 ..................................................................................................................................... 157 
Conclusions and Future Directions ............................................................................................. 157 
Research Summary ................................................................................................................. 158 
Wnt and pluripotency  .......................................................................................................... 158 
Shh and neural patterning ................................................................................................... 163 
Future challenges and directions for studying gene regulation on system level  ..................... 169 
References ............................................................................................................................... 172 
 
   	 ﾠ xi	 ﾠ
List of Figures and Tables 
Figure 1.1  
 
Figure 1.2 
 
Figure 2.1 
Figure 2.2 
Figure 2.3 
Figure 2.4  
Figure 2.5  
Figure 2.6 
 
Figure 2.7  
 
Figure 2.8 
Figure 2.9  
 
Figure 2.10 
 
Figure 2.11 
 
Figure 2.12 
Table 2.1  
Figure 3.1 
Figure 3.2 
 
Figure 3.3 
 
 
Figure 3.4 
Figure 3.5 
 
Figure 3.6 
Figure 3.7 
 
Figure 4.1 
Figure 4.2 
In vivo early embryonic development and in vitro mESC differentiation into 
neural progenitor cells 
Using next-generation sequencing techniques to study gene regulatory 
networks 
Generation of Ctnnb1-BioFLneo;BirA and BirA ESCs 
Genome-wide mapping of β-catenin binding regions in mESCs cultured in CM 
Characterization of β-catenin ChIP-seq data, Related to Figure 2.2 
Summary for mESC ChIP-seq data from literature 
Characterization of β-catenin and ESC pluripotency factors binding 
CisGenome browser screenshots showing combinatorial binding pattern of β-
catenin and core pluripotency factors in CM 
Integration of β-catenin ChIP-seq and expression profiling in mESCs treated 
with an activator or inhibitor of canonical Wnt signaling 
Roles of small molecules CHIR and PD03 in 2i 
Kohonen U-matrix showing geometrical relationships between genes, 
representing similarity of gene expression patterns across different conditions 
Physical association of β-catenin, Oct4, Sox2, and Tcf3 and in vitro binding 
properties of Oct4, Sox2, and Tcf3 to an Oct-Sox composite motif 
In vitro luciferase assay shows that canonical Wnt signaling contributes to the 
transcription of pluripotency genes via the Sox site within an Oct-Sox motif 
Schematic model of β-catenin-dependent regulation of pluripotency network 
Sequences for ChIP-qPCR primers and genomic coordinates for peaks tested 
The use of in vitro differentiation system for neural patterning studies. 
Sox2 binding might prime cis-regulatory elements by opening up chromatin  
structure prior to repressor binding 
Nkx2.2, Olig2, and Nkx6.1 ChIP-seq reveals ventral progenitor cell 
maintenance by preventing alternative progenitor cell fates and post-mitotic 
cell differentiation 
Active enhancer signature characterizing Olig2 NEB binding regions 
CisGenome browser examples showing the combinatorial binding patterns of 
Olig2 and Sox2 
E-box motif variants are differentially preferred by Olig2 in NEB 
Olig2 peaks with different E-box variants are associated with genes with 
distinct expression domains and involved in different biological processes 
Preliminary results of PD03-independent ESC culture for Etv4-EnR ESC line 
Examples of Shh-responsive lincRNA from RNA-seq data.
 	 ﾠ xii	 ﾠ
List of Abbreviations 
bHLH 
Bmp 
ChIP-seq 
CNS 
CRM 
EMT 
ERK 
ES (or ESC) 
Fgf 
GBR 
GRN 
GSK 
H3K4me1/2/3 
H3K27ac 
H3K27me3 
HD 
ICM 
iPSC 
LIF 
lincRNA 
MAPK 
ME 
MEF 
MN 
mRNA 
NE 
NEB 
NT 
OLP 
PBM 
PCR 
PE 
PWM 
qPCR 
RT-qPCR 
Shh  
siRNA 
SOM 
TE 
TF 
TGF- β 
VNT 
Wnt 
Basic-loop-helix-loop 
Bone morphogenetic protein 
Chromatin immunoprecipitation coupled with high throughput sequencing 
Central nervous system 
cis-regulatory module 
Epithelial-mesenchymal transition 
Extracellular signal-regulated kinases 
Embryonic stem (cell) 
Fibroblast growth factor 
Gli1-binding region 
Gene regulatory network 
Glycogen synthase kinase 
Histone H3 lysine 4 mono-/di-/tri-methylation 
Histone H3 lysine 27 acetylation 
Histone H3 lysine 27 tri-methylation 
Homeodomain 
Inner cell mass 
induced pluripotent stem cell 
Leukemia inhibitory factor 
Large intergenic non-coding RNAs 
Mitogen-activated protein kinases 
Mesoderm  
Mouse embryonic fibroblast 
Motor neuron 
Messenger RNA 
Neuroectoderm 
Neural embryoid body 
Neural tube 
Oligodendrocyte progenitor 
Protein binding microarray 
Polymerase chain reaction 
Primitive endoderm 
Positional weight matrix 
Quantitative polymerase chain reaction 
Real time quantitative polymerase chain reaction 
Sonic Hedgehog 
Small interference RNA 
Self-organizing map 
Trophectoderm 
Transcription factor 
Transforming growth factor- β 
Ventral neural tube 
Wingless Chapter 1 
 
Genomic analysis of gene regulatory networks underlying development 
   	 ﾠ 2	 ﾠ
Abstract 
 
The availability of whole-genome sequencing and advances in next-generation sequencing 
technology  have  transformed  our  approach  to  studying  cell  fate  decisions  during 
embryonic development. Gene regulatory networks have been elucidated by correlating 
genome-wide  localization  of  transcription  factors  at  cis-regulatory  elements  with  gene 
expression  patterns  under  different  physiological  conditions.  Furthermore,  extensive 
databases  of  epigenetic  modifications  and  knowledge  of  crosstalk  among  signaling 
pathways add to our understanding of cell fate determination and cellular homeostasis. 
Together,  these  multi-pronged  approaches  allow  for  the  characterization  of  embryonic 
development at the systems level in an unbiased manner. 	 ﾠ 3	 ﾠ
Introduction 
The response to different signaling pathways governs how a single cell divides and differentiates 
into a multi-cellular organism. A wide variety of cell types, each with distinct characteristics and 
functions, determine the ability of an organism to survive, thrive, and proliferate. Despite the 
morphological and functional variety, all cells in an organism share the same genomic material. 
Therefore,  the  regulatory  processes  governing  gene  expression  determine  distinct  cellular 
difference such as when a cell replicates or differentiates into a more specialized cell type. 
Our  understanding  of  gene  regulatory  networks  has  accelerated  with  the  advent  of 
genome sequencing advances since the completion of the Human Genome Sequencing Project 
that  have  made  direct  sequence  analysis  at  a  genome  scale  a  cost-effective  option  for  the 
laboratory researcher (Lander et al., 2001; Venter et al., 2001) (Metzker, 2010; Shendure and Ji, 
2008). Together with sophisticated computational and experimental strategies for genomic data 
processing (Burge and Karlin, 1997; Okazaki et al., 2002), a new era of genome-scale science 
has  emerged.  The  application  of  next-generation  sequencing  (NGS)  and  advanced  genomic, 
transcriptomic, proteomic, and epigenomic approaches have resulted in a tremendous amount of 
data (Hawkins et al., 2010). These genome-wide approaches eclipse studies at the single-gene 
level in identifying complete regulatory networks and identifying emergent properties that are 
only apparent at the systems level (Hasty et al., 2001; Mogilner et al., 2006). 
The  pluripotency  networks  that  maintains  embryonic  stem  cells  (ESCs)  serves  as  an 
excellent example. Several studies have mapped specific target genes of the a core pluripotency 
network made up of transcription factors (TFs) such as Nanog (Chambers et al., 2003; Mitsui et 
al.,  2003),  Oct4  (Nichols  et  al.,  1998),  and  Sox2  (Avilion  et  al.,  2003)  using  chromatin 
immunoprecipitation  coupled  with  high-throughput  sequencing  (ChIP-seq).  A  comprehensive 	 ﾠ 4	 ﾠ
understanding  has  emerged  from  these  studies  of  a  “pluripotency  network”  and  signaling 
pathways that maintain this network (Boyer et al., 2005; Chen et al., 2008; Cole et al., 2008; 
Jiang et al., 2008; Kim et al., 2008; Liu et al., 2008; Loh et al., 2006; MacArthur et al., 2009; 
Muller et al., 2009). Interestingly, multiple regulatory factors bind at discrete regions of the 
genome and their action at these putative cis regulatory regions is generally presumed to govern 
local gene expression (Chen et al., 2008). 
The  regulatory  actions  have  also  been  examined  through  other  strategies.  The  Hi-C 
technique, a powerful tool for studying long-range DNA-DNA interactions, has characterized 
architectural  dynamics  of  the  human  genome,  which  exists  in  complex  open  and  closed 
chromatin states (Lieberman-Aiden et al., 2009). Mass spectroscopy using affinity purification 
has  revealed  protein-protein  interaction  networks  including  the  core  pluripotency  factors  in 
mESC (Ding et al., 2012; Gao et al., 2012; Liang et al., 2008; Mallanna et al., 2010; Pardo et al., 
2010; van den Berg et al., 2010; Wang et al., 2006; Wu et al., 2006). Liver development has been 
shown to result from a complex GRN involving various hepatic TFs intertwined into a cross-
regulatory  and  auto-regulatory  network  (Kyrmizi  et  al.,  2006).  Another  intriguing  and  well-
studied system is the intestinal epithelium, which exhibits an elegant balance of multi-potent 
intestinal stem cell self-renewal and differentiation (Sasai et al., 2012). 
Multiple studies have uncovered signaling pathways involved in cell fate determination. 
Notch and Bmp signaling promotes differentiation of intestinal cell sub-types, while Hedgehog 
and Bmp signaling facilitates reciprocal communication between epithelial and mesenchymal 
cells (Crosnier et al., 2006; Madison et al., 2009). Wingless (Wnt) signaling functions in cell 
migration via Eph-ephrin signaling (Batlle et al., 2002); it also plays a role in proliferation of 
undifferentiated cells (Van Der Flier et al., 2007). 	 ﾠ 5	 ﾠ
In this thesis, I studied the interplay of Wnt and Sonic Hedgehog (Shh) signaling in the 
determination  of  pluripotency  in  ESCs  and  the  differentiation  of  ESCs  to  specific  neural 
progenitors  focusing  on  the  GRNs  triggered  by  these  signaling  pathways.  The  approach 
integrated our own data with the existing knowledge of in vivo protein-DNA and protein-protein 
interactions  providing  important  insights  into  the  GRNs  governing  maintenance  and 
differentiation of stem cells, and the early programs of neural diversity. 
In this opening chapter, I present an overview of early mouse embryonic development, as 
well as available genomic technologies that facilitate systematic analysis of underlying GRNs 
governing early cell states. 
 
Biological system review 
Early mouse embryonic development 
A fertilized egg develops into the blastocyst over the course of 7 to 8 cell divisions (Figure 1.1A). 
When first formed, the blastocyst consists of an outer epithelium of trophectoderm (TE), whose 
descendants  generate  chorionic  components  of  the  placenta,  and  internally,  a  cluster  of 
pluripotent cells called the inner cell mass (ICM). At implantation, the blastocyst is comprised of 
128-256 cells. The ICM has progressed to pluripotent epiblast cells giving rise to an inner layer 
of primitive endoderm (PE) at the blastocoel surface. The PE ultimately generates additional 
extraembryonic cell types of the parietal and visceral yolk sacs while the epiblast gives rise to all 
the  future  somatic  tissues  of  the  adult  mouse,  the  germ-line  and  additional  cells  for 
extraembryonic support functions. (Nowotschin and Hadjantonakis, 2010) (Figure 1.1A). 
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Figure 1.1 (Continued) 
In  vivo  early  embryonic  development  and  in  vitro  mESC  differentiation  into  neural 
progenitor cells. 
(A) Schematic of a blastocyst stage embryo, highlighting PE, TE and epiblast. PE and epiblast 
together are derived from the earlier ICM. ESCs are a product of ICM culture. 
(B)  In  the  absence  of  ligand  (-Shh),  Ptch1  negatively  regulates  smoothened  and  the  Gli 
repressor (Gli
Rep) form accumulates to silence target genes. In the presence of ligand (+Shh), 
Shh  inhibits  Ptch1  function  allowing  Gli  TFs  to  become  activated  (Gli
Act).  Gli  activators 
translocate to the nucleus to positively regulate target genes. Importantly, this also results in 
the  loss  of  Gli-mediated  repression  allowing  genes  to  become  activated  by  other  non-
Hedgehog dependent mechanisms. 
(C) Schematic of a transverse section of an E10.5 mouse NT, and D-V progenitor domains 
established by the concentration gradient of various morphogens. 
(D) Cell fate determinant TFs and expression domains are highlighted on the right. In vitro 
differentiation of mESCs to embryoid bodies (EBs) expressing different VNT markers under 
RA and SAG stimulation mimics the in vivo VNT cell fate specification. 	 ﾠ 8	 ﾠ
Shortly after implantation, the proximal-distal and anterior-posteriors axes are established 
as a starting point for embryonic pattern formation. Gastrulation then starts around embryonic 
day 6. (E6.0). The appearance of the primitive streak is the first morphological signature (Robb 
and Tam, 2004; Stern et al., 1992; Tam and Behringer, 1997). Primitive streak cells form the 
progenitors  for  the  three  embryonic  germ  layers:  endoderm,  mesoderm,  and  ectoderm. 
Subsequently,  various  signaling  pathways  activate  downstream  effectors  of  different  cell 
lineages. For example, nascent mesoderm is formed by a process called epithelial-mesenchymal 
transition  (EMT)  under  Wnt,  Bmp  and  Fgf  signaling.  Nodal,  a  ligand  of  the  Transforming 
growth factor β (TGF-β) family, activates an endoderm-specific program demarcated by Sox17, 
FoxA2, and Hhex (Zorn and Wells, 2009). Finally, epiblast cells that fail to migrate through the 
primitive streak differentiate into ectodermal derivatives, including the surface layer of the skin 
and the central nervous system (Arnold and Robertson, 2009). Meanwhile, the germ-cell-specific 
program  is  initiated  in  pluripotent  epiblast  cells  under  control  of  inductive  Bmp4  signaling, 
leading  to  formation  of  primordial  germ  cells  (PGCs).  At  around  E6.25  in  the  early  post-
implantation embryo, expression of the key factor Blimp1 marks the suppression of the somatic 
program  and  the  activation  of  the  PGC-specific  germ-cell  program  (Lawson  et  al.,  1999; 
Tremblay et al., 2001; Hayashi et al., 2002; Ohinata et al., 2005; Vincent et al., 2005). 
 
Embryonic stem cells, pluripotency & transcription factors 
All blastocyst lineages are capable of generating self-renewing stem cell lines in culture; namely, 
ESCs from the ICM, epiblast stem cells (EPI) from the epiblast, trophoblast stem cells (TSCs) 
from the TE, and extraembryonic endodermal cells (XEN-cells) from the visceral endoderm 
(Rossant, 2001). TSCs and XEN-cells can only differentiate into extraembryonic cells of their 	 ﾠ 9	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lineages (Hemberger et al., 2004; Kunath et al., 2005; Stewart and Mintz, 1981; Tanaka et al., 
1998). ESC and EPI cells, however, are pluripotent—they possess the capacity to give rise to all 
lineages in the living adult. Initially derived from mouse blastocyst in 1981 (Evans and Kaufman, 
1981; Martin, 1981), and from the human blastocyst in 1998 (Thomson et al., 1998), ESCs have 
become a powerful tool for both scientific and clinical endeavors, especially in regenerative 
medicine and disease modeling. 
ESCs have traditionally been cultured on a layer of ‘feeder’ cells in medium containing 
fetal calf serum to maintain pluripotency and stimulate cell division (Evans and Kaufman, 1981; 
Martin, 1981). Feeder cells were later found to produce a signal that inhibits ESC differentiation, 
which was identified as leukemia inhibitory factor (LIF) (Koopman and Cotton, 1984; Smith et 
al., 1988; Smith and Hooper, 1987; Smith and Hooper, 1983; Williams et al., 1988). LIF is a 
cytokine produced by the TE and normally required for implantation (Bhatt et al., 1991; Cheng 
et al., 2001; Stewart et al., 1992). LIF functions by binding a transmembrane receptor complex to 
activate  Jak/Stat  signaling,  which  results  in  Stat3  phosphorylation  and  ESC  self-renewal 
(Matsuda et al., 1999; Niwa et al., 1998). Later experiments sought to replace the requirement for 
serum components. These studies identified bone morphogenetic factor-4 (BMP4), as a serum 
substitute for replication of ES cells with a 129 strain background (Ying et al., 2003). Most 
recently, the combination of a glycogen synthase kinase-3 (GSK3) inhibitor (CHIR99021) and 
Mitogen-activated  protein  kinases/Extracellular  signal-regulated  kinases  (MAPK/ERK) 
inhibitors (PD0325901) have been shown to enable derivation and maintenance of mESCs in 
completely defined, feeder-free culture conditions. This is referred to as the ‘2i’ culture system 
(Wray et al., 2010; Ying et al., 2008). More importantly, this system allows the derivation and 
culture of embryos of various backgrounds, including rat ESCs, which had previously defied 	 ﾠ 10	 ﾠ
conventional derivation conditions (Li et al., 2008). 
The various supplements and ingredients added to ESC cultures highlight distinct roles of 
specific signaling pathways in regulating pluripotency in ESCs. LIF acts through the STAT3 
signaling pathway, which has been shown to maintain the undifferentiated state of ESCs by an 
active form of a (estrogen receptor) fusion protein (Matsuda et al., 1999), while Bmp4 acts via its 
downstream effector Smad1 to activate inhibitor of DNA binding (Id) regulatory factor family 
members, replacing serum requirements (Niwa et al., 1998; Ying et al., 2003). mESCs produce 
fibroblast growth factor 4 (Fgf4) and this is thought to stimulate differentiation via MEK/ERK 
signaling (Ma et al., 1992). Ets-family inhibition may underlie the action of PD03 in 2i medium 
(ref), though this remains to be demonstrated. 
The role of Wnt signaling in development is significantly more complex (Sokol, 2011; 
Wray et al., 2011). This pathway acts during gastrulation, as revealed by analysis of Wnt3 and 
Wnt3a mutants (Liu et al., 1999; Ikeya et al., 2001), and β-catenin knockout mESCs and mouse 
strains (Haegel et al., 1995; Huelsken et al., 2000). β-catenin is the transcriptional activator and 
functions in a complex with Lef and Tcf in response to Wnt signaling. Moreover, by analyzing 
outgrowths from β-catenin knockout morulae, it was suggested that ESC formation and self-
renewal did not require β-catenin, although β-catenin might be important for cell adhesion and 
forming compact cell colonies (Haegel et al., 1995; Huelsken et al., 2000). Thus early evidence 
suggested that canonical Wnt signaling is not required for ESC self-renewal. 
However, increasing evidence is suggesting a positive role for Wnt/β-catenin pathway in 
the maintenance of mESC pluripotency. LIF, together with Wnt3a, an activator of β-catenin-
directed canonical Wnt signaling, are reported to support ESC pluripotency in the absence of 
other factors (Ogawa et al., 2006a; Singla et al., 2006; Ten Berge et al., 2011). Involvement of β-	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catenin  is  supported  by  the  observation  that  its  overexpression  is  sufficient  to  sustain  self-
renewal under low levels LIF (Ogawa et al., 2006b; Takao et al., 2007). Furthermore, CHIR-
mediated stimulation of canonical Wnt signaling in the presence of PD03 in 2i medium blocks an 
intrinsic tendency of mouse ESCs to differentiate (Ying et al., 2008). In addition, BIO, another 
GSK-3 inhibitor, has been reported to maintain ESCs via up-regulation of LIF (Sato et al., 2004) 
and  to  enhance  somatic  cell-fusion-mediated  somatic  cell  reprogramming  through  the 
accumulation of β-catenin (Lluis et al., 2008). 
Wnt  signaling  also  promotes  reprogramming  in  induced  pluripotent  cells  (iPSCs), 
substituting for c-Myc in the efficient propagation of iPSCs derived from mouse embryonic 
fibroblasts transfected with Sox2, Oct4, and Klf4 (Marson et al., 2008a). The down-regulation of 
“stemness marker genes” in ESCs lacking functional β-catenin supports a role of canonical Wnt 
signaling in maintenance of pluripotency (Anton et al., 2007). 
However,  the  increased  expression  of  Wnt/β-catenin  target  genes,  including 
differentiation genes like T and Cdx1, in GSK3 double knockout mESCs also indicated the 
contribution of Wnt/β-catenin signaling to early lineage-specific differentiation (Doble et al., 
2007). Moreover, during embryonic development, Wnt/β-catenin signaling is important for the 
formation of mesoderm from epiblast, the lack of which results in failure of EMT (Lindsley et al., 
2006). Further, one study reported the stimulation of human ESC proliferation and differentiation 
by Wnt3a (Dravid et al., 2005). There is also substantial controversy on whether Tcf-dependent 
transcriptional activities from canonical Wnt signaling are required for Wnt pathway regulation 
of pluripotency. Lyashenko et al. (2011) highlighted β-catenin cell-adhesion function rather than 
signaling function as being significant in Wnt-mediated ESC maintenance (Lyashenko et al., 
2011). Yi et al. (2011) and Wray et al. (2011) reported that the abrogation of Tcf3 repression, not 	 ﾠ 12	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β-catenin-Tcf activation of target genes, is important for ESC self-renewal (Wray et al., 2011; Yi 
et al., 2011). Due to the conflicting views on the requirement of Wnt/β-catenin signaling in 
mESC maintenance versus embryonic development, its regulatory mechanism is of great interest. 
An overarching question in the development field is how a unique pluripotency state is 
created and propagated compared with more differentiated cell types. At the end of various 
signaling pathways lie TFs, which are proteins that directly interact with DNA to regulate gene 
expression. The first known regulator of pluripotency, discovered about 15 years ago, is Pou5f1 
(also known as Oct4), a member of the Pit-Oct-Unc (POU) family of homeodomain (HD) factors 
(Nichols et al., 1998). Knockout of Oct4 is pre-implantation lethal: TE forms but the ICM does 
not  (Nichols  et  al.,  1998).  In  mESCs,  Oct4  knockout  results  in  rapid  differentiation,  and 
interestingly, Oct4 dosage is tightly controlled. Oct4 depletion by 50% results in differentiation 
of mESCs into trophectodermal cells, while overexpression by 50% promotes mesodermal and 
endodermal differentiation (Niwa et al., 2000). 
A later screen for factors capable of maintaining pluripotency in mESCs identified the 
HD protein Nanog (Chambers et al., 2007; Mitsui et al., 2003; Silva et al., 2009). While it is also 
expressed in the ICM, Nanog is suggested to be dispensable once pluripotency is achieved, as 
Nanog-null mESCs can retain pluripotency and do not commit to differentiation (Chambers et al., 
2007; Mitsui et al., 2003; Silva et al., 2009). A third member of the core ESC pluripotency 
network, the high-mobility group box protein Sox2, shows a similar behavior to Oct4. Sox2 is 
expressed  within  the  epiblast  and  the  extra-embryonic  ectoderm  of  the  pre-implantation 
blastocyst. It is indispensable for the formation of a pluripotent ICM. Lack of Sox2 results in 
primarily trophectodermal cells (Avilion et al., 2003). The importance of Oct4 and Sox2 as core 
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(iPSCs) from differentiated cells using Oct4, Sox2, c-Myc, and Klf4 (Maherali et al., 2007; Okita 
et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007). Since then, combinations of 
TFs as well as small molecule substitutes have been developed to reprogram various cell types 
into iPSCs (Meissner et al., 2008; Nakagawa et al., 2008; Yu et al., 2007). 
Besides  the  core  pluripotency  networks,  additional  pluripotency  regulators  have  been 
discovered by various approaches, including analyses of protein-protein interactions (Ding et al., 
2012; Gao et al., 2012; Liang et al., 2008; Mallanna et al., 2010; Pardo et al., 2010; van den Berg 
et al., 2010; Wang et al., 2006; Wu et al., 2006), large scale RNA interference-mediated gene 
knockdown (Ivanova et al., 2006), and genome-wide small interference (siRNA) screening (Ding 
et al., 2009). These factors include chromatin regulators, remodelers and modifiers, and DNA 
methyltransferases.  Recently,  MicroRNAs  (miRNAs)  and  large  intergenic  non-coding  RNAs 
(lincRNAs) have been shown to be involved in the ESC pluripotency network (Kanellopoulou et 
al., 2005; Wang et al., 2007b). For example, Marson et al. (2008) showed that Oct4, Sox2, 
Nanog, and Tcf3 bind at ESC-related miRNA targets and PcG-occupied tissue-specific miRNAs 
(Marson et al., 2008b). By loss-of-function studies on a number of ESC-expressed lincRNAs, 
Guttman et al. (2011) reported similar gene expression changes similar to the removal of ESC 
regulatory factors, suggesting key roles of lincRNAs in ESC self-renewal comparable to known 
core transcription factors (Guttman et al., 2011). 
 
Morphogen and tissue patterning 
Signals can act as both analog and digital information carriers. Morphogens are secreted signals 
that form a concentration gradient centered at the tissue-organizing center cells. This gradient 
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give period of time (Kicheva et al., 2012; Rogers and Schier, 2011). At increasing distances from 
the source, the signal gradually decreases, resulting in different cell fate determinants that are 
triggered  by  distinct  signal  concentrations.  One  example  is  the  patterning  of  the  Drosophila 
embryo along the anterior-posterior axis, which is set by the Bicoid TF that responds to the 
morphogen and controls downstream gap gene expression in a concentration-dependent manner 
(Stjohnston and Nussleinvolhard, 1992). In vertebrates, the formation of different progenitor cell 
types in the ventral neural tube (VNT) is the most widely studied example of how the Shh 
morphogen gradient activates different downstream genes at differential concentration threshold 
(Dessaud et al., 2008; Ingham and Placzek, 2006; Nishi et al., 2009; Ribes and Briscoe, 2009). 
 
Early embryonic neural tube patterning and Shh signaling 
The  Hh  signaling  pathway  has  a  broad  developmental  role  through  the  regulation  of  cell 
proliferation, cell survival, and cell specification (Ingham and McMahon, 2001; Ingham and 
Placzek,  2006).  Shh,  Desert  Hedgehog  (Dhh),  and  Indian  Hedgehog  (Ihh)  are  the  three  Hh 
ligands identified in vertebrates (Echelard et al., 1993). Dhh is most closely related to Drosophila 
hedgehog, while Shh and Ihh are more similar to each other and also regulate ongoing tissue 
maintenance and repair in the adult organisms. Mis-regulation of these pathways can lead to 
diseases, such as cancer (Wang et al., 2007a). 
As a processed signal peptide, the lipoprotein Shh contains a cholesterol group at the C-
terminus and is palmitylated at the N-terminus. Within the VNT, Shh forms a concentration 
gradient emanating from two ventral sources, the notochord and floor plate (Grili Linde et al., 
2001; Chamberlain et al., 2008). In the receiving cell, Hh ligands bind to the receptor Patched1 
(Ptch1), a 12-pass transmembrane protein (Figure 1.1B). Ptch1 inhibits a 7-pass transmembrane 	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protein,  Smoothened  (Smo),  an  essential  activator  for  all  Hh  targets  (ref).  This  inhibition  is 
relieved upon binding of the Hh ligand to Ptch1, allowing transduction of the signal across the 
membrane (Hooper and Scott, 2005; Ingham and McMahon, 2001; Jacob and Lum, 2007). The 
de-repressed Smo then activates Gli TFs, which are downstream effectors of Shh signaling. Gli 
TFs complete Shh signaling by promoting expression of target genes (Hooper and Scott, 2005). 
In  the  vertebrate  VNT,  notochord-derived  Shh  induces  different  progenitor  domains 
along the dorsal-ventral (D-V) axis. Here, a graded distribution of Shh is transformed into a 
gradient of Gli transcriptional activity that induces different neural progenitor domains (Dessaud 
et al., 2008; Stamataki et al., 2005)
 (Figure 1.1C). Each progenitor domain gives rise to distinct 
classes of interneurons or motor neurons (MNs). In the absence of Shh signal, the Gli-family TF 
Gli3 is processed to an N-terminal repressor form that mainly functions in the medial-to-ventral 
NT. In contrast, Shh input blocks the production of Gli repressor and generates Gli activator 
forms  where  signal  levels  are  highest  in  the  most  ventral  region  of  the  NT  (Ingham  and 
McMahon, 2001). NT transcription factor determinants are classified into Class-I and Class-II, 
depending on their responses to Shh signaling. Class-I TFs are repressed by Shh, and Class-II 
TFs  are  activated  by  Shh.  The  combinatorial  actions  of  Gli  repressor  and  Gli  activator  are 
translated  into  transcriptional  responses  that  activate  Class-II  transcriptional  regulators  and 
repress Class-I transcriptional regulators (Briscoe et al., 2000; Briscoe et al., 1999; Ericson et al., 
1997; Persson et al., 2002). Class-II regulatory factors are fate determinants of ventral cell types. 
Class-I TFs mostly express in the dorsal NT, but a few of them are also expressed in the ventral 
NT. 
More specifically, there are six distinct cell types in the VNT. From dorsal to ventral, 
these comprise five neural progenitor types (pV0, pV1, pV2, pMN and pV3) and a non-neuronal 	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floor plate (FP) (Ingham and McMahon, 2001) (Figure 1.1C). Neural progenitors will later give 
rise to different interneuron or MN cell types. Along the D-V axis of NT, each of the progenitor 
domain expresses different TFs. For example, from ventral to dorsal, Foxa2 species FP; Nkx2.2, 
pV3; Olig2, pMN; while Nkx6.1 is more broadly expressed from the FP to dorsal pV2 boundary. 
Ventral cell types, with the exception of the floor plate, emerge from dorsal to ventral, reflecting 
dynamics of the Shh signaling response where time and concentration are critical (Dessaud et al., 
2007). 
 In addition to initial signal-mediated activation, reciprocal repression between TFs is 
thought to play a major role in defining sharp boundaries between adjacent progenitor domains 
(Briscoe et al., 2000; Briscoe et al., 1999; Ericson et al., 1997; Persson et al., 2002). For example, 
Shh signaling represses one group of dorsal TFs indirectly (Class I), while directly activates a 
second group within the VNT (Class II) (Briscoe et al., 2000). Cross-repression between the 
Class I TF Irx3 and the Class II TF Olig2 sharpens the boundary between immediately adjacent 
pV2 and pMN progenitor compartments. Similarly, the pV3 and pMN boundary is defined by 
cross-repression between the Class I Pax6 protein and Class II Nkx2.2 protein. In the simplest 
model, cross-repression is carried out directly by each regulatory factor. Most HD and basic-
Helix-Loop-Helix (bHLH) proteins that act as ventral neural progenitor determinants are thought 
to act as repressors though the precise mechanisms of action have not been determined (Briscoe 
et al., 1999; Ericson et al., 1997; Mizuguchi et al., 2001; Muhr et al., 2001). 
Besides  Shh,  other  signaling  molecules  have  also  been  reported  to  play  a  role  in 
progenitor domain specification, such as Wnt (Ahn et al., 2008; Alvarez-Medina et al., 2009; 
Chesnutt et al., 2004; Lei et al., 2006; Megason and McMahon, 2002; Zechner et al., 2003), Bmp 
from the roof plate (Samanta and Kessler, 2004), retinoic acid (RA) (Novitch et al., 2003) and 	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Fgf signals from flanking somites (del Corral et al., 2003), and Notch signaling (Holmberg et al., 
2008; Kageyama et al., 2008). 
 
In vitro differentiation from mouse embryonic stem cells to neural progenitors 
One  advantage  of  utilizing  an  in vitro differentiation  system  is  that  mESCs  can  be  used  to 
provide an inexhaustible source of differentiated cell types, which is extremely important for 
genome-wide studies that require a substantial amount of cell material. However, it has been 
extremely  challenging  to  directly  differentiate  ESCs  into  the  desired  lineage  because  of  the 
complexity of the system. Recently, benefiting from growing understanding of various signaling 
pathways, ESCs have been shown to form specific germ-layer derivatives with high frequency 
(Fehling et al., 2003; Kubo, 2004; Ying et al., 2003). Methodologies for directed differentiation 
into specific cell-types have become increasingly sophisticated (Murry and Keller, 2008). 
In  the  neural  lineage,  ESC  have  been  shown  to  differentiate  into  NT  derivatives  by 
pharmaceutical intervention of culture conditions (Wichterle et al., 2002). In this study, mESCs 
were induced into neuronal lineage by RA induction, and were at the same time exposed to Shh 
pathway activation by a Smo agonist, SAG, a small molecule that acts as a potent activator of the 
pathway (Figure 1.1D) (Chen et al., 2002). This in vitro system has been shown to induce Class-
II  VNT  genes  in  a  time-  and  concentration-dependent  manner,  which  mimics  the  in  vivo 
patterning process (Wichterle et al., 2002). By adjusting SAG concentration, we are able to 
maximize the ventral cell types of interest, with a higher SAG concentration resulting in a more 
ventralized cell type. 
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Technology review 
Genome-wide TF binding, epigenetic change & gene regulation 
As the mechanistic foundation of cell fate decision, gene regulation has been the core interest of 
molecular biologists, the heart of which lies the study of TF target regulation (Figure 1.2A). TFs 
are the class of genes that control gene expression by direct binding at cis-regulatory elements 
via DNA binding domains (DBD) in a sequence-specific manner. Multiple pathways cross talk 
and converge at the level of TFs (Figure 1.2A) (Brivanlou and Darnell, 2002). Sequence-specific 
binding  and  antibody-mediated  recognition  of  the  target  TF  enables  genome-wide 
immunoprecipitation of TF-associated DNA sequences. Analysis of these regions facilitates the 
prediction of sequence-specific binding feature of a TF. A metric called positional weight matrix 
(PWMs) defines a consensus DNA recognition motif, based on the DNA sequence enrichment in 
TF binding sites (Elnitski et al., 2006; Morgan et al., 2007; Wright and Funk, 1993). 
Most recently, local epigenetic profiles, defined as the chromatin states that are found at a 
given time point and cell type (Park, 2009; Wang et al., 2008), have been shown to be crucial in 
creating  a  permissive  chromatin  structure  to  allow  accessibility  of  TFs.  Different  epigenetic 
modifications have been defined, but histone modifications, especially the combinatorial patterns 
of different histone modification codes, have been most widely studied. Histone octamers that 
allow  the  DNA  to  compact  into  nucleosomes  are  the  major  targets  of  various  covalent 
modifications. For example, the N- and C-termini of histone H3 can be extensively methylated, 
phosphorylated, acetylated, and ubiquitinylated in a functionally important manner (Bernstein et 
al., 2007; Goldberg et al., 2010; Kouzarides, 2007; Lister et al., 2009). For example, methylation 
of histone 3 lysine 9 (H3K9), histone 3 lysine 27 (H3K27) and Histone 4 lysine 20 (H4K20) 
were first observed as playing a role in heterochromatin formation and gene repression  	 ﾠ 19	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Figure 1.2 (Continued) 
Using next-generation sequencing techniques to study gene regulatory networks. 
(A) Schematic of developmental cues from signaling ligands to TF-mediated gene regulation 
to phenotypic changes as the read out. 
(B) Standard ChIP-seq experiment. Adapted from Park et al. Figure 1 (Park, 2009). 
(C) Standard RNA-seq experiment. Adapted from Wang et al. Figure 1 (Wang et al., 2009). 	 ﾠ 21	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(Martens  et  al.,  2005).  One  of  the  best  characterized  histone  codes  is  the  bivalent  domains 
marked by histone 3 lysine 4 tri-methylation (H3K4me3) and histone 3 lysine 27 tri-methylation 
(H3K27me3), which marks key developmental genes that are repressed in ESCs but are poised 
for expression later in development (Bernstein et al., 2006). In addition, histone 3 lysine 27 
acetylation (H3K27ac) has been shown by different studies to be an important active enhancer 
signature  in  both  human  and  mouse,  together  with  histone  3  lysine  4  mono-/di-methylation 
(H3K27me and H3K27me2) (Creyghton et al., 2010; Rada-Iglesias et al., 2011; Zentner et al., 
2011). 
By  integrating  global  chromatin  binding  profiles  for  the  same  factor  at  different 
physiological  conditions  or  of  different  TFs  under  the  same  condition,  scientists  are  able  to 
create  a  dynamic  and  integrated  picture  of  TF-mediated  GRNs  in  different  developmental 
contexts.  However,  the  information-rich  nature  of  this  idea  is  not  achievable  without  the 
technology for sequencing DNA in a high-throughput manner. 
  
ChIP-seq overview 
Technological  advances  in  NGS,  defined  as  the  use  of  established  platforms  such  as 
Illumina/Solexa  Genome  Analyzer,  Roche/454  Genome  Sequencer  and  Applied  Biosystems 
SOLiD platforms have made the collections of extensive DNA sequence information straight-
forward and cost-effective (Metzker, 2010; Pareek et al., 2011; Shendure and Ji, 2008). Genome-
wide mapping of protein-DNA interactions and epigenetic profiles have been studied extensively 
by  ChIP-seq  in  the  last  five  years  (Figure  1.2B)  (Barski  et  al.,  2007;  Johnson  et  al.,  2007; 
Mikkelsen et al., 2007; Robertson et al., 2007). The procedure cross-links a protein, for example 
a  TF  or  modified  histone,  to  associated  DNA.  Antibodies  against  the  TF  or  a  histone 	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modification of interest are used to pull down the target proteins with locally cross-linked DNA. 
After a series of fragmentation and selection steps, DNA fragments approximately 200-600bp 
long are purified, cross-linking reversed, DNA fragments are size selected, ligated to common 
adaptors, and PCR amplified, then subjected to sequencing on one of the NGS platforms. The 
basic principles for NGS are similar: the adaptor-linked ChIP’ed DNA forms clonal clusters on 
the flow cell. During each step of enzyme-driven extension of the DNA template, fluorescent 
labels are incorporated and detected by high-resolution imaging. The output will be an unbiased 
consortium of sequences of various lengths ranging from 35bp to 200bp that the protein of 
interest interacts with (Shendure and Ji, 2008). Subsequent steps involve data processing and 
management. With various algorithms being produced and compared, each one bears its own 
advantage and limitations that should be chosen with caution depending on the desired purpose 
(Ji et al., 2008; Schones et al., 2008; Zhang et al., 2008). 
 
DNA binding specificity and cell-type specific gene regulation 
DNA recognition site specificity contains important information for in vivo TF functions. For 
example,  using  nucleosome  resolution  ChIP-seq  of  H3K4me1/2/3  under  different  androgen 
stimulations, He et al. (2010) predicted the involvement of Oct1 and Nkx3.1 in the androgen 
response of prostate cancer cells based on de novo motif discovery and validated the predictions 
experimentally (He et al., 2010). Within the same family of TFs, even minor differences in in 
vitro binding specificity may translate into in vivo selectivity. For example, Ets family factors all 
have similar DBDs (Wei et al., 2010). Ets factors can be categorized into four classes depending 
on DNA binding specificity, and the small differences in site recognition were validated in vivo 
by ChIP-seq. Similarly, despite the fact that NeuroD2 and MyoD are bHLH family proteins with 	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an E-box DNA recognition site, both can bind to different variants of E-box sites and regulate 
distinct lineage-specific gene regulation (Fong et al., 2012). Interestingly, the observation that 
TFs may recognize different sites in a context-dependent manner adds additional flexibility on 
top of DNA sequence recognition specificity. For example, one of the core pluripotency factors 
Oct4 was reported to bind to different motifs, depending on the presence or absence of Sox2 
binding (Mason et al., 2010). 
The study of sequence specificity benefits from the increase in genome-wide TF DNA 
specificity  databases.  Significant  advances  were  made  when  a  new  DNA  microarray-based 
technology  called  protein  binding  microarrays  (PBMs)  were  developed,  allowing  for  the 
sequence specificities of TFs to be characterized in vitro in a high-throughput manner (Badis et 
al., 2009; Berger and Bulyk, 2009; Bulyk, 2006). Briefly, the full length or DBD of the target TF 
is epitope-tagged, purified and applied to double-stranded DNA microarrays with a large number 
of DNA sequences designed in a way to exhaust all combinations of N-mer DNA sequences 
(Mukherjee et al., 2004). Then the protein-linked DNA microarray is labeled with a fluorophore-
conjugated antibody against the epitope tag. After a series of washing, scanning, normalization 
and  calculation,  DNA  sequences  most  significantly  bound  by  the  applied  protein  are  then 
identified, which will be the final consensus or PWM for the in vitro binding specificity of the 
target protein. Compared to other techniques studying protein-DNA interactions, PBM has the 
advantage  of  being  easily  scalable  and  the  array  preparation  and  in  vitro  binding  are 
straightforward. 
Using this technique, Badis et al. (2009) examined 104 distinct mouse DNA binding 
proteins  (Badis  et  al.,  2009).  The  UniPROBE  database,  created  from  PBM  technology  and 
harboring DNA binding data for 406 non-redundant proteins ranging from a diverse range of 	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organisms has facilitated genome-wide studies for elucidating GRNs. Most recently, Jolma et al. 
(2013) conducted a comprehensive study on human TF sequence-specific binding using a high-
throughput SELEX (HT-SELEX) (Jolma et al., 2010; Jolma et al., 2013), which is more useful 
for long motif studies in comparison with PBM. Their results add to our understanding of the 
DNA-protein binding specificity model, greatly expanded the TF DNA-binding database, and 
also revealed the importance of homodimer orientation, spacing preferences and base-stacking 
interactions on TF-DNA binding specificity. 
As intriguing as it is, caution should be taken. First, the utilization of DBD motifs in 
studying TF binding an lies on the assumptions that the target sequences for a given TF is 
relatively invariant in different conditions or developmental stages. Second, this approach is not 
applicable to the scenario in which a detected binding event actually comes from chromatin 
looping  from  a  more  distal  binding  element.  Third,  the  current  notion  of  whether  TFs  bind 
directly or indirectly to chromatin, based on the presence or absence of TF binding motifs in 
peak regions. However, using PBMs, studies have shown that about half of the 104 mouse DNA-
binding proteins recognize multiple different sequence motifs (Badis et al., 2009), suggesting 
that when analyzing motif data, researchers should be cautious when drawing conclusions that a 
protein of interest directly binds DNA. Finally, closely related family members are likely to 
recognize similar motif sequences, preventing the accurate identification of target TF simply 
based on motif binding information. 
 
TF regulation other than sequence specificity 
In the ideal situation, different TFs are expressed at different levels, and a characterization of the 
top expressed lineage-specific TF would serve as the hub and allow for prediction of a GRN for 	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a certain state. However, in reality, predictions and reconstruction of GRNs is complicated by 
factors such as chromatin accessibility, which is affected by various histone modifications. For 
example, a recent study highlighted the importance of chromatin accessibility in directing cell 
lineage  differentiation  determined  by  combinatorial  histone  modification  codes  (Fong  et  al., 
2012). In this study, Neurod2 is a TF in neurons, while MyoD is a TF in skeletal muscle tissues. 
Neurod2 and MyoD direct differentiation to two completely distinct lineages, but the question is 
when both factors are expressed and how is a certain lineage chosen against the other. The 
authors show that epigenetic profiles in a particular cell state is determinant of which DNA 
sequences  are  exposed  and  then  bound  by  one  of  the  two  factors.  He  et  al.  (2010)  also 
demonstrated the predictive power of using only combinatorial histone modification signatures 
in predicting critical TFs for cell fate decisions (He et al., 2010). 
Besides epigenomic influences, the analysis of GRNs is complicated by the observation 
that for some TFs, the number of genomic binding regions far exceed the known direct target 
genes. For example, one ChIP-seq study on MyoD uncovered 30000 to 60000 binding sites in 
skeletal muscle cells, most of which were not associated directly with target gene regulation 
(Cao et al., 2010). Instead, this study proposes a reciprocal effect of MyoD binding on local 
epigenomic changes. Thus besides the direct regulation of lineage specific gene expression, TFs 
can be involved in a broader diversity of activities that may not be directly associated with their 
target  gene  regulation;  alternatively,  TF  can  be  involved  in  binding  events  without  obvious 
transcriptional consequences. 
 	 ﾠ 26	 ﾠ
RNA-seq overview 
NGS  sequencing  has  had  a  similar  impact  on  our  understanding  of  the  transcriptome;  the 
complete map RNA transcripts for a particular cell type in a certain physiological state; this 
includes mRNAs and non-coding RNAs in mammalian genome. The application of sequencing 
technology  on  transcriptome  profiling,  called  RNA-seq  (Figure  1.2C),  is  a  huge  advance, 
especially in identifying novel transcripts and in expanding our understanding of low abundance 
non-coding RNAs (Cloonan et al., 2008; Mortazavi et al., 2008). Briefly, this technique analyzes 
RNAs which are converted to complementary DNAs (cDNAs) and are ligated to adaptors at the 
ends. Similar to ChIP-seq, the samples are subjected to fragmentation either as RNA before 
reverse  transcription  or  as  cDNA.  Short  cDNA  sequences  of  several  hundred  bps  are  then 
subjected to library construction and sequencing essentially as above. In comparison with the 
traditional hybridization-based quantification of the transcriptome, it is the first in which all 
transcripts, known or de novo, can be systematically detected and quantified without any prior 
knowledge. Associating TF binding to its target sites, and associating binding with functional 
significance, is facilitated by transcriptional profiling approaches including RNA-seq. However, 
connecting TF to target gene may not be straightforward when other co-factors are required 
besides the TF of interest, or when TF binding site needs to be directed to target promoter by 
mechanisms like looping. 
 
Summary 
The  work  presented  in  this  thesis  has  addressed  many  foundational  questions  in  the 
developmental biology field. Chapter 2 focuses on fate choice for mESCs. It describes using a 
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regulates mESCs self-renewal and early differentiation in a context dependent manner. The β-
catenin-mediated  GRN  is  tightly  intertwined  with  core  pluripotency  network  by 
Nanog/Oct4/Sox2. We propose a model where β-catenin contributes to pluripotency by utilizing 
cis-elements  in  common  with  core  pluripotency  factors.  In  addition,  in  the  absence  of 
pluripotency factors, β-catenin-mediated canonical Wnt signaling promotes differentiation gene 
expression together with the Fgf/ERK pathway effector Ets. In Chapter 3, cell fate decision-
making is addressed in VNT progenitors in forming distinct neuronal progenitor cell types under 
the influence of the Shh pathway in collaboration with the pan-neural factor Sox2 through a 
genome-wide method. Further, neuronal subtype differentiation to oligodendrocyte progenitor 
cells from Olig2-expression progenitors is investigated, with a focus on different fate choices via 
sequence specific binding of different Olig2 dimer species. The observations and results from 
analyzing genomic data from these studies have added to our understanding of TF direct gene 
regulation via sequence specificity, TF chromatin binding in relation to genome accessibility, 
combinatorial regulation through multiple TFs, and the integration of expression and binding 
data to facilitate network studies. Chapter 4 summarizes the major conceptual advances that have 
stemmed from this thesis work and proposed follow-up directions based on current results in 
order to further mechanistic studies of inhibition of Fgf/ERK/Ets signaling in 2i-based mESC 
culture  conditions.  It  will  also  allow  for  the  exploration  of  RNA-seq  data  focused  on  Shh-
responsive non-coding lincRNA in VNT patterning. This final chapter also provides a summary 
of challenges facing next-generation sequencing-based genomics and forward-looking statements 
on the future of GRN construction. 	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   Chapter 2 
 
Gene regulatory networks mediating canonical Wnt signal directed control of pluripotency 
and differentiation in embryo stem cells 
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Abstract 
 
Canonical Wnt signaling supports the pluripotency of embryonic stem cells (ESCs) but also 
promotes differentiation of early mammalian cell lineages. To explain these paradoxical 
observations, we explored the gene regulatory networks at play. Canonical Wnt signaling is 
intertwined with the pluripotency network comprising Nanog, Oct4, and Sox2 in mouse 
ESCs. In defined media supporting the derivation and propagation of ESCs, Tcf3 and β-
catenin interact with Oct4; Tcf3 binds to Sox motif within Oct-Sox composite motifs that 
are also bound by Oct4-Sox2 complexes. Further, canonical Wnt signaling up-regulates the 
activity  of  the  Pou5f1  distal  enhancer  via  the  Sox  motif  in  ESCs.  When  viewed  in  the 
context  of  published  studies  on  Tcf3  and  β-catenin  mutants,  our  findings  suggest  Tcf3 
counters  pluripotency  by  competition  with  Sox2  at  these  sites,  and  Tcf3  inhibition  is 
blocked by β-catenin entry into this complex. Wnt pathway stimulation also triggers β-
catenin  association  at  regulatory  elements  with  classic  Lef/Tcf  motifs  associated  with 
differentiation  programs.  The  failure  to  activate  these  targets  in  the  presence  of  a 
MEK/ERK inhibitor essential for ESC culture suggests MEK/ERK signaling and canonical 
Wnt signaling combine to promote ESC differentiation. 	 ﾠ 45	 ﾠ
Introduction 
A central question in all stem cell-based systems is how the balance of stem cell maintenance 
and commitment is regulated. ESCs derived directly from the early mammalian embryo provide 
a particularly attractive model given their capacity for long-term propagation as stem cells under 
defined culture conditions and their potential to generate all cell types of the adult organism 
(Brook  and  Gardner,  1997).  The  pluripotency  of  ESCs  is  dependent  on  a  set  of  core 
transcriptional regulators, including Nanog, Oct4/Pou5f1 and Sox2 (NOS) (Kim, 2008; Loh et al., 
2006). The co-expression of Oct4, Sox2, and Klf4, a member of a family of transcriptional 
regulators with redundant roles in ESC maintenance (Jiang et al., 2008), is sufficient for a broad 
range of differentiated cell types to acquire a pluripotent state closely resembling that of ESCs 
(Gonzalez et al., 2011; Takahashi and Yamanaka, 2006). Direct analysis of the targets of these 
transcriptional  regulators  has  demonstrated  that  core  pluripotency  factors  co-occupy  cis-
regulatory elements near ESC specific genes, providing strong evidence for co-regulatory inputs 
into the pluripotency GRN, as well as mutual reinforcement of each factor’s own expression 
(Chen et al., 2008; Jiang et al., 2008; Kim, 2008; Loh et al., 2006; Marson et al., 2008b). 
Several  secreted  factors  are  pivotal  to  maintaining  ESC  properties;  their  addition  to 
culture medium replaces the requirement for serum and feeder cell support in the maintenance 
and propagation of ESCs (Evans and Kaufman, 1981; Williams et al., 1988; Ying et al., 2003). In 
particular, LIF acts through Stat3 to maintain the pluripotency of mouse ESCs (mESCs), whereas 
bone  morphogenetic  protein  (BMP)-directed  activation  of  inhibitor  of  DNA  binding  (Id) 
regulatory factor family members replaces serum requirements (Niwa et al., 1998; Ying et al., 
2003). 	 ﾠ 46	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Recent  studies  have  identified  two  small  molecule  pathway  modulators,  PD0325901 
(PD03) and CHIR99021 (CHIR), which substitute for LIF and BMP in defined ESC medium to 
enable the isolation and propagation of mouse ESCs (Ying et al., 2008b), and for the first time, 
ESCs from the rat (Li et al., 2008). PD03 is an inhibitor of mitogen-activated protein kinase 
kinase (MEK) (Bain et al., 2007); MEK action lies downstream of several receptor tyrosine 
kinase-mediated signaling pathways (McKay and Morrison, 2007) including the Fgf pathway. 
Fgf signaling is critical in establishing and maintaining trophectodermal (TE) precursors, the first 
differentiated cell lineage to be established by the totipotent mammalian embryo (Lanner and 
Rossant,  2010).  CHIR  inhibits  glycogen  synthase  kinase-3  (GSK3);  as  GSK3β-directed 
phosphorylation and degradation of β-catenin suppresses canonical Wnt signaling, CHIR is a 
potent agonist of the Wnt signaling pathway (Aberle et al., 1997; Bain et al., 2007; Murray et al., 
2004; Rubinfeld et al., 1996). In canonical Wnt signaling, the accumulation of cytoplasmic β-
catenin  enables  complex  formation  with  members  of  the  Lef/Tcf  family  of  DNA-binding, 
transcriptional regulators (Taelman et al., 2010). In the absence of β-catenin, Lef/Tcf factors 
bind  DNA  directly  at  a  consensus  Lef/Tcf  site,  and  recruit  transducin-like  enhancer  of  split 
(TLE) proteins to silence target gene activity. In contrast, dimerization with β-catenin generates 
transcriptional activating complexes that bind to cis-regulatory modules (CRMs) activating target 
genes (Nusse, 2005). 
Analysis of ESC culture and embryonic development provide conflicting views of the 
role of β-catenin-dependent, canonical Wnt signaling on ESC cultures. Together, LIF and Wnt3a, 
an activator of canonical Wnt signaling, are reported to support ESC pluripotency in the absence 
of feeder cells but in the presence of serum (Ogawa et al., 2006; Singla et al., 2006), and even in 
the absence of both feeder cells and serum (Ten Berge et al., 2011). Further, CHIR-mediated 	 ﾠ 47	 ﾠ
stimulation of canonical Wnt signaling in the presence of PD03 blocks an intrinsic tendency of 
mouse ESCs to differentiate, enabling continued replication of ESCs in a pluripotent state (Ying 
et  al.,  2008b).  BIO,  another  GSK-3  inhibitor,  has  been  reported  to  maintain  ESCs  via  up-
regulation  of  LIF  (Sato  et  al.,  2004),  and  to  enhance  a  cell  fusion-mediated  somatic  cell 
reprogramming process through the accumulation of β-catenin (Lluis et al., 2008). Wnt signaling 
also promotes reprogramming to induced pluripotent cells (iPSCs), substituting for c-Myc in the 
efficient propagation of iPSCs derived from mouse embryonic fibroblasts infected with Sox2, 
Oct4, and Klf4 (Marson et al., 2008a). The down-regulation of “stemness marker genes” in ESCs 
lacking  functional  β-catenin  supports  a  role  for  canonical  Wnt  signaling  in  maintenance  of 
pluripotency  (Anton  et  al.,  2007),  though  a  second  study  of  an  independently-generated  β-
catenin-deficient mES cell line draws a different conclusion (Lyashenko et al., 2011). 
At the DNA level, genome wide interaction studies of canonical Wnt signaling effectors 
have largely focused around transcription factor 7 like 1 (Tcf7l1, commonly known as Tcf3), a 
transcriptional  component  that  is  thought  to  predominantly  repress  Wnt-target  genes.  Tcf3 
binding shows a strong intersection at sites co-bound by major pluripotency regulators (Cole et 
al., 2008; Marson et al., 2008b). Recent reports indicate that a loss of Tcf3 can substitute for 
CHIR in 2i, which is consistent with an inhibitory action of this member on the pluripotency 
program (Wray et al., 2011). CHIR-mediated stimulation of β-catenin activity is proposed to 
both abrogate Tcf3 repression on the pluripotency network through a transactivation independent 
mechanism and to promote pluripotency through an interaction with Oct4 (Kelly et al., 2011; 
Wray et al., 2011; Yi et al., 2011). Together these data provide evidence for a canonical Wnt/β-
catenin pathway action in promoting the pluripotent state of stem cells. 	 ﾠ 48	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Conversely, canonical Wnt signaling has also been shown to induce specification of TE 
and mesendoderm lineages (Bakre et al., 2007; He et al., 2008; Lindsley et al., 2006), and mouse 
embryos  lacking  β-catenin,  Wnt3,  or  two  Wnt  co-receptors,  Lrp5  and  Lrp6,  arrest  prior  to 
gastrulation linking canonical Wnt signaling to axial specification and mesendodermal induction 
(Barrow et al., 2007; Behringer et al., 1999; Birchmeier et al., 2000; Merrill et al., 2004; Morkel 
et al., 2003; Skarnes et al., 2004). The conflicting reports present a mechanistic paradox: how 
does β-catenin-dependent canonical Wnt signaling promotes both the stem cell state and the 
early commitment of pluripotent cells to specific cell lineages of the gastrulating embryo? 
To address this question, we engineered a mESC line to produce a Biotin-FLAG epitope 
tagged form of β-catenin from the β-catenin (Ctnnb1) locus, and performed genome-wide ChIP-
seq to directly address β-catenin target sites on canonical Wnt signaling activation in mouse 
ESCs. When these data are viewed in conjunction with extensive expression profiling of ESCs 
under pluripotency and differentiation promoting conditions, together with DNA binding studies 
of key pluripotency determinants and their complex formation with β-catenin, a mechanistic 
model emerges that can reconcile the opposing actions of canonical Wnt signaling discussed 
above.  
 
Results 
Genome-wide profiling of the canonical Wnt regulatory network in mESCs 
To take advantage of in vivo biotinylation and FLAG-tag technologies in analyzing canonical 
Wnt signaling in mESCs, we generated a Ctnnb1-Biotin-3xFLAG knock-in ESC line (Ctnnb1-
BioFLneo ESC) using gene-targeting strategies (Figure 2.1A) (de Boer et al., 2003; Wang et al., 	 ﾠ 49	 ﾠ
2006). The modified allele places a carboxyl-terminal epitope tag on β-catenin comprising three 
tandem copies of a FLAG (3xFLAG) epitope (Hernan et al., 2000) and a short peptide that serves 
as a substrate for in vivo biotinylation in cells expressing the Escherichia coli biotin ligase, BirA 
(de Boer et al., 2003; Howard et al., 1985; Schatz, 1993) (A). Correct targeting of the modified 
Ctnnb1 knocked-in allele was confirmed by long-range PCR (Figure 2.1B). Ctnnb1-BioFLneo 
ESCs were then engineered to stably express BirA to ensure biotinylation of β-catenin-BioFL 
proteins (Ctnnb1-BioFLneo; BirA ESC). We confirmed the integrity, specificity and activity of 
the allele through the following observations. First, production and localization of β-catenin-
BioFL protein was comparable to that of the wild-type protein (Figure 2.1C and 2.1D). Second, 
biotinylated β-catenin-BioFL proteins were detected using streptavidin conjugated reagents in 
Ctnnb1-BioFLneo;BirA  ESCs,  but  not  in  Ctnnb1-BioFLneo  ESCs  (Figure  2.1D).  Finally, 
biotinylated  β-catenin-BioFL  appeared  to  function  normally;  mice  homozygous  for  Ctnnb1-
BioFL alleles carrying BirA ligase are viable with no apparent abnormalities (SO and APM, 
manuscript in preparation). As a control cell line for subsequent analyses, we also generated a 
BirA-expressing ESC line (BirA ESC; Figure 2.1E). 
To better understand the roles of canonical Wnt signaling in ESC biology, we set out to 
identify  genomic  targets  of  β-catenin,  applying  ChIP-seq  to  Ctnnb1-BioFLneo;BirA  ESCs. 
Ctnnb1-BioFLneo;BirA  ESCs  were  cultured  on  feeder  cells  in  standard  condition  with 
serum+LIF  complete  media  (abbreviation:  CM),  and  treated  with  CHIR  (CM+CHIR)  for  16 
hours, then subjected to a series of ChIP-seq procedures. β-catenin-DNA complexes were pulled 
down using anti-FLAG antibody (FLAG-ChIP), or streptavidin (Biotin-ChIP), in parallel. DNA 
obtained from each ChIP procedure was independently sequenced. We also repeated FLAG-
ChIP on Ctnnb1-BioFLneo;BirA ESCs without CHIR treatment. 	 ﾠ 50	 ﾠ
    
Ctnnb1 wild-type
R
4.0 kb
A
Exon 9
Ctnnb1 wild type
allele
Targeting vector
R
Bio
Targeted Ctnnb1
BioFLneo
allele
P2 P1
R
Bio
B P1 – P2
(5.8 kb)
P3 – P5
(5.0 kb)
P4 – P5 
(2.8 kb)
F
L
n
e
o
/
+
F
L
n
e
o
/
+
F
L
n
e
o
/
+
(kb)
3.0
5.0
6.0
B
i
o
F
+
/
+
B
i
o
F
+
/
+
B
i
o
F
+
/
+ (kb)
2.0
D
b-catenin 
b-cat
b-cat-BioFL
FLAG
SA-HRP
b-cat-BioFL
  Biotinylated
b-cat-BioFL
RI RI
3.0 kb
RI RI
otin-3xFLAG
PGK
Neo
bplox2
PGK
DTA
I R I R
P3 2 P5
RI
otin-3xFLAG
P4
PGK
Neo
bplox2
DAPI b-catenin C
FLAG
b-catenin
FLAG
E
V5
(BirA) ( )
Actin
Figure 2.1!	 ﾠ 51	 ﾠ
   
Figure 2.1 (Continued) 
Generation of Ctnnb1-BioFLneo;BirA and BirA ESCs. 
(A) Targeting strategy for Ctnnb1-BioFLneo knock-in alleles. 
(B) Confirmation of targeted Ctnnb1-BioFLneo loci by long-range PCR. Primers used are 
shown in (A). 
(C) Immunofluorescence for β-catenin (green) and FLAG (red) in Ctnnb1-BioFLneo;BirA 
ESC. Nucleus was stained with DAPI (blue). Bar, 50 mm. 
(D) Protein expression of β-catenin (b-cat), b-cat-BioFL, and biotinylated b-cat-BioFL. SDS-
PAGE and western blotting were performed using whole cell lysates of WT v6.5 (Ctnnb1
+/+), 
Ctnnb1-BioFLneo  (Ctnnb1
BioFLneo/+),  and  Ctnnb1-BioFLneo;BirA  (Ctnnb1
BioFL-neo/+;BirA) 
ESCs. Note that biotinylated b-cat-BioFL was detected in Ctnnb1-BioFLneo;BirA, neither in 
Ctnnb1-BioFLneo nor WT ESCs. 
(E) Comparison of BirA expression between six clones of BirA ESCs, determined by SDS-
PAGE and western blotting. BirA ESC clone #6 (bold) showed comparable expression of 
BirA to Ctnnb1-BioFLneo;BirA ESC. The clone #6 was used for a mock ChIP control. 	 ﾠ 52	 ﾠ
We  obtained  15947  and  16069  binding  regions  for  Biotin-ChIP  and  FLAG-ChIP 
replicates, respectively, from ChIP-seq of CHIR treated Ctnnb1-BioFLneo;BirA ESCs (Figure 
2.3A-C; two sample peak calling by MACS using input as controls under p-value <1e-5 and 
FDR<0.05; see methods for detailed peak calling program and criteria) (Zhang et al., 2008). In 
contrast, only a small number of regions were bound by β-catenin in CM without CHIR (data not 
shown),  suggesting  only  background  levels  of  endogenous  canonical  Wnt  signaling  in 
serum+LIF supplemented feeder-supported cultures. 
The intersection of the two CHIR-dependent data sets identified 9885 regions (62.0% in 
Biotin-ChIP  and  61.5%  in  FLAG-ChIP)  in  common  (correlation=0.89,  Figure  2.3C).  Shared 
peaks have a higher peak ranking than ChIP regions unique to a single dataset suggesting that the 
intersection  represents  the  most  robust  set  of  bone-fide  interaction  sites  (Figure  2.3D). 
Representative peaks associated with pluripotency sustaining transcriptional components were 
validated by qPCR (Figure 2.3E). The intersection of the two datasets formed the foundation for 
subsequent  analysis  (Figure  2.2A).  All  binding  sites  were  annotated  relative  to  ref-seq  gene 
predictions  (Figure  2.2B).  When  compared  across  the  genome,  β-catenin  associated  regions 
show enrichment within 10kb of the transcriptional start site (TSS), and a relative depletion in 
intronic  and  exonic  regions  (Figure  2.2B).  Approximately  16%  of  all  annotated  genes  are 
associated with β-catenin binding in CHIR treated mESCs using a ‘gene’ definition as the region 
10 kb upstream of the TSS plus the gene body. 
Motif analysis was performed on 400 base-pair regions centered on the peak summit of 
β-catenin association to identify statistically enriched DNA motifs within the data set (Figure 
2.3F). As expected, the DNA target site for Lef/Tcf factors, the DNA-binding partner for β- 	 ﾠ 53	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Figure 2.2 (Continued) 
Genome-wide mapping of β-catenin binding regions in mESCs cultured in CM. 
(A) Venn diagram showing the overlap between β-catenin Biotin ChIP-seq and FLAG ChIP-
seq peaks. 
(B) Genome-wide distribution of β-catenin binding regions relative to mouse genes compared 
with random control region genomic distribution. Binding regions were annotated as exon, 
introns, 5’ un-translated region (5’ UTR), 3’ UTR, within 0-1 kb upstream of TSS (TSSup1k), 
within  1-10  kb  upstream  of  TSS  (TSSup10k),  within  0-1  kb  downstream  of  TES 
(TESdown1k), within 1-10kb downstream of TES (TESdown10k), or > 10kb away from the 
nearest genes (intergenic). 
(C) (D) Top enriched motifs recovered from de novo motif analysis of β-catenin binding 
regions. Left panels show motif logos. HMG box motif is highlighted in light blue, and POU 
family  motif  in  light  red.  Right  panels  show  histogram  of  motifs   300bp  around  peak 
summit of β-catenin (orange) or matched control peak (blue). 
(E) (F) GO terms enriched for β-catenin peaks containing Lef/Tcf motif (E) or Oct-Sox motif 
(F) using GREAT. The –log10 of the raw binomial p-value is reported. 	 ﾠ 55	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Figure 2.3 (Continued) 
Characterization of β-catenin ChIP-seq data, Related to Figure 2.2. 
(A)  Sequencing  summary  of  β-catenin  ChIP-seq.  *Reversing ChIP  and  control  in  MACS 
yields 784 and 342 negative peaks for β-catenin-FLAG and β-catenin-Biotin, respectively. 
(B)  Sequencing  depth  in  β-catenin  FLAG  and  Biotin  ChIP-seq  according  to  the  method 
described in Cao et al(Cao et al., 2010). 
(C) Peak signal strength correlation of the two replicates of FLAG and Biotin ChIP-seq. Each 
circle represents one binding peak that is called in both replicates. The X-axis and Y-Axis are 
-log10 (p-value) of each peak in the two replicates according to MACS output. The red and 
blue line represents regression line using linear model and LOWESS, respectively. 
(D) Ranking based on peak intensity for the three categories of β-catenin peaks: FLAG only, 
FLAG-Biotin  intersected,  and  Biotin  only.  Peaks  with  strong  intensities  rank  high  and 
therefore have small values in ranking. 
(E) qPCR validation of representative β-catenin binding peaks. Data are represented as mean 
± s.e.m of three independent experiments (n=3). 
(F) Motifs over-represented in β-catenin-bound regions. Putative enriched motifs logos, motif 
occurrences in  β-catenin  peak  regions and matched  control  regions  (grey),  and –Log10(P-
value) calculated from two-proportion z-test are shown. Motif mapping was performed using 
CisGenome package using likelihood ratio of 500. 	 ﾠ 57	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catenin, was highly enriched: 35.0% of all β-catenin peaks predicted a Lef/Tcf site, versus 11.1% 
in matched control regions (two-proportion z test, p-value < 1e-350). Strikingly, an Oct-Sox 
composite  motif  was  also  highly  enriched  appearing  in  26.1%  of  all  β-catenin  peaks  (two-
proportion z test, p-value < 1e 324) and like Lef/Tcf predictions, this motif was centered at the 
predicted  peak  of  β-catenin  binding  (Figure  2.2C  and  2.2D).  We  also  identified  motifs  that 
matched binding sites for Klf4, Zic, Esrrb, E2a, and AP-2 (Figure 2.3F). The distribution of these 
suggests enrichment in the region but a less direct association with β-catenin binding (data not 
shown). Importantly, the enrichment of Lef/Tcf sites provides strong support for the quality of 
the data set, while the enrichment of Oct-Sox motifs near β-catenin peak summits suggests an 
interplay between β-catenin and the pluripotency circuit on canonical Wnt signaling stimulation. 
Interestingly, gene ontology (GO) analysis using Genomic Regions Enrichment of Annotations 
Tool  (GREAT)(McLean  et  al.,  2010)  revealed  that  while  embryogenesis-related  and  Wnt 
receptor signaling pathway-related genes were both enriched in Lef/Tcf motif-containing and 
Oct-Sox motif-containing β-catenin peaks, the former category was also enriched in mesoderm 
development-related term, and the latter stem cell- and neural-related terms (Figure 2.2E and 
2.2F). 
 
Analysis of β-catenin, Tcf3, Sox2, Oct4, and Nanog interactions at target genes points to 
distinct enhancer modules mediating the actions of canonical Wnt signaling 
The recovery of Oct-Sox motif within β-catenin binding regions prompted us to compare the β-
catenin data with previously-published ChIP-seq data for 19 TFs associated with maintenance of 
pluripotency, induction of iPSCs, and Wnt action (Figure 2.4A): the core pluripotency factors  	 ﾠ 58	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Figure 2.4!
Factor Total reads Unique reads Peaks identiﬁed 
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Figure 2.4 (Continued) 
Summary for mESC ChIP-seq data from literature. 
(A) Summary of published ChIP-seq data used in this study. 
(B and C) Venn diagram showing intersection of β-catenin binding regions with 
Nanog/Oct4/Sox2 ones obtained from two separate studies (Chen et al., 2008; Marson et al., 
2008b). GO terms enriched for genes near the intersected peaks are listed. 	 ﾠ 60	 ﾠ
Nanog/Oct4/Sox2  (NOS,  see  Figure  2.4B  and  2.4C  for  the  comparison  of  two  independent 
datasets)  (Chen  et  al.,  2008;  Marson  et  al.,  2008b);  Smad1/Stat3,  effectors  of  key  mESCs 
signaling pathways (Chen et al., 2008); Tcfcp2l1/Tbx3/Klf4/C-Myc/N-Myc/Zfx, reprogramming 
factors important for self-renewal (Chen et al., 2008; Han et al., 2010); Ring1b/Ezh2/Suz12, 
components  of  polycomb  repressive  complexes  (PRC)  (Chen  et  al.,  2008;  Ku  et  al.,  2008); 
Esrrb/Nr5a2, nuclear receptors linked to the ESC state (Chen et al., 2008; Heng et al., 2010); and 
Tcf3,  the  most  abundant  of  the  Lef/Tcf  family  of  canonical  Wnt  transcriptional  effectors  in 
mESCs (Marson et al., 2008b). 
Through pair-wise co-binding analyses, we were able to classify binding patterns for 
these  regulatory  factors  into  several  clusters;  notably  Tcf3,  Nanog,  Sox2,  Smad1,  and  Oct4 
interactions most closely resembled those observed through β-catenin ChIP-seq (Figure 2.5A). 
Given  that  β-catenin  regulates  gene  expression  through  Tcf  TFs,  of  which  Tcf3  is  most 
abundantly expressed in the mESCs, we performed a two-way intersection of β-catenin and Tcf3 
binding  peaks  taking  only  the  β-catenin::Tcf3  regions  to  increase  the  credibility  of  binding 
events. A further intersection with NOS peaks, produced Group-A (β-catenin::Tcf3) and Group-
B (β-catenin::Tcf3::NOS) (Figure 2.5B): comparison of these two categories provides an insight 
into whether canonical Wnt signaling action differs in the presence of NOS. 
Motif enrichment, chromatin state, and functional properties of predicted target genes 
adjacent to these binding regions were explored in each peak dataset grouping. A clear consensus 
Lef/Tcf  motif  was  the  most  over-represented  motif  in  Group-A  (p-value  <  1e-336,  two-
proportion z test) (Figure 2.5C), while the most enriched motif in Group-B closely resembled the 
published Oct-Sox motif (p-value < 1e-561, two-proportion z test) (Figure 2.5D). Stem cell- and 
ectoderm-related terms were enriched in Group-B targets, while axis  	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Figure 2.5 (Continued) 
Characterization of β-catenin and ESC pluripotency factors binding. 
(A) Heat map depicting the correlation of β-catenin and ESC factors bindings. Red: positive 
correlation; blue: negative correlation. 
(B) Venn diagram of β-catenin, Tcf3, and intersection of Nanog/Oct4/Sox2 peak regions. 
Two groups of peaks are highlighted: Group-A: β-catenin::Tcf3, and Group-B: β-
catenin::Tcf3::NOS. 
(C) (D) Enriched motifs in Group-A and Group-B. Red: motif occurrence in β-catenin peaks; 
grey: motif occurrence in matched control regions with the same coverage. P-value was 
calculated according to two proportion z-test. 
(E) (F) Functional annotation of Group-A and Group-B regions using GREAT. The –log10 of 
the raw binomial p-value is shown. 
(G) Aggregation plots of H3K4me1, H3K4me2, and H3K27ac signals  3 kb around the peak 
summit for binding regions in Group-A (red) and Group-B (blue) as well as corresponding 
matched control regions with standard error bars (black and grey). The analysis is done using 
HOMER (Heinz et al., 2010). Bin size 100 bp. 	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specification and mesoderm terms were over-represented in Group-A targets (Figure 2.5E and 
2.5F).  In  terms  of  chromatin  state,  both  groups  displayed  a  strong  H3K4me2  signature,  an 
indicator of poised or active enhancer regions (He et al., 2010), but the signature was more 
prominent amongst Group B regions, suggestive of a more active state in ESCs (Figure 2.5G). 
Consistent  with  this  view,  Group-B  displayed  a  stronger  H3K4me1  and  H3K27ac  active 
enhancer signature than Group-A (Figure 2.5G) (Creyghton et al., 2010; Rada-Iglesias et al., 
2011; Zentner et al., 2011). 
In summary, the data suggest two types of β-catenin associated regulation of two distinct 
categories of target genes, one through a Lef/Tcf-mediated DNA interaction of β-catenin with 
poised enhancers around differentiation-related genes (Group A) and one through cooperative 
interactions  of  NOS  and  β-catenin/Lef/Tcf  with  active  enhancers  around  stem  cell-  and 
ectoderm-related genes (Group B). A CisGenome browser screenshot of representative genes of 
Group-A (Cdx2, Figure 2.6A; Axin2, Figure 2.6C), and Group-B (Nanog, Figure 2.6B) shows the 
relative  signal  intensity  of  β-catenin  to  Nanog/Oct4/Sox2  data  for  Group-A  versus  Group-B 
associated genes. 
 
Activation of canonical Wnt signaling directs early mesoderm differentiation 
To connect DNA association profiles of these factors with canonical Wnt signaling-mediated 
gene expression, we intersected β-catenin ChIP peaks with neighboring genes, with a focus on 
those genes that displayed differential expression between mESCs cultured in CM+CHIR and 
CM+XAV939 (XAV); XAV is a tankyrase inhibitor antagonizing Wnt signaling (Huang et al., 
2009b).  Among  the  intersected  gene  set,  genes  associated  with  a  canonical  Wnt  signaling 
response, and early mesoderm and TE cell types, were the most significant up-regulated gene 	 ﾠ 64	 ﾠ
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Figure 2.6 (Continued)  
CisGenome  browser  screenshots  showing  combinatorial  binding  pattern  of  β-catenin 
and core pluripotency factors in CM. 
β-catenin binding to known Wnt target genes related to differentiation (Cdx2), pluripotency 
(Nanog, B), and canonical Wnt target gene (Axin2, C). Endogenous association of β-catenin is 
also displayed in the absence of CHIR stimulation (CHIR-). Tcf3, Nanog, Oct4, Sox2 and 
histone  modification  profiles  displayed  here  are  from  published  datasets  (see  Results).  A 
zoom in on highlighted regions with motif annotation is displayed to the right side.  	 ﾠ 66	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targets.  Even  though  Oct4  and  Sox2  were  diminished  upon  CHIR  treatment  (see  above), 
pluripotency-related genes showed no strong differential expression. 
The integrity of our microarray data set was supported by two analyses: prediction of 
canonical Wnt signaling target genes and correlation with published expression data sets. First, 
we applied an approach based upon an empirical finding that the potential of a gene being a 
direct target for a given TF decreases monotonically as a function of the distance of the binding 
site to that gene’s TSS (Tang et al., 2011). Second, using a rank product based method, we made 
a probabilistic prediction of β-catenin target gene list (Figure 2.7A) (Breitling et al., 2004). 
Using a false discovery rate (FDR) of 10%, we obtained 376 and 362 putative direct target genes 
that  were  positively  and  negatively  regulated  by  CHIR,  respectively,  in  CM.  This  method 
accurately predicted known target genes of canonical Wnt signaling, such as Axin2, T, Sp5, Lef1, 
Cdx2, and Tcfcp2l1. Interestingly, the identification of Porcn, which encodes a key factor in the 
palmitoylation  and  secretion  of  Wnt  ligands  (Takada  et  al.,  2006),  suggests  a  hitherto 
unrecognized positive feedback loop in canonical Wnt signaling. 
We calculated the correlation of the up-regulated genes in our data with the published 
microarray data comparing gene expression between ESCs, mesendoderm cells (MECs), and 
neural ectoderm cells (NECs) (Shen et al., 2008). The top 100 genes displaying a high MEC/ESC 
expression  ratio  showed  some  correlation  (>  0.5)  with  genes  exhibiting  a  high  CHIR/XAV 
expression  ratio.  No  correlation  was  observed  with  genes  associated  with  neural  ectoderm 
development (high NEC/ESC) (Figure 2.7B), consistent with the known role of canonical Wnt 
signaling in inducing mesendoderm and suppressing neural ectoderm development (Barrow et al., 
2007; Takada et al., 1994; Yamaguchi et al., 1999). 	 ﾠ 67	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Figure 2.7 (Continued)  
Integration of β-catenin ChIP-seq and expression profiling in mESCs treated with an 
activator or inhibitor of canonical Wnt signaling.  
(A)  Scatter  plot  of  β-catenin  direct  target  gene  prediction  based  on  distance  weighted 
regulatory potential score from ChIP-seq and t-value of differential CHIR/XAV expression in 
CM. Red dots: up-regulated genes with FDR < 0.10; blue dots: down-regulated genes with 
FDR < 0.10. The darker red/blue represents the higher likelihood for a gene being β-catenin 
direct target. The horizontal and vertical histograms reflect the distribution of the index for 
distance weighted regulatory potential and differential expression t value, respectively.  
(B) Correlation of top 1000 genes of high MEC/ESC or NEC/ESC expression ratio (from 
microarray data in Shen et al., 2008) (x-axis) with their differential expression fold changes in 
CM+CHIR/CM+XAV (y-axis). Step size: 20 genes. 
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Similarity of β-catenin chromatin binding between CM+CHIR and 2i 
To examine the interactions of β-catenin and pluripotency network components under the 2i 
conditions, Ctnnb1-BioFLneo;BirA ESCs were cultured in 2i medium supplemented with LIF; 
LIF addition enhances clonal propagation of 2i cultures (Ying et al., 2008b). ChIP-qPCR for 
Sox2, Oct4, and Tcf3 binding were conducted at cis-elements near pluripotency genes in 2i, 
2i+LIF  and  CM  conditions;  binding  of  the  three  factors  were  comparable  under  all  three 
conditions (Figure 2.8A, p-value > 0.05 from two sample t-test). 
To understand which gene category was regulated by each 2i component, and how β-
catenin may participate in this regulation, we performed ChIP-qPCR for β-catenin in 2i-adapted 
Ctnnb1-BioFLneo;BirA ESCs cultured with DMSO, PD03, CHIR, 2i, or 2i+LIF for 24 hours 
(Figure 2.8B). A strong enrichment of β-catenin was observed in CHIR-, 2i-, and 2i+LIF-treated 
cells at the same pluripotency-related gene regions as those bound by β-catenin in CM+CHIR 
(Figure 2.8C, upper panel); binding was dependent on the activation of canonical Wnt signaling 
as binding was lost within 24-hour of CHIR removal (Figure 2.8C; DMSO and PD03 in upper 
panel). Thus, stabilization of β-catenin leads to similar interactions at the DNA level in quite 
different culture regimens, and β-catenin likely contributes to expression of pluripotency-related 
genes under 2i conditions by the direct association with CRMs governing expression of the 
pluripotency network. Interestingly, inhibition of Mek activity by PD03 did not affect β-catenin 
interaction at putative regulatory regions around target genes associated with differentiation of 
ES cells in response to canonical Wnt signaling (Figure 2.8C, lower panel). 
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Figure 2.8 (Continued)  
Roles of small molecules CHIR and PD03 in 2i. 
(A) ChIP-qPCR for Oct4, Sox2 and Tcf3 interaction at defined regulatory regions 
surrounding pluripotency target genes in mESCs cultured in 2i, 2i+LIF, and CM. Data 
represent the mean of biological replicates. 
(B) Experimental scheme for studying the role of CHIR and PD03 in CM and 2i-adapted 
mESCs. ChIP-qPCR and microarray analysis were performed in 2i-adapted mESCs cultured 
for 24 hours with DMSO (control), PD03, CHIR, 2i, and 2i+LIF. Cells at passage 20 under 
the 2i+LIF condition were subjected to each assay. Cells that had been maintained in CM on 
feeder cells were cultured for 24 hours in CM with CHIR or XAV prior to microarray 
analysis. 
(C) ChIP-qPCR for β-catenin at selected loci near pluripotency-related genes (upper), 
differentiation-related and Wnt target genes (lower) on 2i-adapted mESCs. ChIP using anti-
FLAG antibodies was performed according to the experimental scheme described in (B). Data 
show the mean and standard error of the mean (s.e.m.) for three biological replicates. 
(D) K-means clustering was used to classify genes with expression fold change > 2 in at least 
one comparison group of 2i/PD03, 2i/CHIR, 2i/DMSO, 2iLIF/2i, 2iLIF/DMSO, and 
CM+CHIR/CM+XAV. A total of 388 genes were clustered into six clusters. 
(E) Individual component maps are shown for each pair-wise comparison. Top left: 2i/PD03; 
middle left: 2i/CHIR; bottom left: 2i/DMSO; top right: 2iLIF/2i; middle right: 2iLIF/DMSO; 
bottom right: CM+CHIR/CM+XAV. In general, red indicates up-regulation and blue down-
regulation. The number by each color bar indicates the fold change. 
(F) Five bp core Ets motif logo TCCTW from TRANSFAC motif M00339. 
(G) Enrichment of Ets core motif   500bp around β-catenin peak summit (orange) compared 
with matched control regions (blue). 	 ﾠ 72	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Differentiation-associated genes fail to be up-regulated by CHIR in 2i medium 
The predominant activation of a mesendoderm lineage differentiation program by CHIR in CM 
(Figure 2.7B), and the association of β-catenin with differentiation-related gene regions in 2i 
(Figure 2.8C) raises a question of how differentiation is inhibited in 2i conditions We performed 
microarray analysis in 2i-adapted Ctnnb1-BioFLneo;BirA ESCs cultured with DMSO, PD03, 
CHIR, 2i, and 2i+LIF according to the same experimental scheme as in Figure 2.8B. In this, the 
effect of CHIR is distinguished by comparing the relative gene expression level in the ESCs 
cultured  in  2i  to  those  cultured  in  PD03  where  CHIR  is  absent  (2i  /  PD03).  Comparing 
CM+CHIR over CM+XAV (CM+CHIR / CM+XAV) provides another metric of CHIR activity, 
while a comparison of 2i+LIF over 2i (2iLIF / 2i) sheds light on any direct effect of LIF on gene 
expression. 
Using Kohonen Self-Organizing Maps (SOM) (Kohonen, 2012), we identified groups of 
genes that shared similar patterns of expression changes amongst the groups (Figure 2.8D), and 
visualized target gene expression change in a series of heat maps (Figure 2.8E). Genes that 
showed a greater than 2-fold differential expression in at least one comparison were clustered 
(Figure 2.8D): the six cluster associated gene names are presented in Figure 2.9. In Figure 2.8D, 
each hexagonal map unit represents a SOM node, which has an underlying vector of a pair-wise 
fold change under different conditions. In Figure 2.8E, the gradient of each pair-wise fold change 
is displayed separately while maintaining the same topological structure as in Figure 2.8D. On 
comparing Figure 2.8D and 5E, clusters-1,-3, and -4 represented genes strongly up-regulated by 
CHIR  (2i  /  PD03),  LIF  (2i  LIF  /  2i),  and  PD03  (2i  /  CHIR),  respectively,  in  2i.  Cluster-2 
represented genes moderately up-regulated by CHIR (2i / PD03), LIF (2i LIF / 2i) and PD03 (2i /  	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Figure 2.9 (Continued) 
Kohonen  U-matrix  showing  geometrical  relationships  between  genes,  representing 
similarity of gene expression patterns across different conditions. 
In comparison with Figure 2.8D and Figure 2.8E, addition hexagons are inserted in between 
the original hexagons, which represent the distance between the two neighboring hexagons. A 
dark red color represents that the neighboring hexagons (ie, genes) are far apart in expression 
patterns,  while  a  dark  blue  indicates  that  the  difference  of  expression  pattern  for  the 
neighboring hexagons is small. The color indicates the average distance between one location 
and  the  neighboring  hexagons.  K-means  clustering  into  six  clusters  from  Figure  2.8D  is 
annotated by dividing the U-matrix with black lines. 	 ﾠ 75	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CHIR).  Genes  in  cluster-6  were  up-regulated  by  CHIR  in  serum  conditions  (CM+CHIR  / 
CM+XAV), and those in cluster-5 were down-regulated in all comparison groups. 
There are three key insights from this analysis. First, CHIR, PD03, and LIF up-regulated 
different sets of genes in 2i, as shown in cluster-1, cluster-3, and cluster-4, respectively. Second, 
CHIR up-regulated different sets of genes in 2i from those in serum conditions (cluster-1 versus 
cluster-6): several differentiation-related genes, including T, Cdx2, Cdx1 appear in cluster-6 but 
were down-regulated in 2i compared to CHIR (see 2i / CHIR) (Figure 2.9). In support of the 
former, an Ets motif was significantly enriched in β-catenin binding regions – Ets factors provide 
the transcriptional output to MEK/ERK signaling (Figure 2.8F and 5G; see Discussion). Thirdly, 
the effect of 2i over DMSO (2i / DMSO, left bottom) appears to be an additive result of the 
effect of CHIR (2i / PD03, left top) and PD03 (2i / CHIR, left middle). Similarly, the effect of 
2i+LIF over DMSO (2i LIF / DMSO, right middle) appears to be an additive result of CHIR (2i / 
PD03, left top), PD03 (2i / CHIR, left middle), and LIF (2i LIF / 2i, right top). 
  
β-catenin complexes with Oct4 and Tcf3 at Oct-Sox motifs in 2i cultured mESCs 
Binding of Oct4 and Sox2 to pluripotency-related gene regions was unaltered under 2i condition 
in contrast to the effect of CHIR on cells grown in CM (see earlier). To investigate the physical 
interaction of β-catenin and Tcf3 with these two pluripotency determinants we performed co-
immunoprecipitation (Co-IP) analysis with nuclear extracts from mESCs cultured in 2i or 2i+LIF 
with  antibodies  specific  to  β-catenin,  Tcf3,  Sox2  and  Oct4.  Oct4  and  β-catenin  were  co-
immunoprecipitated  with  anti-Oct4  antibodies  (Figure  2.10A);  the  failure  of  a  reciprocal  IP 
likely reflects epitope masking of the epitope recognized by the β-catenin antibody in an Oct4 
complex (Kelly et al., 2011). Tcf3 was associated with β-catenin and Oct4, but not Sox2 (Figure 	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2.10A). Consistently, Sox2 only pulled down Oct4, not β-catenin or Tcf3. These results suggest 
that two regulatory complexes exist under 2i conditions: one containing β-catenin, Tcf3, and 
Oct4, and another with Sox2 and Oct4. 
Given the overlap in ChIP peaks between Oct4, Sox2, and Tcf3, the Oct-Sox composite 
motif  recovered  in  β-catenin  ChIP-seq  data,  sequence  similarity  within  this  consensus  motif 
between Sox and Tcf DNA binding sites, and their structural similarities sharing an HMG DNA 
binding domain, we tested whether Tcf3 directly bound to the Oct-Sox composite motif in vitro 
by electrophoretic mobility shift assay (EMSA). Nuclear extracts (NE) were prepared from 293T 
cells over-expressing Pou5f1 (Oct4), Sox2, or Tcf7l1 (Tcf3) (Figure 2.10C) and tested for their 
ability to bind a double-stranded DNA probe incorporating an Oct-Sox composite motif located 
within a distal Pou5f1 enhancer (Figure 2.10B). 
Oct4 and Sox2 alone complex with the Oct/Sox probe (Figure 2.10D, lanes 2-7) whereas 
no binding was observed for Tcf3 (Figure 2.10D, lanes 8-10). In contrast, Tcf3 was complexed 
with a Lef/Tcf binding motif (LT probe) under the same conditions (Figure 2.10D, lanes 12-20; 
band E). Next, we examined co-binding for cooperative interactions. Oct4 and Sox2 co-binding 
led to additional band (C) not seen when only Oct4 (A) or Sox2 (B) bound (Figure 2.10E, lane 2-
8 (Chew et al., 2005)). As above, no Tcf3 interaction was observed with the Oct/Sox motif and 
Tcf3 failed to compete with Sox2 at the Sox2 binding site (Figure 2.10E, lanes 9-13). However, 
in the presence of Oct4 and Tcf3, additional bands were observed that likely reflect ternary 
complexes of Oct4 and Tcf3, with Tcf3 bound at the Sox2 site (band D in Figure 2.10E, lanes 
14-22). 	 ﾠ 77	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Figure 2.10 (Continued)  
Physical association of β-catenin, Oct4, Sox2, and Tcf3 and in vitro binding properties of 
Oct4, Sox2, and Tcf3 to an Oct-Sox composite motif. 
(A)  Co-immunoprecipitation  analysis  of  β-catenin,  Tcf3,  Oct4,  and  Sox2  complexes  in 
mESCs.  IP,  immunoprecipitation;  IB,  immunoblotting.  Asterisk  indicates  heavy  chains  of 
antibodies used in IP. 
(B) Sequence of oligonucleotide probes used in EMSA. Oct motif is underlined; Sox and 
Lef/Tcf motifs are bolded. Mutations are shown in lowercases. 
(C) Expression of  Oct4,  Sox2,  and  Tcf3  in  293T  cells over-expressing  each  of the  three 
factors  for  EMSA.  Forty-eight  hours  after  transfection  of  the  indicated  plasmids,  nuclear 
extracts were isolated from the cells. Protein expression was determined by western blotting 
and  subsequent  immunoblotting  using  specific  antibodies  against  each  factor.  IB, 
immunoblot. 
(D) Binding of Oct4 and Sox2 alone to the OS composite motif and Tcf3 to the LT motif. 
(E) Cooperative bindings of Oct4, Sox2 and Tcf3 to OS composite motif. Probe sequences are 
indicated in Figure 2.10B. Bands A, B, C, and D denoted with arrows indicate Oct4-binary, 
Sox2-binary, Oct4-Sox2-ternary, and Oct4-Tcf3-ternary complexes with the Oct/Sox probe, 
respectively. Band E indicates Tcf3-binary complex with the LT probe. Asterisks indicate 
non-specific  bands.  NE,  nuclear  extracts;  Con,  extracts  from  mock-transfected  cells;  O4, 
extracts from Oct4-overexpressing cells; S2, extracts from Sox2-overexpressing cells; S2S, 
smaller amount of extracts (0.2 mg) from Sox2-overexpressing cells; S2L, larger amount of 
extracts (2 mg) from Sox2-overexpressing cells. T3, extracts from Tcf3-overexpressing cells; 
Comp,  unlabeled  competitors;  Ab,  antibodies;  a-O4,  anti-Oct4  antibody;  a-S2,  anti-Sox2 
antibody; a-T3, anti-Tcf3 antibody. 	 ﾠ 79	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Several lines of evidence support this view. First, the additional band was eliminated by 
unlabeled LT probe or anti-Tcf3 antibodies (Figure 2.10E, lanes 19 and 22), but not by unlabeled 
mutated  LT  probe  (Figure  2.10E,  lane  20).  Second,  the  additional  band  was  competed  by 
unlabeled  WT  Oct/Sox  probe,  by  a  probe  with  the  Oct-motif  mutated,  but  not  by  a  probe 
containing mutations in both Oct and Sox motifs (Figure 2.10E, lanes 15, 16, and 18). Finally, 
when Oct4 binding was competed by unlabeled Sox-mutated probe, or blocked with anti-Oct4 
antibodies, the additional band disappeared (Figure 2.10E, lane 17 and lane 21, respectively). 
Together, these results suggest that Tcf3 binds to the Sox site in the Oct/Sox composite motif in 
an Oct4-dependent manner whereas Oct and Sox factors can independently associate with their 
target sites. 
To clarify possible patterns of complex formation when all of the three proteins were 
present we incubated the Oct-Sox composite motif with Oct4, Sox2, and Tcf3 (Figure 2.10E, 
lanes 23-25). When low amounts of Sox2 were present with the other two proteins, we observed 
band shifts indicative of Oct4-DNA, Sox2-DNA, and Oct4-Tcf3-DNA complexes (Figure 2.10E, 
lanes 24; bands A, B, and D, respectively). With higher concentrations of Sox2 we observed the 
formation  of  an  additional  Oct4-Sox2-DNA  complex  (Figure  2.10E,  lane  25,  band  C):  a 
competition between Sox2 and Tcf3 at target sites has been computationally predicted (Mason et 
al., 2010). Together these data suggest a mutually exclusive competitive interaction for Tcf3 and 
Sox2 at Oct-Sox motifs where the association of Tcf3 requires a cooperative interaction with Oct 
factors to overcome the less favored consensus of Sox versus Lef/Tcf binding motifs. 
The functional significance of canonical Wnt signal directed complexes at an Oct-Sox 
motif was supported by in vitro luciferase reporter assay using the Pou5f1 distal enhancer region 
(Figure 2.11A). The region belongs to Group B in Figure 2.5B-G: the sequence of the Oct/Sox 	 ﾠ 80	 ﾠ
probe used in the EMSA analysis above derives from this region. We confirmed copy number-
dependent enhancer activity specific to 2i-cultured mESCs (v6.5), not observed in NIH3T3 cells, 
(Figure  2.11B).  Further,  2i-cultured  mESCs  showed  an  up-regulation  of  enhancer  activity 
compared to PD03-cultures, suggesting a positive effect of CHIR stimulus, and consequently, 
canonical Wnt input into enhancer activity; up-regulation was notably diminished upon mutation 
of the Sox motif to the similar extent as mutation of both Oct and Sox motifs. In contrast, when 
the Oct motif was mutated, we still observed elevated enhancer activity, though to a lesser extent 
compared to wild type, when 2i-culture was compared to PD03-treated alone (Figure 2.11C, left). 
The similar trend was recapitulated in mESCs cultured with serum+LIF (Figure 2.11C, right). 
Together,  these  data  support  the  conjecture  that  canonical  Wnt  signaling  contributes  to  the 
transcription of pluripotency genes via the Sox site within an Oct-Sox composite motif. 
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Figure 2.11 (Continued) 
In  vitro  luciferase  assay  shows  that  canonical  Wnt  signaling  contributes  to  the 
transcription of pluripotency genes via the Sox site within an Oct-Sox composite motif. 
(A) Schematic of luciferase reporter constructs used in (B) and (C). Pou5f1 distal enhancer 
region containing the Oct-Sox composite motif drives the luciferase gene with a minimal 
TATA-box promoter element under pGL4 vector backbone. Each mutation corresponds to 
mutant motifs in EMSA analysis. 
(B) Luciferase reporter assay using Pou5f1 distal enhancer region in NIH3T3 cells and 2i-
cultured mESCs  (v6.5).  Forty-eight hours after transfection  with reporter  constructs,  cells 
were subjected to the assay. mESCs were maintained under 2i+LIF condition for 11 passages 
prior to the assay. 
(C) Luciferase reporter assay in mESCs (v6.5) cultured under 2i condition (left) or serum+LIF 
(right). mESCs were maintained under 2i+LIF condition for 11 passages prior to the assay. 
Upon transfection with reporter constructs, cells were switched into basal media of 2i culture 
(mixture of neurobasal media, DMEM/F12, N2, and B27 supplements) with PD03 or 2i (left), 
or CM in the presence or absence of CHIR (right). The assay was performed 48 hours after 
transfection. RLU, relative light unit. 	 ﾠ 83	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Discussion 
Our transcriptional analysis of Wnt pathway action in ESCs has generated several new insights 
into pluripotency and differentiation networks. First, ChIP-seq analysis enabled the identification 
of genomic targets of β-catenin activity in mESCs. Second, a strong association is observed 
between β-catenin bound regions and those occupied by core pluripotency factors (NOS) and 
Tcf3. Third, there are marked differences in bound regions and candidate target genes between 
regions where only β-catenin::Tcf3 overlap, and those where β-catenin::Tcf3 also intersect with 
the core pluripotency networks (NOS). This is observed in motif enrichment (Lef/Tcf motif vs. 
Oct-Sox  motif)  suggesting  distinct  binding  modes,  the  function  of  associated  genes  (axis 
specification- and mesoderm-related genes vs. stem cell- and ectoderm-related genes) suggestive 
of different biological outcomes, and the activity status of likely enhancer regions in mESCs 
(high  activity  for  β-catenin::Tcf3::NOS  and  low  activity  for  β-catenin::Tcf3).  Fourth,  under 
standard  culture  condition,  the  activation  of  canonical  Wnt  signaling  elevated  expression  of 
differentiation-related genes, while activity of pluripotency-related genes was maintained. Fifth, 
under  2i  condition,  β-catenin  also  engaged  at  likely  enhancers  for  TE  lineage-  and  axis 
specification-related genes but under 2i conditions, these targets are not activated. Inhibition of 
MEK/ERK  signaling  by  PD03  is  critical  in  blocking  these  differentiation  pathways  and  the 
enrichment of Ets motifs within differentiation related enhancers suggest a cooperative interplay 
of Ets and canonical Wnt complexes for gene activity. Sixth, β-catenin, Tcf3, and Oct4 interact 
under 2i conditions. Finally, canonical Wnt signaling up-regulated transcription in cell culture 
utilizing Oct-Sox  motifs  that  could  also  be  engaged  directly  by  Oct4-Tcf3  and  Oct4-Sox2. 
Considering  all  data,  we  propose  that  under  the  2i  condition,  canonical  Wnt  signaling 
participates  in  the  pluripotency  network  via  Oct4/β-catenin/Tcf3  complex  formation  and 	 ﾠ 84	 ﾠ
although Sox2 is absent, engagement of β-catenin still favors activity of pluripotency-associated 
genes (Figure 2.12, upper). 
The analysis of canonical Wnt pathway mutants sheds additional light on this process. 
First, β-catenin activity is essential under 2i conditions for the derivation and maintenance of 
mESCs (Wray et al., 2011). Second, our work, and that of others indicate that Tcf proteins are 
required for occupancy at Oct4-dependent promoter (Kelly et al., 2011; Wray et al., 2011; Yi et 
al., 2011). Further, engagement of β-catenin can enhance Oct4 promoter activity (Kelly et al., 
2011; Wray et al., 2011; Yi et al., 2011). Tcf3 is a key component in the transcriptional complex; 
Tcf3 actions are linked to Groucho-mediated gene silencing (Brantjes et al., 2001). Tcf3 inhibits 
pluripotency and the removal of Tcf3 can functionally substitute for the actions of β-catenin 
under 2i conditions (Guo et al., 2011; Schaniel et al., 2009). Thus, the main action of β-catenin 
appears  to  be  to  neutralize  the  destabilizing  activity  of  Tcf3  in  the  pluripotency  network. 
Interestingly,  mutant  forms  of  β-catenin  lacking  the  transcriptional  activating  domain  are 
effective  in  maintaining  pluripotency  (Wray  et  al.,  2011)  suggesting  that  β-catenin  acts  by 
abrogating Tcf3 silencing rather than forming a β-catenin-dependent activation complex. The 
conclusion that Tcf3 and β-catenin do not form an active transcriptional complex is supported by 
recent studies of Tcf3 mutant mouse embryos (Wu et al., 2012). 
Wnt actions in maintaining a state of pluripotency have also been linked to the control of 
telomerase  activity  through  direct  regulation  of  Tert promoter  activity  in  mESCs.  β-catenin 
binding was reported to be enriched around the Tert gene in ChIP analysis of ESCs and binding 
further enhanced by Wnt3a treatment, or expression of a stabilized form of β-catenin (Hoffmeyer 
et al., 2012). In contrast, we see no enrichment at the Tert locus in our whole genome analysis 
(data not shown). 	 ﾠ 85	 ﾠ
 
Figure 2.12!
Tcf3 T Oct4
  i 2   F I L + m u r e S
Oct4
Oct  Sox 
4 Sox2
Oct4
Oct  Sox 
4 Sox2
Tcf3 Oct4
Oct  Sox
β-catenin
Oct  Sox
Tcf3 T Oct4
β-catenin
Oct  Sox
Oct4
Oct  Sox 
4 Sox2
Tcf3 T Ets
β-catenin
Lef/Tcf
Tcf3
Lef/Tcf
Ets Tcf3
Lef/Tcf
β-catenin
+CHIR
+CHIR
Pluripotency
genes
Differentiation
genes	 ﾠ 86	 ﾠ
 
   
Figure 2.12 (Continued) 
Schematic model of β-catenin-dependent regulation of pluripotency network. 
Oct4-Sox2  binding  to  Oct-Sox  composite  motifs  maintains  activity  of  key  regulators  of 
pluripotency. Tcf3 interaction with Oct factors at the same motif is predicted to destabilize 
this circuit. CHIR-mediated stabilization of β-catenin has opposing actions. Entry of β-catenin 
into Oct4/Tcf3 complexes abrogates Tcf3 actions thereby promoting pluripotency. However, 
the  production  of  active  canonical  Wnt  transcriptional  complexes  engages  differentiation 
targets destabilizing pluripotency. PD03-mediated inhibition of MEK/ERK signaling restores 
a  pluripotency  balance  blocking  the  activation  of  Wnt  dependent  differentiation  genes 
enabling culture under 2i conditions. Given the role of MEK/ERK signaling downstream of 
receptor tyrosine kinases in the regulation of the Ets-family of transcriptional regulators, and 
the enrichment of Ets motifs in predicted cis-regulatory, we propose the combined action of 
Wnt and RTK signaling in the differentiation of ES cells. 	 ﾠ 87	 ﾠ
Summary 
ESCs are in an inherently unstable state wherein endogenous Tcf3 activity antagonizes the core 
pluripotency  network  through  competition  at  Oct/Sox  motifs  for  Sox2  binding.  Surprisingly, 
analysis of Sox2, Nanog, and Oct4 binding suggest that Tcf3 is not a transcriptional target of this 
network (data not shown). Under standard culture conditions of serum and LIF, β-catenin plays 
no significant role in maintaining pluripotency: its activity is not essential (Lyashenko et al., 
2011)  (Wray  et  al.,  2011)  and  stimulation  of  the  pathway  favors  differentiation  through 
engagement  at  “classic”  Lef/Tcf  motifs  around  differentiation  associated  target  genes. 
Presumably,  LIF  actions  are  dominant  and  the  levels  of  activation  of  target  genes  are  not 
sufficient to trigger widespread differentiation. In contrast, in 2i medium Tcf3 actions are critical 
and β-catenin is essential to overcome Tcf3’s inhibitory effects within the pluripotency network. 
What  remains  to  be  determined  is  how  the  inhibition  of  MEK/ERK  signaling  blocks  the 
differentiation promoting arm of Lef/Tcf::β-catenin -directed gene regulation. Our data on motif 
recovery  and  β-catenin  engagement  suggest  a  cooperative  role  for  MEK/ERK  directed  Ets 
factors  independent  of  Lef/Tcf::β-catenin  binding  to  activate  target  differentiation  promoting 
genes  consistent  with  the  critical  actions  of  Fgf  and  Wnt  signaling  in  promoting  lineage 
commitment in early mammalian development (Figure 2.12, lower). 
 
Materials and methods 
Generation of ES cell lines 
For the construction of Ctnnb1 targeting vectors, homologous arms were sub-cloned by PCR 
from a BAC clone RP24-499-N24 using Platinum pfx DNA Polymerase (Invitrogen, 11708-013). 
5’ homologous arm (chr9:120,864,661-120,868,632) carrying Aat II and Nde I sites at its C-	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terminus was cloned into Sac II and Not I sites of the pPGKneobpAlox2PGKDTA (generously 
provided by P. Soriano, Mount Sinai School of Medicine, NY, U.S.A), upstream of the PGKneo 
cassette  flanked  by  two  loxP  sites.  Biotin-3xFLAG  sequence  (5’-
GGGTCCGGCCTGAACGACAT 
CTTCGAGGCTCAGAAAATCGAATGGCACGAAGGCGCGCCGAGCTCGAGG-
GACTACAAAGA 
CCATGACGGTGATTATAAAGATCATGACATCGACTACAAGGATGACGATGACAAG-
3’)  was  cloned  into  the  Aat II  and  Nde I  sites  of  5’  homologous  arm  with  stop  codon.  3’ 
homologous  arm  (chr9:120,868,654-120,871,607)  was  cloned  into  the  Hind  III  site  of  the 
pPGKneobpAlox2PGKDTA, downstream of the PGKneo cassette. The final targeting vector was 
linearized with Apa I and electroporated into 129/Sv x C57BL/6J F1 hybrid ESC (v6.5). After 
the expansion of G418-resistant clones, homologous recombination was screened by PCR using 
5’ and 3’ external primers on genomic DNA (Fig S1B). Primer sequences used in the screening 
are as follows: P1, 5’-ttgtctcagaatagaacagaggaatgttac-3’ (in 5’ external region of the homologous 
arm);  P2,  5’-atccttgtagtcgatgtcatgatctttat-3’  (within  Biotin-3xFLAG  sequence)  ;  P3,  5’-
gattataaagatcatgacatcgactacaag-3’  (within  Biotin-3xFLAG  sequence);  P4,  5’-
ttggtcgaggagtaacaatacaaat -3’ (in the 3’ homologous arm); P5, 5’-atgtgactagcagctttaaccaagag-3’ 
(in 3’ external region of the homologous arm). A clone in which homologous recombination was 
confirmed by the PCR (2A3) was used as the Ctnnb1-BioFLneo ESC. 
To generate BirA-expressing Ctnnb1-BioFLneo ESC lines (Ctnnb1-BioFLneo;BirA ESC) 
and v6.5 (BirA ESC), linearized pCAGGS-BirA-V5-IRES-Hyg was electroporated into Ctnnb1-
BioFLneo ESC clone 2A3 or v6.5 cells. After the expansion of Hygromycin-resistant clones, 
BirA-expressing clones were screened by immnoblotting for the V5 epitope. For the construction 	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of  the  pCAGGS-BirA-V5-His-IRES-Hyg,  we  first  subcloned  IRES-Hyg  cassette,  of  which 
internal Not I site was mutated, from pIRES-Hyg3 vector (Clonetech, 631620). The IRES-Hyg 
cassette was exchanged with IRES-dsRed on pCIR (Tenzen et al., 2006) using Sma I and Not I 
sites  to  generate  the  pCAGGS-IRES-Hyg  vector.  BirA-V5-His  fragments  derived  from  the 
pEF1a-BirA (generously provided by A. B. Cantor, Children’s Hospital Boston, MA, U.S.A) 
were then cloned into the Eco RV site of pCAGGS-IRES-Hyg vectors to make the pCAGGS-
BirA-V5-IRES-Hyg. 
 
ESC culture 
All ESCs were maintained in complete ES media (15% fetal bovine serum, 0.1 mM non-essential 
amino  acids,  0.1  mM  β-mercaptoethanol,  2  mM  L-glutamine,  10
3  units/ml  LIF,  and  1X 
nucleotide mix in DMEM high glucose) with feeder cells isolated from DR4 mice (Tucker et al., 
1997). 2i culture of ESCs was performed as described using CHIR99021 (3 mM, Stemgent, 04-
0004) and PD0325901 (1 mM; Stemgent, 04-0006) (Ying et al., 2008a). 
 
Immunofluorescence, Immunoblot, and Co-immunoprecipitation Assays 
Cells cultured on gelatinized chamber slides were fixed with 4% paraformaldehyde/PBS. After 
blocked with 0.1% Tween, 3% BSA (Sigma, A7906), and 1% heat inactivated sheep serum 
(Sigma, S2263) in PBS, slides were incubated with anti-FLAG M2 (1:500; Sigma, F3165) and 
anti-β-catenin antibodies (1:500; Epitomics, 1247-1). 
 Whole cell lysates were obtained using RIPA buffer (10 mM Tris-HCl, 150 mM NaCl, 1 
mM EDTA, 1% NP-40, 0.1% SDS, and 1% deoxycholic acid; pH 7.8). Nuclear extracts were 
isolated according to the manufacturer’s instructions for Nuclear Complex Co-IP Kit (Active 	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 ﾠ
Motif,  54001).  Co-immunoprecipitation  was  performed  according  to  the  manufacturer’s 
instructions for Protein A/G HP SpinTrap Buffer Kit (GE Healthcare, 28-9135-67). Lysates or 
immunoprecipitated  materials  were  subjected  to  SDS-PAGE  and  blotted  onto  nitrocellulose 
membranes. The following antibodies were incubated overnight at 4°C in PBS containing 3% 
non-fat  milk  and  0.1%  Tween20:  HRP-conjugated  anti-FLAG  M2  antibody  (1:500;  Sigma, 
A8592), HRP-conjugated streptavidin (1:500; Perkin Erlmer, NEL750), anti-V5-HRP antibody 
(1:5000;  Invitrogen,  R961-25),  anti-β-catenin  (1:1000;  Epitomics,  1247-1),  anti-Tcf3  (1:200; 
Santa Cruz Biotechnology), anti-Oct4 (1:200; Santa Cruz Biotechnology), and anti-Sox2 (1:400; 
R&D  Systems)  antibodies.  HRP-conjugated  secondary  antibodies  for  western  blotting  were 
purchased from Southern Biotech and Jackson Immunoresearch. 
 
ChIP, ChIP-seq and ChIP-qPCR 
After treated with CHIR99021 (3 mM) for 16 hours, Ctnnb1-BioFLneo;BirA and BirA ESC were 
collected with feeder cells using 0.25% trypsin-EDTA. After leaving cells on gelatinized plates 
for an hour, we collected floating cells as an ESC-enriched fraction. 10,000,000 cells were used 
per ChIP. Chromatin was sonicated by 6 sessions of 30 pulses (1 sec on and 1 sec off) at 50% 
amplitude  using  the  Branson  sonifier  250D.  Isolation  of  chromatin  and  FLAG-ChIP  were 
performed as described (Vokes et al., 2007). For Biotin-ChIP, sonicated chromatins were first 
incubated  with  protein  A  dynabeads  (Invitrogen,  100-01D)  at  4  °C  for  an  hour.  Dynabeads 
MyOne Streptavidin T1 (Invitrogen, 656.01) was incubated with 2% Gelatin from cold water 
fish skin (Sigma, G7041) in PBS at 4 °C for an hour prior to use. Pre-cleared chromatins were 
incubated with 60 mL of Dynabeads MyOne Streptavidin T1 overnight with rotation at 4 °C. 
Beads were washed with 2% SDS, 10 mM Tris, and 0.5 M EDTA five times, and with TE once. 	 ﾠ 91	 ﾠ
ChIP DNA was eluted by the overnight incubation of beads in 10 mM Tris, 1 mM EDTA, 1% 
SDS, and 0.5 M NaCl at 65 °C. DNA was purified as described (Vokes et al., 2007). ChIP DNA 
was  analyzed  by  SYBR  green  real-time  PCR  (see  primers  in  Table  2.1).  Enrichment  was 
calculated relative to the control region. ChIP-seq libraries were constructed using ChIP-seq 
DNA Sample Prep Kit (Illumina, IP-102-1001) according to manufacturer’s instruction. We also 
generated input control library for both anti-FLAG and Biotin replicates, in addition to the mock 
IP controls generated from BirA ESC. 
For ChIP in 2i culture system, 2i-adapted mESCs cultured in 2i+LIF were treated with 
PD0325901 (1 µM), CHIR99021 (3 µM), or 2i (PD0325901+CHIR99021) for 24 hours and 
subjected to ChIP procedures. 
ChIP-qPCR  was  performed  with  Biorad  iQ™  SYBR®  Green  Supermix  (#170-8880). 
Fold enrichment was calculated by normalizing ChIP sample against input, and target region 
against control region as follows. 
ΔCt=Ct(ChIP)- Ct(input); 
ΔΔCt=ΔCt(target region)-ΔCt(control region); 
Fold enrichment=2
-ΔΔCt 
 
Expression Profiling 
For  culture  in  CM  with  feeder  cells,  Ctnnb1-BioFLneo;BirA  ESCs  were  transferred  onto 
gelatinized plates 24 hours before the 24-hour-treatment of CHIR99021 (3 µM) or XAV939 (1 
µM; Stemgent, 04-0046) (Hall et al., 2001; Huang et al., 2009b; Ring et al., 2003); for culture in 
2i system, Ctnnb1-BioFLneo;BirA ESCs were treated with DMSO only, PD0325901 (1 µM) 
only, CHIR99021 (3 µM) only, 2i (PD0325901 1µM +CHIR99021 3µM) or 2i+LIF for 24 hours 	 ﾠ 92	 ﾠ
After the treatments, total RNA was isolated using TRIZOL Reagent (Invitrogen, 15596-026). 
RNA  was  then  treated  with  DNaseI  (QIAGEN,  79254)  and  purified  by  RNeasy  Mini  Kit 
(QIAGEN, 74104) according to manufacturers’ instruction. 300 ng of total RNA were labeled 
for  each  sample  using  the  GeneChip  WT  cDNA  Synthesis  and  Amplification  Kit  and  WT 
Terminal Labeling Kit (Affymetrix, 900673 and 900671). Labeled sense-strand DNA targets 
were hybridized onto GeneChip mouse Gene 1.0 ST array (Affymetrix, 901169). Hybridization 
signal was scanned on the GeneChip Scanner 3000 (Affymetrix). All array-related procedures 
were performed according to Affymetrix GeneChip protocols. 
Data analysis was performed by loading CEL files into the statistical computing language 
R software, and probes were normalized using robust multi-array average (RMA) (Irizarry et al., 
2003). LIMMA was used for differential gene expression analysis, and adjusted P-value < 0.005 
were considered differentially expressed, unless otherwise noted. 
Expression microarray of ESCs, mesoendoderm cells, and neuroectoderm cells were from 
GEO GSE12982 (Shen et al., 2008). Correlation plots of Figure 2.7B were generated in the 
following way. Top differentially expressed genes in MEC/ESC and NEC/ESC in different tiers 
(step size: 20 genes) were extracted. The Pearson correlation of their fold changes in ME/ES or 
NE/ES with that in CM+CHIR/CM+XAV were calculated using R. 
 
EMSA 
Pou5f1 and Sox2 cDNA were provided by Dr. Taku Saito (The University of Tokyo Graduate 
School of Medicine, Tokyo, Japan); Tcf7l1 cDNA was obtained from Open Biosytems. Plasmids 
expressing Pou5f1, Sox2, or Tcf7l1 were constructed by cloning each cDNA into pcDNA3.1(-) 
vectors  (Invitrogen,  V795-20).  293T  cells  were  transfected  with  pcDNA3.1(-)-Pou5f1, 	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pcDNA3.1(-)-Sox2,  pcDNA3.1(-)-Tcf7l1,  or  pcDNA3.1(-)  empty  vectors  using  FuGENE  6 
Transfection Reagent (Promega, E2691). Forty-eight hours after transfection, nuclear extracts 
were isolated as described (Dignam et al., 1983). Isolated extracts were then dialyzed with Slide-
A-Lyzer G2 Dialysis Cassette (Pierce Biotechnology, 87717) in dialysis buffer (20 mM HEPES, 
pH  7.9,  20%  glycerol,  100  mM  KCl,  0.83  mM  EDTA,  1.66  mM  DTT)  supplemented  with 
protease inhibitor cocktail (Complete, EDTA-free; Roche, 1873580) for 1 hour at 4 °C. The 
concentration of nuclear extracts was determined by the Qubit fluorometer and Quant-iT Protein 
Assay Kit (Invitrogen, Q33211). 
Probes  were  labeled  using  DIG  Gel  Shift  Kit,  2nd  generation  (Roche,  3353591) 
according to manufacturer’s instruction. Two microgram of nuclear extracts were added to the 
binding mixture containing 12 mM HEPES (pH 7.9), 12% glycerol, 60 mM KCl, 0.5 mM EDTA, 
1  mM  DTT,  1  mg  of  poly  (dG-dC)·poly  (dG-dC)  (Sigma,  P9389),  and  30  fmol  of  the 
digoxigenin  (DIG)-labeled  probe.  Binding  reaction  was  performed  for  15  min  at  room 
temperature.  Competition  assay  was  performed  by  incubating  nuclear  extracts  with  133-fold 
molar  excess  of  unlabeled  probes  for  30  minutes  on  ice  prior  to  binding  reaction.  When 
antibodies  were  used,  nuclear  extracts  were  incubated  with  4  mg  of  anti-Oct-3/4  (sc-9081x, 
Santa Cruz Biotechnology, Inc.), 6 mg of anti-Sox2 (sc-17320x, Santa Cruz Biotechnology, Inc.), 
or 6 mg of anti-TCF3 (sc-8635x, Santa Cruz Biotechnology, Inc.) for 30 minutes on ice prior to 
binding  reaction.  Oligonucleotide  probes  used  are  as  follows:  wild-type  Oct/Sox  motif-
containing probe (OS-WT), 5’-GGCAGATGCATAACAAAGGTGC-3’; OS mutant 1 (OS-M1), 
5’-GGCAGCCCCATAACAAAGGTGC-3’;  OS  mutant  2  (OS-M2),  5’-
GGCAGATGCATAACACCCGTGC-3’;  OS  mutant  3  (OS-M3),  5’-	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GGCAGCCCCATAACACCCGTGC-3’;  LRE-WT,  5’-TTCCCCCTTTGATTCGCGGC-3’; 
LRE mutant (LRE-MT), 5’-GGGCTTCCCCCTTTCGAACGCGGCCCC-3’. 
Binding mixtures were run on pre-run 6% TBE gels (Invitrogen, EC62652BOX) in 0.25x 
tris-borate-EDTA (TBE) buffer at 150 V for 60 min. Gels were transferred onto positive-charged 
nylon membranes (Roche, 1209272) by electro-blotting at 400 mA for 30 minutes in 0.5x TBE 
buffer. After cross-linked at 120 mJ with a transilluminator, DIG-labeled probes were detected 
with  anti-Digoxigenin-AP  (Roche,  1093274)  in  combination  with  CDP-star  (Roche,  T2145) 
according to manufacturer’s instruction. Images were taken with ImageQuant LAS 4000mini 
(GE Healthcare UK Ltd.). 
 
Luciferase reporter assay 
A 117 bp fragment corresponding to the β-catenin peak region 2.1 kb upstream of mouse Pou5f1 
gene was obtained by PCR using Platinum pfx DNA polymerase (Invitrogen) and cloned into 
pBluescript II SK (-) (Stratagene, 212206) at Kpn I and Hind III sites (pBS-Oct::Sox). In the 
PCR, Kpn I-Sal I and Hind III-Xho I sequences were added to 5’ and 3’ ends of the fragment, 
respectively. Cloning of tandem fragments were performed using Sal I and Xho I sites on the 
pBS-Oct::Sox.  The  single  or  triplet  copies  of  fragments  were  then  transferred  into 
pGL4.26[luc2/minP/Hygro] vector (Promega, E844A) at Kpn I and Hind III sites. 
For luciferase reporter assays, cells were plated on 24-well plates and transfected with 0.4 
mg of pGL4 reporter constructs and 8 ng of pGL4.74[hRluc/TK] using FuGENE 6 transfection 
reagent  (Promega,  E2691).  pGL4.74[hRluc/TK]  was  used  for  the  normalization  of  the 
transfection efficiency. Forty-eight hours after transfection, luciferase activities were measured 	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using Dual-Luciferase Reporter Assay System (Promega, E1910) and GloMax 96 Microplate 
Luminometer (Promega). 
 
ChIP-seq data analysis 
The first 25 bp of raw reads were used for mapping against mouse mm9 genome assembly 
(NCBI Build 37). If a read has a unique mapping location (2-mismatch allowed) in the genome, 
we call it a mappable read. If in this sequencing data set, only one read maps to this genomic 
location, we call it a non-redundant read. In peak calling, we compared using input control 
versus  mock  IP  control,  and  no  significant  differences  were  observed.  Peak  detection  was 
performed  using  MACS  software  (Zhang  et  al.,  2008)  with  a  p-value  cutoff  of  1e-5  and 
FDR<0.05 using input controls. Identified peaks were normalized to 400 bp each by extending 
200  bp  upstream  and  downstream  of  peak  summit.  Enrichment  peaks  were  annotated  using 
CisGenome  package  build  37  of  the  mouse  genome,  and  CisGenome  Browser  was  used  to 
visualize  the  peak  signal  (Ji  et  al.,  2008).  Other  published  sets  of  ChIP-seq  data  were 
downloaded from Gene Expression Omnibus (Chen et al., 2008; Creyghton et al., 2010; Han et 
al.,  2010;  Heng  et  al.,  2010;  Ku  et  al.,  2008;  Marson  et  al.,  2008b;  Meissner  et  al.,  2008; 
Mikkelsen et al., 2007). Raw data were processed in the same way as the β-catenin ChIP-seq 
data. Over-represented motif analysis were performed using Cistrome Analysis Pipeline (Liu et 
al., 2011), and motif positional weight matrix mapping to genome coordinates were performed 
by CisGenome package using the default setting of likelihood ratio 500 (Ji et al., 2008). The 
distribution of motifs near peak summit and motif logos were plotted in R. For the matched 
control regions, for each peak in the input, we calculated its distance to the nearest TSS, and 
randomly chose a gene and exacted one matched control region around this gene that had the 	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same distance to that TSS. The p-value for motif enrichment is calculated by a two-proportion z-
test. 
Sequencing depth in Figure 2.3B was evaluated by the method modified from Cao et al 
(Cao et al., 2010). We randomly sampled 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, and 90% 
of total raw reads, and calculated the proportion of background reads (defined as the reads that 
were not within the peaks called under that sequencing depth) that were converted to foreground 
reads (the reads that were within the peaks called under that sequencing depth). If sequencing 
depth is sufficient, we expect that the rate for this conversion will decrease to an asymptote of 
zero  in  the  ideal  case.  Both  replicates  reach  plateau  at  around  80%  total  sequencing  reads, 
indicating enough reads have been sequenced to have sufficient coverage. 
 
Gene and enhancer annotation 
Gene ontology analyses were performed using DAVID (http://david.abcc.ncifcrf.gov/) (Huang et 
al.,  2009a).  The  association  of  genome  regions  with  gene  ontology  terms  was  done  using 
GREAT (version 1.8.2) (http://great.stanford.edu/) (McLean et al., 2010). 
 
Histone modification analysis 
Aggregates plot of histone modifications were performed using Homer (Heinz et al., 2010). 
Genomic regions 3 kb upstream and 3 kb downstream from the peak summit were divided into 
60 100-bp bins each. Error bars indicate standard errors of the means of all the normalized ChIP-
seq fragment densities in the respective bin. Box plot of expression values was drawn in R. 
Statistical significance was calculated by the Wilcoxon rank-sum test. 
 	 ﾠ 97	 ﾠ
Direct target gene prediction 
Direct target genes of β-catenin were predicted by the method described by Tang et al (Tang et 
al., 2011). The FDR was calculated based on a permutation method described in (Breitling et al., 
2004). The scatter plots in Figure 2.7A was generated using R. 
 
Hierarchical clustering, heat map and Venn diagram 
For the hierarchical clustering of 20 factors based on chromatin co-occupancy, peak regions for 
each  factor  with  p-value  <  1e-8  were  trimmed  or  expanded  to  400  bp  centered  at  the  peak 
summit. Pair-wise intersection was performed between every pair of factors to generate a matrix 
of  the  number  of  co-bound  regions.  Complete  linkage,  correlation  distance,  hierarchical 
clustering  was  performed  and  heat  map  generated  using  R.  Peak-peak  intersection  were 
conducted using BEDTools (v2.10.1) (Quinlan and Hall, 2010). Venn diagrams were draw in 
Cistrome analysis pipeline(Liu et al., 2011). 
 
Kohonen Self-organizing map (SOM) 
Kohonen  SOM  was  generated  in  Matlab  using  SOM  Toolbox 
(http://www.cis.hut.fi/somtoolbox/).  Genes  with  expression  fold  change  >  2  in  at  least  one 
comparison  group  of  2i/PD03,  2i/CHIR,  2i/DMSO,  2iLIF/2i,  2iLIF/DMSO,  and 
CM+CHIR/CM+XAV  were  extracted  and  subjected  to  K-means  clustering  (Figure  2.8D), 
individual component analysis (Figure 2.8E), and U-matrix generation (Figure 2.9). 
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Table 2.1!
Loci name Primer-Forward Primer-Reverse Position
T-Up0.1k chr17 8626866 8627266 CTTTGATGGAGGTGCAAACAT ACCCTTTGAAGTACCGAGCAG Upstream
Porcn-Up13k chrX 7796887 7797287 CCTTATCACTGAGAGGAGGAACA AATAACTTGTGGGCAAAGGAGAT Upstream
Cdx4-In5.3k chrX 100521894 100522294 TCTGACATTTGTTTAGGGCTTGT TAAAGTGGGTCCCTAAACTCCAT Intron
Eomes-Up9.8pk1 chr9 118377272 118377672 GAGTGTTCCATCTCTCAAAAGGA GGTAAACAAGGTCTGGGACTAGG Upstream 
Eomes-Up9.8pk2 chr9 118380437 118380837 GCTCCCTAGAGAGGTCTCAGAAT AGGAGCTGAGGCTAAGTGAAACT Upstream
Cdx2-In2.8k chr5 148115783 148116183 AAAACCTTTGCAAACCACTACAA GGGCTGTGTTTATGTTAATGCTC Intron
Klf4-Down57k chr4 55488284 55488684 GAATGAAGTTGTGTGGAGGTCAT ATTCCTAGAAGTGGCCTCAAAAG Downstream
Klf4-Down68k chr4 55477019 55477419 CAGTAAACCATTGTTGTTGACCA TTAAAGGGTACGGAAGAATAGGG Downstream
Klf2-Up2.9k chr8 74834952 74835352 GTCTGAGTCAGCTCTCCAAATGT TCACAGACCTCTCTTGAGACCTT Upstream
Klf2-Down87k chr8 74858115 74858515 CTTGGGAAGAATCTGCACTTAAC GGCATTTCAAAGTCACACTCTTT Downstream
Epha1-Up7.7k chr6 42330763 42331163 AGAAAAGGAGTTTTCTGCGAAGT GAGGAAGAAAAGGAACGCTACAT Upstream
Tead1-In12k chr7 119834629 119835029 CATTTGTGATTGAGACCTGTGAA CTCTTTGTTTCCACATCAAGGAC Intron
Tead1-In9k chr7 119832052 119832452 TTTAAGGGGACAGGACTTTTGTT AACAGCTGACTTCCAAAACTACG Intron
Lin28-Up2k chr4 133576534 133576934 GGTCTTCTGAAGGGAAGAAGAAA GAAAGATGCAAAGCAGGAAAGTA Upstream
Tcfcp2l1-Up2.3k chr1 120522039 120522439 GGTTCATCTGCATATCAGTCCTC AAGTGGATTCTTTTGTCCAAGTG Upstream
Nanog-Up4.7k chr6 122652653 122653053 GCTTCCCTGGATAAGGAATGTAG CCACCATAGCCTTAAGTTTACCC Upstream
Nanog-TSS chr6 122657229 122657629 TTGACCTGAAACTTCCCACTAGA GGACATTGTAATGCAAAAGAAGC TSS
Pou5f1-Up0.9k chr17 35641866 35642266 TATCTCCATCTGAGGCTCTGTCT GGCAGCTCTAACCCTAAACAAGT Upstream
Pou5f1-Up1.9k chr17 35640797 35641197 CCCAGGGAGGTTGAGAGTTC TTGTGGAACAGTGCCATAGG Upstream
Utf1-Down1.8k chr7 147131387 147131787 TCCTCAGGGACTAGAGAGTCAGA GGACTTCCCTTAGCCAAGACTTA Downstream
Lef1-Up4.4k chr3 130808751 130809151 TCCAGGCTTGATTTTTATTTTCA TGTGTGACTAAATTTGGCAAGAA Upstream
Lef1-Up8k chr3 130805157 130805557 GAGGAAGGCCTGAAGTATCTACC AATAAAGCCCTTTGTTTCATGCT Upstream
Msx2-Down11.2k chr13 53556747 53557147 TAAAGAAAGTAGGGAGGCTTGCT AGAAATCCACACAGCTCAAGAAG Downstream
Sp5 (TSS) chr2 70312855 70313150 CCTCAGTGTGAGGATGCAGA GGCAGTGCTCAAAGTGACAA TSS
Axin2 (TSS) chr11 108466633 108466948 GTGCGCCAGCGGATCAATGGTGAGT AATAGCCGGCCTGCCAACTTCAAAG TSS
Id3-Down3.1k chr4 135702721 135702964 AGTGGAGCAAGCCGCTTCTCTCTG CTCAGAGGTTTCTGACCTAGGGCTAAAG Downstream
Tbx3-In9.3k chr5 120129896 120130187 AGTACTCCAGCAGAGTTCTGAGGTCACG TCCCAGACTTCATTTTCCCAGTCTG Intron
Sox2-Up20k chr3 34567416 34567728 CACTCCTAGACTGTTCCCCTCC ACATATTGAGCTATCTCTCCTGGGAAG Upstream
Rif1-Up0.5k chr2 51927635 51927912 TGGGGTCCAATGGAAGTAAA TAACAAAGGCCTGGAAATGG Upstream
control* chr2 121973115 121973242 TCAGGTCCTAAGTCCTTTTCTGAGTGG TGGACCCTTGGTGCCCTACTATCTAG
*Nature. 2006 Nov 16;444(7117):364-8.
Peak Genomic Coordinates
Table-2.1: Sequences for ChIP-qPCR primers and genomic coordinates for peaks tested.	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Genome-wide study of Shh-directed neural patterning in mouse ventral neural tube 
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Abstract 
In the developing vertebrate neural tube, Sonic Hedgehog (Shh) signaling acts in a time- 
and  concentration-dependent  manner  to  activate  position-specific  ventral  programs  of 
neural progenitor specification. Gli proteins are transcriptional regulators that act at the 
interface between Shh signaling and its gene targets to specify six different ventral cell 
populations. Subsequently, these populations are further refined and sharpened via cross-
repression by ventral cell determinants. This study seeks to understand how dynamic Shh 
signaling governs a complex patterning response by focusing on the Gli factors, the pan-
neural  factor  Sox2  and  their  transcriptional  targets.  We  highlight  Sox2  as  an  early 
delineator of the neural lineage by switching on Shh-responsive ventral neural patterning 
together with Gli1. Furthermore, by assessing in silico DNA binding specificity of different 
Olig2  dimer  species,  we  also  propose  a  model  that  describes  how  Olig2  mediates 
specification  of  oligodendrocytes  progenitor  cell  fate  from  motor  neuron  progenitors 
mediated by Olig2. 
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Introduction 
Pan-neural factor Sox2 and neural priming 
The secreted signaling molecule Sonic hedgehog (Shh), a member of the Hh family, is a long-
range morphogen that patterns many embryonic structures including the VNT, limb bud and 
somites  (Ingham  and  McMahon,  2001)(Figure  1.1C).  How  this  broadly  utilized  signaling 
pathway mediates tissue-specific regulatory responses is a general question of interest. 
Recent  studies  have  started  to  address  specific  outcomes  through  broadly  utilized 
signaling processes. A cell-type specific response may be established by promoting chromatin-
remodeling  activities  that  enable  cell-type  specific  access  to  a  transcriptional  component 
regulated by a given pathway. The Zon and Young groups’ work （2011）has demonstrated that 
a master TF defines lineage-specific target genes, and the action of this factor is followed by 
binding  of  transcriptional  effectors  of  specific  signaling  pathways  (Mullen  et  al.,  2011; 
Trompouki et al., 2011). Similarly, Fox factors are known to modify local epigenetic status to 
generate TF accessible sites. Cell-type specific response can also be established via a passive 
mechanism, in which a TF can prevent nucleosome repositioning and serve as a placeholder to 
facilitate the binding of a second TF. In both mechanisms, the action of the first regulatory factor 
determines the subset of target sites in the genome that can be bound by the second TF. The 
action of both factors is required to activate a given regulatory program in target cells. 
Shh morphogen signaling establishes an activity gradient of the Gli family of TFs along 
the dorsal-ventral (D-V) axis of the VNT. Gli factor binding to DNA dictates the transcriptional 
response to Shh signaling. As elaborated above, the neural-specific response to Shh signaling 
could result from differential accessibility of Gli factors to cell-type specific enhancers. However, 
previous work from the McMahon lab on the Gli3 directed GRN in mammalian limb patterning 	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 ﾠ
showed that almost all verified neural, cis-regulatory elements are bound by Gli3 which acts 
largely to silence Hedgehog target genes. However, when Gli3 is removed neural targets are not 
inappropriately activated within the limb. These results argue for context specific inputs acting in 
conjunction with Gli factors. In the context of the developing CNS, general neural identity genes 
may act in concert with Gli factors to ensure an appropriate cell type specific response to Shh. 
Of  the  three  classes  of  transcriptional  activators  that  are  broadly  expressed  in  early 
neuronal cells, Pax, Pou, and Sox, only Sox family factors are expressed prior to Shh signaling 
activation (Peterson et al., 2012; Scotting and Rex, 1996). Furthermore, expression of a Sox-
engrailed repressor fusion leads to a loss of neural identity consistent with Sox genes playing a 
critical early role in neural identity (Kishi et al., 2000). Within the Sox family, SoxB1 proteins 
(Sox1, Sox2, and Sox3) are expressed in most neural progenitors. Sox2 is present within neural 
cells prior to Shh signaling, while Sox1 is activated in conjunction with Shh signaling, and Sox3 
is expressed in neural precursor cells (Bergsland et al., 2011). Sox2 level has been shown to 
modulate  neural  ectodermal  differentiation  over  mes-endoderm  differentiation  with  opposing 
roles to Oct4 during ESC early differentiation (Thomson et al., 2011). Sox2 is therefore the most 
likely pioneer Sox factor to mediate the initial neural specific response to Shh signaling in the 
NT. 
 
bHLH Protein Olig2 and differentiation of pMN into motor neuron and oligodendrocytes 
progenitors 
In  the  VNT,  most  cell  type  determinants  are  repressors,  raising  the  question  of  how  Olig2 
repressor activity specifies a MN progenitor state that when Olig2 activity is removed, cells then 
differentiate  into  MN  or  OLP.  In  addition,  by  over-expressing  Pax6,  Olig2,  or  Nkx2.2  and 	 ﾠ 111	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examining the faction of differentiated cells within the population, Sugimori et al. (2007) showed 
that these patterning factors can bias certain fates, but in general cannot promote differentiation 
(Sugimori et al., 2007). To examine these issues, I have focused on Olig2--a key regulator of 
motor neuron (MN) and oligodendrocytes progenitor (OLP) fate specification which arise at 
different times from a shared progenitor pool. 
The  bHLH  TF  Olig2  was  first  discovered  to  have  a  deterministic  role  in  OLP 
specification (Zhou et al., 2001; Zhou et al., 2000), but later was found to have an earlier role in 
MN precursor generation (Lu et al., 2002; Nieto et al., 2001; Zhou and Anderson, 2002). Olig2 
expression is restricted to MN progenitors in the ventricular zone of the early VNT. Later in 
development, Olig2-expressing cells encompassing the early MN progenitor domain switch to 
the production of OLP (Sugimori et al., 2007; Zhou and Anderson, 2002). Thus, the pMN Olig2 
population undergoes sequential programs of neurogenesis and gliogenesis, which generate all of 
the MNs and ~80% of the OLPs in mouse spinal cord (Li et al., 2011). The pMN domain is 
bounded ventrally by an Nkx2.2-expressing pV3 interneuron progenitor domain and dorsally by 
an Irx3-expressing pV2 interneuron progenitor domain. Repression by Nkx2.2 and Irx3 is critical 
for  delimiting  the  Olig2  domain.  In  mouse  embryos  lacking  both  Olig1  and  Olig2,  two 
structurally and functionally similarly bHLH family proteins, both MN and OLP differentiation 
are largely eliminated (Lu et al., 2002; Zhou and Anderson, 2002). The animals also exhibited 
ventral expansion of the pV2 domain and a switch of cell fate from MN to pV2 interneurons and 
astrocytes. 
Where it has been best studied in MN specification, Olig2 functions as a transcriptional 
repressor (Mizuguchi et al., 2001; Novitch et al., 2001). An EnR-Olig2 fusion construct in which 
the engrailed repressor domain was fused to the DNA binding bHLH domain of Olig2 mimicked 	 ﾠ 112	 ﾠ
the  patterning  activities  of  the  full-length  Olig2,  and  induced  ectopic  MN  generation  on 
electroporation in the chick spinal cord. Conversely, expression of an Olig2 fusion construct with 
the transcriptional activation domain of the viral protein herpes simplex virus protein 16 (Olig2-
VP16) reduced MN generation (Mizuguchi et al., 2001; Novitch et al., 2001). 
Olig2 functions alongside other bHLH factors to determine the initiation of neurogenesis, 
neuronal subtype specification, and the MN-to-OLP switch (Li et al., 2011). These factors are 
divided into two major groups: proneural TFs that promote terminal differentiation, and anti-
neuronal TFs that promote progenitor fate maintenance (Castro et al., 2006; Nieto et al., 2001; 
Zhou et al., 2000) based on there cellular activities; the timing of neurogenesis is determined by 
proneural and anti-neuronal bHLH proteins. bHLH proteins can also be classified as repressor or 
activator type according to their transcriptional activity. Hes family factors contribute to the 
repressor-type represented and Ascl1, Math, and Neurogenin to the activator-type. 
For example, Neurog2 (Neurogenin2) and Ascl1 (achaete-scute complex homolog-1) are 
two major proneural bHLH proteins expressed in progenitor cells in the ventral ventricular zone 
with  distinct  temporal  features.  Expression  of  Neurog2  correlates  with  neurogenesis,  during 
which it partly overlaps with Olig2 expression and is turned off before oligodendrogenesis. In 
contrast, Ascl1 is co-expressed with Olig2 in pMN from the beginning of OLP generation, after 
Neurog2 expression is lost. The fact that Neurog2:Ascl1 double-mutant mice exhibit a reduction 
of neurogenesis and a premature generation of astrocytic precursors with a comprise in OLPs 
suggests a critical role of Neurog2 and Ascl1 in neurogenesis and oligodendrogenesis (Nieto et 
al., 2001). In contrast, in mice deficient for Hes1 or Hes5, an anti-neuronal bHLH family under 
Notch  pathway,  premature  neural  differentiation  occurs  (Kageyama  and  Nakanishi,  1997; 
Kageyama and Ohtsuka, 1999; Kageyama et al., 2008). Other studies have suggested synergistic 	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or antagonistic roles of proneural proteins and Olig2 in neuronal subtype specification using 
chick electroporation or in vitro biochemical assay (Lee et al., 2005). However, these studies are 
mostly  restricted  to  analysis  of  individual  genes,  and  are  inadequate  to  formulate  a  general 
mechanism for the regulation by proneural factors, and Olig2 in cell fate specification programs. 
bHLH  proteins  also  have  unique  DNA  sequence  specificity.  bHLH  proteins  bind  to 
chromatin as either hetero- or homodimers. The consensus sequence is CANNTG (Murre et al., 
1989). Within the bHLH factors, different family has slightly different preference to the center 
two nucleotides or a modified E-box six-mer. For example, Hes factors have a higher affinity to 
CACNAG consensus than to E-box consensus. Altering dimerization partners has been proposed 
as a mechanism underlying tissue-specific cell fate determination by Olig2 (Li et al., 2011). 
Neurog2  has  been  shown  to  form  a  heterodimer  with  Olig2  during  MN  differentiation 
(Mizuguchi et al., 2001; Novitch et al., 2001). Li et al. (2011) proposed that a phosphorylated 
Olig2 monomer could form homodimers and repress OLP gene expression, while heterodimers 
with E47 activate MN specific gene expression. Later in development, Olig2 is dephosphorylated 
and interacts with different co-activator bHLH factors to direct OLP specific gene expression. 
E47 has been shown to interact with Olig2 to directly activate the Sox10-U2 promoter in the 
oligodendrocytes lineage (Kuspert et al., 2011). Interestingly, Nkx2.2 has also been proposed as 
a potential dimerization partner of Olig2 during OLP lineage specification (Sun et al., 2003), 
when their expression domains overlap during OLP differentiation (Zhou et al., 2001). 
While these studies have provided a solid foundation for understanding the role of Olig2 
in MN-OLP fate determination, their focus on extrapolating insights from single genomic loci 
begs the question of the generality of these regulatory modalities. 	 ﾠ 114	 ﾠ
In this study, we showed that Sox2 is a context-specific determinant of the Shh response 
in the NT. We found that assessing genomic footprints of both Sox2 and Gli1 allows for the 
identification of Shh responsive ventral determinants in the neural context. We proposed the role 
of Sox2 in transcriptional regulation of Shh target genes by promoting chromatin remodeling that 
enhances promoter accessibility. In addition, to understand the regulatory mechanisms employed 
by repressors, we computationally explored the binding specificity of Nkx2.2, Olig2, and Nkx6.1. 
We found that these factors interact directly with the DNA and share a common set of cis-
elements in many cases. Furthermore, their expression patterns overlap extensively with that of 
Sox2, suggesting the possibility for generating active input for the repressor cis-elements. Lastly, 
we propose that in pMN cell differentiation, Olig2 directs different cell fates by forming various 
dimer species with distinct chromatin-binding properties. 
 
Results 
Gli1  and  Sox2  chromatin  co-binding  in  neural  progenitors  denote  actively  transcribed 
genes with Shh responsiveness 
Specification of Shh-dependent neural progenitor populations within the VNT occurs in a time- 
and dosage-dependent manner (Fig. 1.1C). To further elucidate the transcriptional regulatory 
program downstream from Shh signaling in neural progenitors, we used an in vitro model of 
Shh-dependent patterning (Fig. 1.1D)(Wichterle et al., 2002). 
Shh pathway activation was achieved by exposing in vitro-derived neural progenitors to 
Smo agonist (SAG), a small molecule that acts as a potent activator of the pathway (Chen et al., 
2002). Immunofluorescence characterization of SAG-treated neural progenitors highlighted both 
the time- and concentration-dependent responses of Class II target genes (Figure 3.1A). Probably 	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one of the biggest concerns regarding the usage of in vitro differentiation system to study in vivo 
neuronal development is the similarity between the two. We compared the temporal progression 
of Shh-dependent cell-types in vivo to those observed in an in vitro model of Shh patterning. 
SAG-dependent induction of Class II Shh targets closely followed the in vivo time-course of 
neutral patterning: Foxa2 was detected at 24h, Olig2 and Nkx6.1 at 36h, and Nkx2.2 at 48h 
(Figure  3.1B).  Overall,  we  see  a  similar  feature  in  the  pattern  of  target  gene  activation  via 
immunofluorescence, although we do notice that the in vitro response is much slower in general. 
In addition, several of the identified cis-regulatory elements from the in vitro system have been 
verified by G0 transgenic assay for enhancer elements. Our analysis has focused on a one time-
point after SAG treatment, which is chosen to maximize the diversity of Shh-dependent cell 
types. 
Genome-wide  location  analysis  of  Gli1  DNA  association  in  ESC-derived  neural 
progenitors  was  performed  using  a  Gli1Flag  transgene  (Vokes  et  al.,  2007).  We  defined  a 
prioritized  set  of  841  enriched  Gli1-binding  regions  (GBRs)  by  intersecting  ChIP-seq  data 
independently verified in biological replicates (false discovery rate [FDR] = 0.01; CisGenome 
peak calling algorithm) (Figure 3.1C-G: Gli1 peaks in genome browser) (Ji et al., 2008). A small 
number of developmental signals including Shh are utilized in multiple tissue types but their 
action in each tissue triggers tissue context-dependent GRNs. So this raised the question that 
how neural-specific Shh responses are initiated without activating Shh responses in other tissues? 
We  hypothesize  that  transcriptional  activators  that  are  expressed  prior  to  Shh  signaling  in 
neuronal cells might serve to prime a neural-specific responses. Recent studies have shown that 
SoxB1 family TF Sox2 is expressed within neural cells prior to Shh signaling (Bergsland et al., 
2011), while other neuron expressed transcription activators are expressed after Shh signaling 	 ﾠ 116	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Figure 3.1 (Continued) 
The use of in vitro differentiation system for neural patterning studies. 
(A) Immunofluorescence characterization of key neural markers in E8.5 neural tube. Scale 
bar: 20µm. 
(B) Time-dependent emergence of ventral cell populations in neural embryoid bodies (NEBs) 
treated with retinoic acid (RA) and Hh pathway agonist (SAG). Scale bar: 50µm. 
(C) –(G) CisGenome browser demonstration of Sox2 and Gli1 common regulatory elements 
in neural progenitors. Gli1 (replicate A, purple) and Sox2 (red) ChIP-seq signal is shown. 
Blue underline denotes Gli1 binding signal that passed peak detection threshold with relative 
distance to TSS shown below. 	 ﾠ 118	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activation. Sox2 is therefore the most likely pioneer Sox factor to mediate the initial neural 
specific response to Shh signaling in the NT. To examine the potential regulatory role for SoxB1 
family input to Gli1-bound CRMs, we performed Sox2 ChIP-seq analysis in neural progenitors. 
All the data on chromatin were collected from ES cell generated neural responses. Thus, features 
of the chromatin status may reflect in vitro generated or ES cell-derived signatures. To exclude 
noise from ESC signature, I integrated Sox2 ChIP-seq from mESC (Marson et al., 2008). I 
intersected ChIP-seq data of Gli1 in neural derivatives with that of Sox2 in neural derivatives 
and  excluded  Sox2  peaks  in  mESCs,  and  ~12%  of  GBRs  overlap  specifically  with  neural-
associated Sox2-bound regions (p-value <1.3e-50, Fisher Exact test), with only a small number 
of these also bound by Sox2 in ESCs (Figure 3.2A). 
To  assess  how  Sox2  binding  influences  Gli1-bound  CRM  activity,  we  examined  the 
chromatin state of GBRs using H3K4me2 as a general mark for enhancers and H3K27ac for 
active  enhancers  (Barski  et  al.,  2007;  Creyghton  et  al.,  2010;  Roh  et  al.,  2006).  ChIP-seq 
profiling of H3K4me2 and H3K27ac at GBRs associated with Sox2N (Sox2 binding in NEB, 
abbrev: Sox2N) showed higher H3K4me2 levels than those observed in their non-Sox2N bound 
counterparts  suggesting  that  Sox2  binding  enhances  activity  of  Gli-mediated  CRMs  (Figure 
3.2B-O). Specifically, regions bound by Gli1 but not Sox2N (Gli1+ Sox2N-) showed moderate 
levels of H3K4me2 and H3K27ac independent of Shh pathway stimulation (Figure 3.2C, F, I, M). 
Regions  bound  by  Sox2N  but  not  Gli1  (Gli1-  Sox2N+)  showed  significant  levels  for  both 
H3K4me2 and H3K27ac marks in a largely Shh-independent manner (Figure 3.2B, E, J, N). On 
the other hand, regions bound by both Gli1 and Sox2N (Gli1+ Sox2N+) showed overall high 
levels  of  H3K4me2  and  H3K27ac  signals  that  were  further  enhanced  upon  Shh  pathway 
activation (Figure 3.2H, L, K, O). Meta-site analysis of H3K4me2 and H3K27ac profiles   	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Figure 3.2 (Continued) 
Sox2 binding might prime cis-regulatory elements by opening up chromatin structure 
prior to repressor binding. 
(A) Venn diagram of Sox2 ESC, Sox2 NEB, and Gli1 NEB binding data. 
(B)-(O) Summary of histone modifications (H3K4me2 and H3K27ac) corresponding different 
portions of the Venn diagram. In our in vitro neural progenitor derivation protocol (Figure 
3.1x),  ESCs  are  first  cultured  in  suspension  for  two  days  before  three  days  of  neural 
induction. t=0 (green) is defined as the beginning and t=72h the end of the induction. RA 
(red) and RA/SAG (black) induction was performed in parallel. 
(P)  GO  Biological  Process  analysis  of  the  four  types  of  Gli1  NEB  binding  regions  by 
GREAT. 
(Q) Normalized FPKM values from RNA-seq are shown as box plots across the conditions. 
(R)  Mutation  analysis  of  cis-elements  near  Nkx6.1  (+540kb)  (top)  and  Nkx2.2  (-2kb) 
(bottom) indicate the necessity of Sox2 in enhancer activities. Scale bar: 50µm. 
(S) Percentage of computationally predicted Gli sites at Sox2 sites that are occupied by Gli1. 
Two criteria are used: likelihood ratio (LR) = 500, and LR=500 plus phastcons conservation 
score = 40. 	 ﾠ 122	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highlighted a characteristic dip positioned at the Sox2-binding peak center that was absent from 
regions bound by Gli1 alone, suggesting nucleosome displacement by Sox2 but not Gli1 (Figure 
3.2B–O). In addition, from Gene Ontology (GO) analysis of peak associated genes, we found 
peaks co-bound by Gli1 and Sox2N are significantly more enriched for neural development 
categories, whereas those Gli1 bound sites that do not intersect with Sox2 in NEB are not as 
strongly enriched for neural development, but are enriched for other developmental processes 
(Figure  3.2P).  This  set  of  neural-specific  co-bound  regions  correlated  with  differential  gene 
expression. The largest increase in mean FPKM (fragments per kilo base per million reads) 
values from RNA-seq data were observed for genes near peaks with both Sox2 and Gli1 present 
(Figure 3.2Q). Comparison of GBRs to Sox2 bound regions highlighted a specific intersection 
with neural targets, most notably, Class II targets (Foxa2, Nkx2.2, Nkx2.9, Olig2, Nkx6.1, and 
Nkx6.2) (Figure 3.1C-G). Interestingly, this set of targets bound by Gli1 and Sox2 in neural 
progenitors was distinct from the set of regions bound by Sox2 in ESC. Only a limited overlap 
was observed between Sox2 binding regions in ESCs and neural progenitors, in agreement with a 
recent report (Bergsland et al., 2011). These findings highlight potential interactions between 
Sox2 and Gli1 where Sox2 may help to confer neural specificity to the Shh/Gli response. 
 
Sox2 priming might be necessary for Gli1 binding in Class II gene cis-element prior to Shh 
responsiveness 
Recent studies indicate that Sox2 activity is the earliest determinant of neural identity (Thomson 
et al., 2011), Sox2 expression precedes the Shh response in vivo (Figure 3.1A), and Sox activity 
is required to maintain a neural progenitor state (Bylund et al., 2003). In addition to temporal 
precedence of Sox2 expression to Shh responsiveness, Sox2 binding sites were also required for 	 ﾠ 123	 ﾠ
the activities for Gli-mediated CRM (Figure 3.2R). Mutations predicted to prevent Sox2 binding 
in the Nkx6.1 element (+540kb) and Nkx2.2 element (-2kb) resulted in the silencing of reporter 
activity in 9 out of 10 and all transgenic embryos, respectively. Given previous evidence of Gli-
dependent activity from Gli-directed mutagenesis (Lei et al., 2006), neither Sox2 nor Gli
A input 
alone is sufficient to activate the Nkx2.2 CRM. Thus these results suggest that both Sox2 and 
Gli1 are required for Gli-mediated Shh responsiveness. 
Since  only  ~12%  of  GBRs  overlap  specifically  with  neural-associated  Sox2-bound 
regions, Sox2 is not required for the majority of Gli1 binding. However, the question is whether 
Sox2 binding and Gli1 motif are sufficient for Gli1 binding, especially for GBRs near Class II 
determinants. If so, we expect to see Gli factor occupies a significant number of Gli motif sites in 
Sox2 binding peaks. We observed that close to 25% of Sox2 NEB peaks with Gli motif are 
bound by Gli1 (Figure 3.2S, Sox2N+Gli+SoxE- and Sox2N+Gli+SoxE+), while for Sox2 NEB 
peaks  without  Gli1  binding,  the  percentage  of  Gli  sites  drop  to  less  than  5%  (Figure  3.2S, 
Sox2N+Gli-SoxE+ and Sox2N+Gli-SoxE-). This suggests that either additional factors might be 
required for this set of Gli1 binding or Gli1 can bind to deviant Gli motif in the presence of Sox2, 
but Gli1 preferably interacts with DNA via direct binding. Together with the open chromatin 
histone signature at Sox2/Gli1 binding sites and the temporal precedence of Sox2 expression to 
Shh responsiveness, the result suggests that Sox2 might serve to enable Gli1 binding by opening 
up the chromatin structure, but additional factors remain to be found out that ensure Gli1 binding. 
 
Nkx6.1, Nkx2.2 and Olig2 share a common set of target binding regions 
In the VNT, Shh induces a group of transcriptional repressors (Class II target genes) to specify 
neural progenitor subtypes. Unraveling the regulatory actions of these repressors is an important 
problem. Nkx2.2 and Olig2 mark two of the most ventral progenitor populations, pV3 and pMN, 	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respectively, while Nkx6.1 is present in both these progenitor pools, in the ventral medial floor 
plate adjacent to the pV3 domain, and in more dorsal pV2 progenitor adjacent to the pMN 
population. (Figure 1.1B). Each is a direct target of Shh signaling, and Olig2 and Nkx2.2 are 
both necessary and sufficient for specification of their progenitor type. 
As  a  first  step  we  performed  ChIP-seq  on  SAG-treated  neuralized  embryoid  bodies 
following 72h of SAG treatment as before. Using CisGenome algorithm with FDR=0.01 and 
two-sample peak calling with input as controls, we identified 11747, 5551, and 4094, Olig2, 
Nkx2.2 and Nkx6.1 genomic binding peaks, respectively (Figure 3.3A). GO analysis of binding 
sites  showed  that  each  of  these  is  highly  enriched  for  TF  genes  and  neural  development 
regulators (Figure 3.3B). This is consistent with their roles in neural development and their 
action in progenitors at an early point in regulatory events that ultimately result in appropriate 
neural diversity and functional circuitry. 
Because Nkx6.1 is co-expressed with Nkx2.2 and Olig2, and Nkx2.2 and Olig2 have 
mutually  antagonistic  properties,  we  intersected  their  binding  sites  to  identify  common  and 
unique targets (Figure 3.3C). I saw significant overlap among the binding regions for the three 
factors, which indicates that a common set of cis-regulatory elements are employed and a core 
set of common target genes are co-regulated by different ventral determinants. The overlapping 
binding peaks might come from the same cells and be due to physically interaction between 
Nkx6.1  with  Olig2  or  Nkx6.1  with  Nkx2.2.  However,  since  Nkx2.2  and  Olig2  are  not  co- 
expressed, Nkx2.2 and Olig2 binding at common cis-elements must come from different cells in 
the population, rather than co-binding. In either case, the characterization of the target genes will 
shed light on the functional significance of the co-regulation. 
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ChIP  Input 
Alignable  nrReads  Alignable  nrReads  Peaks 
Nkx2-2  12,610,255  2,533,527  18,750,935 12,945,234  5,551 
Nkx6-1  11,915,999  9,947,294  13,004,887 12,625,556  4,094 
Olig2  10,592,204  7,018,928  14,464,709 12,538,261  11,747 
A 
Nkx6.1 
Olig2  Nkx2.2 
691 
706 
391  1379 
3073 
3763  8971 
4094 
5,551  11,747 
C
Genes  Peak Distance to TSS 
progenitor determinants 
Nkx2-9   (-1,594) 
Foxa2   (+170,290),  (+216,220) 
Nkx6-1 
 (+74,028),  (+126,777),  
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Figure 3.3 (Continued) 
Nkx2.2,  Olig2,  and  Nkx6.1  ChIP-seq  reveals  ventral  progenitor  cell  maintenance  by 
preventing alternative progenitor cell fates and post-mitotic cell differentiation. 
(A) Summary statistics of ChIP-seq from and peak calling by CisGenome using FDR<0.01. 
(B) GO analysis of Olig2, Nkx2.2, and Nkx6.1 peaks and top enriched terms are presented. 
(C) 3-way  Venn  diagram  shows  significant  overlap  of  binding  regions  among  the  three 
factors. 
(D) Representative genes regulated by Nkx2.2/Olig2/Nkx6.1 from GREAT. 
(E) –(H) CisGenome Browser example of the four types of target genes showing common 
cis-element of Nkx2.2, Olig2, and Nkx6.1. Common cis-elements are highlighted by light 
blue squares. 	 ﾠ 127	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Therefore  I  did  a  GO  analysis  of  the  Nkx2.2+Olig2+Nkx6.1+  peaks  using  GREAT 
(McLean et al., 2010), and pooled out representative genes within the top enriched GO terms 
(Figure 3.3D). Firstly, repressors cross-repress Class-II ventral cell determinants, such as Foxa2, 
Nkx2.9, Nkx6.1 (Figure 3.3E). TF Binding near determinants not expressed in the same domain 
might  suggest  the  cross-repression  mechanism  to  prevent  alternative  cell  fate,  such  as  the 
repression of pMN fate by Nkx2.2 binding in pV3 progenitor cells. However, for binding near 
genes expressed in the same domain, such as Nkx2.2 binding near Nxk2.9 and Nkx6.1, the 
specific outcome remains to be determined, and one potential reason is to fine-tune expression 
level of the other. Secondly, repressors binding near Class-I dorsal progenitor cell markers, such 
as Irx3, Pax3, Pax7, and Pax6, might serve to inhibit dorsal program (Figure 3.3F). Thirdly, 
repressors also co-regulate neuronal subtype cell determinants, such as Isl1, Evx1, Tlx3, Foxd3, 
Phox2b, and Vsx1/2 (Figure 3.3G). This might contribute to the maintenance of progenitor cell 
state  by  preventing  post-mitotic  differentiation.  Alternatively,  this  could  represent  direct 
exclusion of other cell fate programs by repressing all other possible neural identity determinants. 
Fourthly, repressors also bind to Hh signaling pathway components, such as Hhip, Ptch1, Boc, 
Gas1, and Gli2. For example, Hhip encodes a highly conserved, vertebrate-specific inhibitor of 
Hh signaling. The observation that ventral repressors interact with a cis-element 3.6kb upstream 
of Hhip promoter suggests a potential feedback loop and fine-tuning of Hh responses (Figure 
3.3H).  Therefore,  Nkx2.2,  Olig2  and  Nkx6.1  are  engaged  in  a  broad  spectrum  of  repressor 
activities by direct chromatin interaction with a common set of cis-regulatory elements, possibly 
by preventing alternative progenitor cell fates and post-mitotic differentiation to maintain their 
corresponding progenitor cell types. 
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Active enhancer signature characterizing Olig2 NEB binding regions 
Because ventral determinants Nkx2.2, Olig2 and Nkx6.1 are all repressors, we are surprised to 
identify H3K4me2 +H3K27ac+ active chromatin signatures at the cis-elements. For example, in 
comparison with the matched control regions, we observed H3K4me2 and H3K27ac enrichment 
near Olig2 peak center (Figure 3.4A-B). The dip of H3K27ac signature in the center of Olig2 
binding sites represents the displacement of histone modifications by TF binding. One caution in 
interpreting the data is that NEB is a mixed population of cells from all ventral cell progenitors, 
and thus the histone modification profiles will be an averaged signature, while in comparison, 
Olig2 peaks will be profiles only from pMN cells. Note that a significant contribution of the 
active signature might come from Sox2 from the extensive intersection of Sox2 with Olig2 in 
neural progenitors (Figure 3.4C). In summary, this result suggests that there is significant active 
input at Olig2 binding regions, and it is likely coming from activators other than Sox2. 
 The first candidate we tested was Sox2, which utilizes lots of common cis-elements with 
Olig2 (Figure 3.4C). An even stronger enrichment of active histone signatures were observed 
when we compare Olig2+Sox2+ peaks with Olig2+Sox2- peaks, although Olig2+Sox2- peaks 
also show a low level of H3K4me2 and H3K27ac (Figure 3.4D). Thus Sox2 activator input is 
likely to account for at least partially the active histone signatures in Olig2 binding regions. 
However, it is unlikely to be the source for maintaining mitotically active progenitor, because 
Sox2 expression is present within neural cells prior to Shh signaling and is gradually turned 
down with differentiation. Indeed, from GO analysis of Olig2+Sox2+ versus Olig2+Sox2- peaks 
(Figure 3.4E-F), we noticed that Olig2+Sox2+ regions seem to regulate genes expressed at an 	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Figure 3.4 (Continued) 
Active enhancer signature characterizing Olig2 NEB binding regions. 
(A) Olig2 binding regions in NEB show the bimodal profile of H3K27ac and an enrichment 
of H3K4me2 during in vitro differentiation. Shh responsiveness is also demonstrated by 
higher active enhancer signature under SAG induction. 
(B) Matched control regions fail to show such enrichment. 
(C) Venn diagram intersection of Olig2 with Sox2 binding regions show that a significant 
part of the active input might come from Sox2. 
(D) Olig2+Sox2+ regions indeed have stronger active enhancer signature. Left: Olig2+Sox2- 
regions; right: Olig2+Sox2+ regions. 
(E) GREAT analysis of different types of Olig2 peaks showing that Olig2+Sox2+ co-binding 
peaks regulate genes earlier in development than targets of Olig2+Sox2- type of peaks. 	 ﾠ 131	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earlier stage than Olig2+Sox2- target genes, with the latter regulating genes more differentiated 
in a specific neuronal lineage. Thus in identifying TFs that promote pMN transition into MN and 
OLP cell types, although Sox2 provides a significant active input to a portion of Olig2 binding 
peaks, it is likely to serve an earlier stage rather than directing a more differentiated cell fate, and 
there  are  other  sources  of  active  inputs  that  specifies  neuronal  subtype  identities.  For  the 
different scenarios of Sox2 and Olig2 binding, see Figure 3.5. Other SoxB1 family members that 
function at a later stage, such as Sox21, promotes neurogenesis as a repressor (Sandberg et al., 
2005), and is thus not our candidate. 
	 ﾠ
E-box motif variants are differentially preferred by Olig2 in NEB 
In searching for TFs that contribute active input to promote pMN differentiation in Olig2 cis-
regulatory elements, I utilized de novo motif discovery and TF DNA recognition site specificity 
to  identify  potential  candidates.  Recent  establishment  of  various  motif  databases,  such  as 
TFANSFAC, UniProbe, and Jaspar have greatly enhanced our knowledge of DNA recognition 
motifs for various DBD families. Meanwhile, the identification of collaborating TFs based on 
motif analyses is highlighted in various studies (He et al., 2010; Mullen et al., 2011; Trompouki 
et al., 2011). The assumption is that motif analysis in Olig2 peak regions will unveil potential 
collaborating TFs that help promote pMN differentiation, and different Olig2 co-factors might be 
associated with MN or OLP cell fates. 
bHLH  family  factors  recognize  a  CANNTG  E-box  motif  and  bind  to  DNA  via 
heterodimers or homodimers. DNA binding motif preferences have been shown to be distinct for 
different bHLH factors and dimer species (Cao et al., 2010; Fong et al., 2012). In order to 
explore the Olig2-mediated dimer species that promote pMN differentiation to MN and OLP, we  	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Figure 3.5 (Continued) 
CisGenome browser examples showing the combinatorial binding patterns of Olig2 and 
Sox2. 
(A) Active enhancer signature of Olig2 binding with Sox2 binding. 
(B) Active enhancer signature of Olig2 without Sox2 binding. 
(C) Closed chromatin signature of Olig2 with Sox2 binding. 
(D) Closed chromatin signature of Olig2 without Sox2 binding. 
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set out to investigate the E-box 6mer motif that is preferred by Olig2 using ChIP-seq data and 
protein  binding  microarray  (PBM).  ChIP-seq  will  reflect  Olig2  sequence  preference  in 
physiological state, while PBM will be in vitro biochemical preference site for Olig2 homodimer 
only. 
In NEB, we noticed an enrichment of some of the ten theoretically possible 6mer variants 
in comparison when compared with those predicted in the genome (Figure 3.6A). In particular, 
CAGCTG and especially CATCTG show the strongest enrichment, 1.33 fold and 2.57 fold, 
respectively, over genomic background. If we plot distribution of the different motif variants 
around Olig2 peak center in NEB, we further discovered CATATG motif being centered near 
Olig2  peak  center,  in  addition  to  CAGCTG  and  CATCTG  (Figure  3.6B).  The  centered 
distribution  of  motif  variants  near  Olig2  peak  center  is  strong  evidence  that  these  DNA 
sequences  are  preferably  bound  by  Olig2  in  a  non-random  manner.  Interestingly,  the  PBM 
recovered  Olig2  motif  is  significantly  different  from  that  recovered  from  ChIP-seq  (Figure 
3.6C):  the  PBM  motif  has  a  consensus  CATATG,  while  ChIP-seq  motif  has  a  consensus 
CAT(G)C(A)TG. Considering the dyad-symmetry of the former versus latter motif, and that 
Olig2 homodimers bind the former in PBM studies, the collective data suggest the ChIP-seq data 
is a mix of homo- and heterodimeric Olig2 containing bHLH complexes. 
We separated Olig2 NEB peaks depending on the E-box motif variants’ presence within 
50bp from peak center. CATATG-containing peaks have a higher rank out of all Olig2 peaks, 
pointing  to  a  potential  higher  affinity  of  Olig2  dimer  to  CATATG  6mer  compared  to  other 
protein-motif  interactions  (Figure  3.6D).  Interestingly,  if  we  explore  the  average  RNA-seq 
readout FPKM values for genes near peaks with different 6mer variants, we find genes near 
CATATG containing peaks have lower expression levels on average (Figure 3.6E), suggesting  	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Figure 3.6 (Continued) 
E-box motif variants are differentially preferred by Olig2 in NEB. 
(A) E-box  6mer  variants  occurrences  in  Olig2  NEB  binding  regions  in  comparison  with 
genomic  background  frequency.  Left:  Olig2  NEB  binding  regions;  right:  genomic 
background. 
(B) Frequency of three variants that show centered distribution relative to Olig2 peak center. 
(C) E-box motif recovered from protein binding microarray (PBM, top) and ChIP-seq in NEB 
(ChIP-seq, bottom) show differential preference to the CANNTG core 6mer with regards 
to the center two nucleotide. 
(D) Rank of Olig2 NEB peaks with different E-box variants within 25bp from peak center. 
CATATG-containing peaks show smaller ranks (ie, stronger peak signals) than CATCTG 
and CAGCTG peaks, suggesting higher affinity of Olig2 dimer to CATATG motif in 
comparison with the other two variants. Red: mean of ranks; blue: median of ranks. 
(E) Boxplot showing low expression levels for gene regulated by CATATG-mediated Olig2 
binding, in comparison with CAGCTG and CATCTG-mediated Olig2 binding peaks. 
(F) Active  enhancer  signature  H3K27ac  and  H3K4me2  near  Olig2  peaks  containing 
CAGCTG (left), CATCTG (middle), and CATATG (right) E-box motif variants. 
(G)-(H) Genome browser showing lack of active enhancer signature for Olig2 binding sites 
mediated  by  CATATG.  (G)  Cis-element  195kb  downstream  from  Irx3  TSS.  (H)  Cis-
element 55 kb upstream from Gas1 TSS. For the ‘6mer’ track showing different E-box 
variant: blue: CAGCTG; orange: CATCTG; green: CATATG. 
(I) Percentage of CATATG Olig2 peaks with CATCTG or CAGCTG consensus within a 
certain  distance  from  CATATG  motif  center,  in  comparison  with  CATATG  motifs 
randomly sampled. Window coverage is from +/-1500 to +/-125bp (left) and from +/-
150bp to +/-25bp (right.) 	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the homodimer binding has a signature consistent with repression. Further, features of active 
enhancer  signatures  were  less  enriched  as  well  as  Shh-responsiveness  when  CATATG 
containing peaks were compared to CAGCTG and CATCTG peaks (Figure 3.6F). Examples of 
peaks with CATATG variant are shown in Figure 3.6G-H. 
We also notice a tendency for the occurrence of multiple E-box sequences when we 
observe CATATG variant. Olig2 peaks with the CATATG variant +/-25bp from an Olig2 ChIP-
peak  center  were  pooled,  and  the  percentage  of  these  peaks  with  additional  CAGCTG  or 
CATCTG variants within different windows were calculated (Figure 3.6I). If the clustering of E-
box sequences are a genome-wide phenomenon, we expect to see higher % of CATATG Olig2 
peaks to have CAGCTG or CATCTG motifs nearby than control CATATG sequences not within 
Olig2 peak centers. 
We observed a clear tendency of more CAGCTG or CATCTG motifs occurring in Olig2 
peaks with a centered CATATG variant: the red and green lines above the black and grey lines in 
Figure 3.6I. The enrichment over control increases as the window decreases from +/-1500bp to 
+/-125bp  suggesting  a  non-random  local  clustering  (Figure  3.6I  left).  As  the  enrichment 
decreases as the window decreases below +/-100bp the data do not suggest a tightly constrained 
clustering reflective of cooperative interactions (Fig. 3.6I right). Together the result suggest that 
multiple motifs likely represent independent protein binding events, and having multiple motifs 
might add the robustness of the regulatory process. 
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Olig2 peaks with different E-box variants are associated with genes of distinct expression 
patterns and biological processes 
Analyses so far suggest that Olig2 peaks with different E-box variants have distinct histone 
modification  profiles,  and  likely  regulate  genes  with  differential  expression  levels.  A  recent 
study provided a mechanism whereby distinct differentiation can be achieved by differential E-
box  sequence  preferences  mediated  by  bHLH  lineage-specific  factors  (Fong  et  al.,  2012). 
Specifically, Fong et al. (2012) profiled chromatin binding of two E-box TFs, NeuroD2 and 
MyoD, in two contexts: in the P19 cell line transduced with NeuroD2 and converted to neurons, 
and mouse embryonic fibroblast (MEF) transduced with MyoD and converted to skeletal muscle 
cells.  They  identified  common  and  distinct  binding  regions  for  NeuroD2  and  MyoD. 
Interestingly, only the distinct binding sites are associated with lineage specific differentiation, 
while the common peaks are not strongly associated with gene transcription regulation. 
This  result  gives  several  insights.  First,  it  supports  the  concept  of  utilizing  motif 
preferences to study cell fate choices to different neuronal subtypes. The hypothesis is that the 
generation of mitotically active MN and OLP precursors might be achieved by different Olig2 
dimers with different sequence specificity preferences. Second, NeuroD2 and MyoD genome-
wide chromatin binding profiles provide a valuable information source to help identify Olig2 
dimerization partners in our data. Thus, I integrated Olig2 NEB ChIP-seq with that of MyoD and 
NeuroD2 (Figure 3.7A). 
The first question I asked is whether a certain E-box motif variant is lineage specific, 
while others may be a generic E-box consensus. To this end, I investigated enriched E-box 6-mer 
variants in Olig2, NeuroD2, and MyoD ChIP-seq datasets. CAGCTG and CATCTG motifs were 
reported to be enriched for NeuroD2 (Fong et al., 2012). The CATATG variant is also strongly 	 ﾠ 140	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Figure 3.7 (Continued) 
Olig2 peaks with different E-box variants are associated with genes with distinct 
expression domains and involved in different biological processes. 
(A)3-way intersection of Olig2, MyoD and NeuroD2 ChIP-seq data. 
(B)E-box 6mer variants occurrences in NeuroD2 and MyoD peak regions, as well as common 
peaks between NeuroD2 and Olig2 as well as MyoD and Olig2. 
(C)–(D) Frequency of representative E-box variants relative to NeuroD2 (C) and MyoD (D) 
peak center. 
(E) Olig2 peaks with different 6mer variants show different MGI expression stage and tissues. 
(a): CAGCTG Olig2 peaks; (b): CATCTG Olig2 peaks; (c): CATATG Olig2 peaks. 
(F) Olig2 peaks with different 6mer variants show different GO enrichment. (a): CAGCTG 
Olig2 peaks; (b): CATCTG Olig2 peaks; (c): CATATG Olig2 peaks. 	 ﾠ 143	 ﾠ
centered around NeuroD2 peak center, and to a less extent CAGGTG (Figure 3.7B-a). In contrast, 
in  the  MyoD  ChIP-seq,  a  CATATG  motif  is  depleted  (Figure  3.7B-b)  and  centering  is  not 
apparent  (Figure  3.7D).  Recall  that  CATATG  encodes  the  optimal  Olig2  homodimer  motif 
recovered from PBM (Figure 3.6C top). This is the sequence strongly centered in the neural 
Olig2 ChIP-seq peaks (Figure 3.6B right). Thus, this motif correlates with neuronal but not 
muscle  datasets.  Meanwhile,  if  we  expect  certain  E-box  variant  to  be  predictive  of  lineage 
differentiation and some to be only generic variants, then the common binding peaks between 
different E-box TFs should have an enrichment of the generic variants, while the distinct peaks 
will be enriched for lineage specific variants. If we do 2-way intersection of Olig2 with MyoD 
and  examine  the  motif  variants  constitution  (Figure  3.7B-d),  we  observe  an  increase  of 
CAGCTG  motif  to  42%  of  all  E-box  variants  for  the  shared  Olig2+MyoD+  peak  regions, 
suggesting that CAGCTG sites might indeed represent a more generally utilized recognition site 
for various E-box TFs independent of cell origin. In contrast, similar analysis on Olig2 and 
NeuroD2  intersection  gave  a  different  result;  both  CAGCTG  and  CATCTG  motifs  are 
consistently  enriched  (Figure  3.7D-c),  but  more  especially  CATCTG  (Figure  3.6A  right).  I 
conclude that CAGCTG sequence may be commonly recognized by E-box proteins of different 
lineages. In contrast, CATCTG and CATATG motifs are likely more significant within neuronal 
lineage specific differentiation. 
Next,  I  asked  whether  Olig2-mediated  differentiation  to  MN  and  OLP  lineages  are 
characterized by different E-box 6-mer variant preferences that might reflect Olig2 dimer partner 
preferences.  GO  analysis  was  performed  on  predicted  target  genes  of  different  Olig2  dimer 
partnerships. In terms of MGI expression patterns (Figure 3.7E), CAGCTG Olig2 peak regulated 
genes have a broad spectrum of tissue expression, not restricted to spinal cord and neuronal 	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lineages. In contrast, CATCTG peak regulated genes are very specifically NT-related genes with 
high enrichment values. Interestingly, through GO analysis (Figure 3.7F), I discovered that glial 
differentiation-related  terms,  in  particular  oligodendrocyte  differentiation,  are  enriched  for 
CATCTG  but  not  CATATG  associated  Olig2  peaks  (Figure  3.7F  b,c).  These  observations 
suggest:  1)  CATCTG  is  the  core  variant  recognized  by  Olig2  in  spinal  cord  motor  neuron 
progenitors and may also be important for later glial cell differentiation into OLP; 2) CATATG 
might function in MN development at a later stage but has little connection to glial lineage; 3) 
CAGCTG is more broadly utilized by bHLH members in non-tissue specific contexts. 
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Discussion 
Our transcriptional analysis of Shh-mediated embryonic neural patterning has generated several 
new insights into the GRNs by elucidating several layers of information that relate TF occupancy 
to chromatin accessibility to gene expression regulation. We propose that as the first stage of 
initiating  Shh  response,  Sox2  functions  to  create  a  permissive  chromatin  structure  for  Gli1 
access; as development proceeds, ventral repressive determinants interact with co-activators to 
promote  further  differentiation.  In  addition,  different  Olig2-mediated  dimer  species  is  one 
potential mechanism for Olig2-mediated cell fate choice from pMN to MN or OLPs. 
 
Shh neural-specific response by integration of Gli1-defined neural CRMs with Sox2 input 
Developmental studies have highlighted a small number of signaling pathways mediating a great 
diversity of tissue patterning, raising the question of how tissue-specific outcomes arise from 
common signaling inputs. ChIP-seq integration of Gli1 and Sox2 established Sox2 as a necessary 
activating input for Gli1-mediated Shh response by having an accessible chromatin structure. We 
demonstrated that Gli1 acts in conjunction with Sox activity to switch on distinct ventral neural 
progenitor determinants. Shh regulation of Gli binding provides the instructive input to direct 
specific  ventral  cell  fates,  and  Sox  binding  provides  the  neural  context.  Genetic  evidence 
indicates that SoxB1 members regulate the proliferation and timing of differentiation of neural 
progenitors, and recent evidence also links their actions to diversification of the progenitor pool 
(Bergsland et al. 2011). In a recent model, Sox factors are proposed to bind sequentially to neural 
target genes, with replacement of Sox2 in ESCs followed by Sox3 and then finally Sox11 in 
mature neurons (Bergsland et al. 2011). Although several neural-specific genes are associated 
with Sox2-bound regions in ESC studies, the putative CRMs highlighted by Sox2 binding do not 	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display a permissive chromatin mark until sometime later, on commitment to a specific neural 
lineage, suggesting that Sox2 engagement is not sufficient to modify the chromatin signature 
(Bergsland et al. 2011). 
To address whether Sox2 primes Class-II ventral gene activation preceding Gli factor 
engagement,  will  require  a  more  comprehensive  time-course  examining  chromatin  binding 
patterns of Sox2 and Gli1 using ChIP-qPCR or ChIP-seq. The expectation is the precedence of 
Sox2 binding relative to Gli1, which might act to open up chromatin to create an assessable 
structure. However, all data to date is based on ectopic activities. Incorporating endogenous 
actions of all Gli factors is needed, and the study on Gli1 may only reveal a certain set of 
information. For example, the presence of another Gli factor in the VNT, Gli2, and current data 
suggesting the up-regulation of Gli2 as early as 12 hours into induction might complicate the 
interpretation of any Sox2N prior to Gli1 binding. Meanwhile, since only 12% of Gli target 
genes  are  also  bound  by  Sox2,  it  remains  to  be  studied  whether  there  is  other  alternative 
mechanism for Gli-mediated neural-specific responses, in addition to the proposed Sox2 priming 
model. 
  
Common cis-regulatory elements for VNT repressor TFs 
The extensive overlap of binding among ventral determinants Nkx2.2, Nkx6.1 and Olig2 within 
what is likely the same CRM further suggested the clear delineation of the adjacent progenitor 
cell  types  via  cross-repression  and  enabled  the  systematic  identification  of  cis-regulatory 
elements in neural derivatives. GO analysis of the co-regulated genes by the ventral repressors 
showed several major classes of target genes are enriched: Class-II ventral cell determinants, 
Class-I  dorsal  determinants,  post-mitotic  neuronal  subtype  determinants,  and  Hh  pathway 	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components. Post-mitotic TFs are particular interesting. This strong enrichment of post-mitotic 
neuronal  fate  determinants  by  repressor  binding  sites  is  a  tantalizing  connection  between 
terminal differentiation and repressor factors. In understanding this gene regulation, identifying 
activating inputs functioning with these repressors is critical. Regionalized versus ubiquitous 
activator input will make a significant difference in understanding the gene regulatory principles 
by these repressors. 
 
bHLH TF DNA recognition site preferences for MN versus OLP fate choices 
We  provided  evidence  supporting  that  differential  DNA  recognition  site  preferences  are 
dependent on different co-factors. Olig2 DNA binding differential preferences in MNs and OLPs, 
together  with  gene  expression  level  information,  points  to  a  model  of  Olig2::X  heterodimer 
promoting OLP cell fate by preferentially binding to CATCTG sequences, in contrast to the 
Olig2::Olig2 homodimer preferences of CATATG in MNs. The next step will be the prediction 
of Olig2 heterodimer partners in MN and OLP lineages. Based on RNA-seq expression data in 
our system and existing expression data from in vivo isolated cells in neuron, oligodendrocyte, 
and astrocyte lineages (Cahoy et al., 2008), NeuroD1 and Ascl1 are the most likely bHLH factor 
candidate for Olig2 dimer, given their strong expression in NEB, and high fold enrichment in 
neuron (16 folds) and OLPs (14 folds). Neurog2 and NeuroD4 are also likely candidates for MN 
fate according to prior knowledge, but their expression enrichment data are not available from 
Cahoy et al. (2008) and further experiments need to confirm. 
A more complete understanding of Olig2 complexes and their actions would benefit from 
a number of approaches. First, PBM can be utilized to study DNA sequence specificity for the 
proposed Olig2 dimers by forced tethering of Olig2 with candidates dimer partners, although 	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steric hindrance on forced tethering, and the absence of helper could influence these results. 
Second, ectopic expression of Olig2 dimers in the chick NT enables their activities to be assayed. 
For  example,  based  on  our  hypothesis,  the  ectopic  expression  of  Olig2::Ascl1  heterodimer 
should contribute to ectopic generation of OLPs. Third, in order to validate activator versus 
repressor function of a certain dimer species, luciferase assay can be performed once the DNA 
binding specificities for different dimer species are confirmed. Finally, the in vivo chromatin 
binding specificity of different Olig2 dimer species will be verified by ChIP against tethered 
Olig2 dimers in neural EB. The neural EB will be differentiated from mESCs expressing tethered 
dimers,  which  can  be  generated  using  recombinase-mediated  cassette  exchange  (RMCE)  in 
mESCs. In the cases that certain antibodies are not available, RMCE system makes the usage of 
epitope tags possible.  
  
Materials and methods 
Neural progenitor culture 
ES cells were maintained on mouse embryonic fibroblast (MEF) feeder cells and cultured in 
DMEM with 15-17.5% FBS supplemented with LIF. To generate neural progenitors from ES 
cells, we followed the NEB culture protocol described in (Wichterle et al., 2002). First, MEFs 
were removed in a gelatin-coated flask and floating ES cells were collected. Cells were rinsed 
once with DFNB medium (DMEM: F12: Neurobasal=1:1:2, 4% B27 supplement; Gibco) or 
DFNK medium (10% Knockout Serum Replacement in place of B27). Cells were plated in Ultra 
Low Attachment 6-well plates or T75 flask at 100,000-200,000/ml density in DFNB/DFNK. 
Two  days  after  MEF  depletion,  the  medium  was  changed  to  a  fresh  DFNB/DFNK  medium 	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containing 500nM all-trans RA (Sigma) and 50-800nM SAG (Alexis Biochemicals). Embryoid 
bodies were harvested 72hrs post induction unless otherwise noted. 
 
Microarray analysis 
Embryoid bodies were generated with the above protocol. Two days after MEF depletion, EBs 
were treated with 500nM RA or 500nM RA and 50nM SAG for 3 days. Whole fraction RNA 
was extracted with mirVana RNA kit (Ambion) according to the manufacturer’s instruction. 
Three  pairs  of  biological  replicates  were  collected.  RNA  samples  were  validated  with 
Bioanalyzer  (Agilent)  and  biotin-labeled  cRNA  was  prepared  with  3’  IVT  Express  kit 
(Affymetrix). The samples were and hybridized to Mouse 430 2.0 arrays (Affymetrix). 
 
ChIP-seq data analysis 
The first 25-nt of each read was mapped to mouse mm9 genome assembly using SeqMap (Jiang 
and Wong, 2008) or ELAND (Illumina). Two-sample peak detection was performed using an 
iterative conditional binomial model (Ma and Wong, 2011). For one-sample peak calling, the 
FDR of each w-bp window with ki reads is the ratio of expected number of windows containing 
at least ki reads (given the negative binomial parameters) to the observed number of windows 
that have at least ki reads. In the two-sample peak detection, the FDR of each w-bp window with 
k1i ChIP reads and ni total reads, is the ratio of the expected number of windows (given r0) to the 
observed number of windows that have at least k1i ChIP reads out of a ni-read window (see 
Methods in (Ji et al., 2008)). In the peak calling process, the forward and reverse strand reads 
were processed separately. First, peaks were identified for each stand and then forward and 
reverse  strand  peaks  were  combined  if  they  were  within  500  bp  of  each  other  and  the 	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corresponding number of reads in the coupled peaks shows less than five-fold change. The start 
and end coordinates for peak boundaries were defined as the modes of the coupled peaks. A final 
peak score was then determined by averaging the heights of the forward and reverse-called peaks. 
The iterative two-sample peak calling was performed separately on the Gli1-A and the Gli1-B 
replicates using the YFP mock input control with FDRs: 0.01, 0.05 and 0.1. Additional ChIP-set 
data sets were obtained for: Sox2 (ESC) (Marson et al., 2008), H3K4me2 (ESC) (Meissner et al., 
2008) and H3K27ac (ESC) (Creyghton et al., 2010). Sox2-ESC peak calls were performed as 
above. 
 
Gene and enhancer annotation 
Gene ontology analyses were performed using DAVID (http://david.abcc.ncifcrf.gov/) (Huang et 
al., 2009). The association of genome regions with gene ontology terms was done using GREAT 
(version 1.8.2) (http://great.stanford.edu/) (Bejerano et al., 2010). 
 
Histone modification analysis 
Aggregates plot of histone modifications were performed using Homer (Heinz et al., 2010). 
Genomic regions upstream and downstream of a certain distance from the peak center were 
divided into 60 100-bp bins each. Error bars indicate standard errors of the means of all the 
normalized ChIP-seq fragment densities in the respective bin. Box plot of expression values was 
drawn in R. Statistical significance was calculated by the Wilcoxon rank-sum test. 
 
Hierarchical clustering, heat map and Venn diagram 	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For the hierarchical clustering of 20 factors based on chromatin co-occupancy, peak regions for 
each factor with p-value < 1e-8 were trimmed or expanded to 400 bp centered at the peak center. 
Pair-wise intersection was performed between every pair of factors to generate a matrix of the 
number of co-bound regions. Complete linkage, correlation distance, hierarchical clustering was 
performed  and  heat  map  generated  using  R.  Peak-peak  intersection  were  conducted  using 
BEDTools (v2.10.1) (Quinlan and Hall, 2010). Venn diagrams were draw in Cistrome analysis 
pipeline(Liu et al., 2011). 
 
RNA-seq analysis 
RNA-seq reads were mapped using TopHat with default settings (http://tophat.cbcb.umd.edu) 
(Roberts et al., 2012). Tophat output data were analyzed by Cufflinks to generate FPKM values 
for both known and de novo transcripts in mouse genome. Cuffdiff was then used to calculated 
significant differential expression across conditions. 
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Research Summary 
In my thesis work, I utilized ESC-models of pluripotency and neural development to investigate 
genome-scale gene regulatory programming of biological processes. In the first study, I explored 
opposing actions of the Wnt pathway in maintenance of pluripotency and commitment of ESCs 
to  early  embryonic  fates.  In  the  second  study,  I  used  Shh-mediated  patterning  of  neural 
progenitors to examine neural progenitor patterning, and neural progenitor programming. My 
focus  was  directed  to  a  large  extent  around  bioinformatics-based  hypothesis  building  and 
hypothesis testing utilizing large collections of genomic datasets generated within the McMahon 
laboratory, or available from published work. 
 
Wnt and pluripotency 
We identified genomic targets of the Wnt signaling pathway co-activator β-catenin: the first such 
genome  scale  study  of  a  Wnt  activator  program  in  ESC  systems.  The  genome-wide 
characterization of β-catenin transcriptional targets allow us to discover a strong association 
between β-catenin and core pluripotency factors, represented by Nanog, Oct4, Sox2, and Tcf3. 
We  were  also  able  to  mechanistically  illustrate  β-catenin  involvement  in  maintaining 
pluripotency via active input onto Oct/Sox chromatin binding sites via a protein complex with 
Oct4 and Tcf3. This additional mode of pluripotency maintenance interchanges dynamically with 
the Oct4/Sox2-mediated known mode of pluripotency maintenance, in the presence of active β-
catenin. Meanwhile, we observed the inhibition of differentiation gene activation via ERK/Ets 
pathway  suppression,  without  altering  DNA-binding  of  β-catenin/Tcf  around  target  genes  of 
differentiation programs. These studies provide a molecular explanation of how two inhibitory 
small molecules may maintain ESC pluripotency under defined serum-free conditions. The two 	 ﾠ 159	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factors are the GSK3 inhibitor CHIR99021 (CHIR) and ERK pathway inhibitor PD0325901 
(PD03). 
We  propose  that  in  this  two  inhibitors  (abbrev:  2i)  culture  system,  where  β-catenin-
directed canonical Wnt pathway activation is triggered by CHIR, and Ets family TF action is 
inhibited by PD03, β-catenin-dependent differentiation targets fail to be activated because of 
simultaneous requirement for Ets-factor engagement at cis-regulatory elements. Fgf-signaling is 
known to regulate ES differentiation, FGFs are secreted by ESCs and FGFs signal through Ets 
family members by the MEK pathway. 
Some preliminary experimental evidence supports this model. In a genetically modified 
mESC  line  in  which  the  Fgf-dependent  Ets-factor  Etv4  is  fused  to  an  engrailed  domain 
(Etv4EnR) (Figure 4.1A), alkaline phosphatase positive cultures indicative of pluripotency are 
maintained in the absence of PD03, in contrast to wild type mESCs (Figure 4.1B-C). Since 
Etv4EnR is expected to bind to the same targets as Etv4/5, both expressed in ES cells, but to 
repress  rather  than  activate  targets  due  to  the  repressive  engrailed  domain,  the  result  are 
consistent  with  PD03  inhibition  of  Ets  factor-mediated  transcriptional  activation  of 
differentiation target genes. 
In addition, we have also shown that for genes associated with differentiation of ESCs to 
mesoderm  and  trophectodermal  lineages,  T  and  Cdx2,  respectively,  Etv4EnR  expression  is 
sufficient to inhibit T and Cdx2 up-regulation in PD03 withdrawn 2i culture (CHIR+/PD03-). 
Expression of T, Cdx2, and Cdx4 increases upon the removal of PD03. Induced expression of 
Etv4EnR  significantly  down-regulated  the  expressions  of  T  and  Cdx2  in  2i-adapted  mESCs 
cultured PD03 withdrawn 2i culture (CHIR+/PD03-) (Figure 4.1D, lower panel). In contrast, the  
 	 ﾠ 160	 ﾠ
 
R26-EtvEnR  ALP staining (CHIR culture, passage 3) 
T
M
 
(
+
)
 
T
M
 
(
-
)
 
bar, 300 mm 
A 
B 
Cell number  (CHIR culture) 
* 
0 
2 
4 
6 
1  2  3 
C
e
l
l
 
n
u
m
b
e
r
 
(
x
 
1
0
6
)
 
Passage 
TM(-) 
TM(+) 
0 
0.4 
0.8 
1.2 
2i  TM (-) TM (+) 
CHIR 
Pou5f1 
0 
0.4 
0.8 
1.2 
2i  TM (-) TM (+) 
CHIR 
Nanog 
0 
0.4 
0.8 
1.2 
2i  TM (-) TM (+) 
CHIR 
Sox2 
0 
2 
4 
6 
2i  TM (-)  TM (+) 
CHIR 
Cdx2 
0 
5 
10 
15 
20 
2i  TM (-) TM (+) 
CHIR 
Cdx4 
0 
15 
30 
45 
2i  TM (-) TM (+) 
CHIR 
T 
* 
* 
* 
*p<0.05 vs. CHIR-TM(-) 
mRNA expression (RT-qPCR, Passage 3) 
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
 
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
 
C 
D 
Figure 4.1!	 ﾠ 161	 ﾠ
   
Figure 4.1 (Continued) 
Preliminary  results  of  PD03-independent  ESC  culture  for  Etv4-EnR  ES  cell  line 
(courtesy of Dr. Ohba, unpublished). 
(A) Schematic of Etv4-EnR knock-in at Rosa26 locus flanked by loxP site (Mao et al., 2009). 
The  Etv4-EnR  locus  will  be  transcribed  when  4-OH-Tamoxifen  is  added  to  the  cell 
culture. 
(B) Comparison of survivals of parental line and 4-OH-TM-treated Etv4EnR-expressing cell 
line in CHIR-only 2i culture system (PD03 withdrawn). Cell number at passage-3 was 
significantly  lower  in  parental  cells  than  in  4OH-TM-treated  (Etv4EnR-expressing) 
ones. 
(C) Alkaline phosphatase staining showing the pluripotency of cell culture from parental line 
and 4-OH-TM-treated cell line at passage-3. Significant AP+ colonies were observed for 
Etv4EnR-expressing cells even after withdrawing PD03 for 3 passages. 
(D) Expression change of representative pluripotency markers (top row) and differentiation 
genes  (bottom  row)  in  parental  and  4OH-TM-treated  cells  before  and  after  PD03 
withdrawal. In contrast, removal of PD03 did not affect Pou5f1 and Sox2 expressions 
compared to 2i, although Nanog expression decreased dramatically upon the removal of 
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 ﾠ 162	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expression levels of pluripotency genes such as Oct4 and Sox2 were not altered on Etv4EnR 
expression,  consistent  with  our  prediction  that  only  differentiation  genes  are  subjected  to 
inhibition  by  PD03  in  2i  culture.  Nanog  expression  is  decreased  after  PD03  withdrawal, 
consistent with published work of a more direct link between PD03-activity and Nanog induction 
(Silva et al., 2009). 
Future experimental tests of our model would use ChIP-qPCR against Etv4EnR and β-
catenin examining cis-elements near differentiation-related genes. We would predict that Etv4 
and  β-catenin  would  co-localize  at  these  cis-elements  and  cooperatively  up-regulate 
differentiation  gene  expression.  The  next  step  will  be  to  functionally  test  regulation  of  key 
differentiation genes by Etv4 and β-catenin. This could be measured in luciferase assays, where 
luciferase is under the regulation of an early differentiation target, such as T. We expect to see 
luciferase signals when both Etv4 and β-catenin are co-transfected, which will be abolished 
when the Lef/Tcf motif is mutated, or Etv4EnR instead is present. 
Though there are concerns with individual experimental approaches that have been used 
to date: pharmacological inhibitor of GSK3, Wnt3a conditional medium treatment, and β-catenin 
or TCF3 modulation; there is good agreement amongst the different systems. Over-expression of 
β-catenin  stimulates  self-renewal  of  mESCs  in  a  similar  way  to  Wnt3a  supplementation  of 
medium (Ogawa et al., 2006; Takao et al., 2007). Moreover, GSK3 inhibition by knockout, 
exogenous expression of β-catenin, as well as Wnt3a treatment all resulted in similar activation 
of endogenous target genes or transfected reporter plasmids (Cole et al., 2008; Doble et al., 2007; 
Kelly et al., 2011; Kielman et al., 2002; Sato et al., 2004; Yi et al., 2008), pointing to β-catenin 
action in each experimental condition. 	 ﾠ 163	 ﾠ
Some controversy exists on how β-catenin exerts its pro-self-renewal effect in mESCs. 
One potential mechanism is Tcf-independent β-catenin function via β-catenin-Oct4 complexes 
(Kelly  et  al.,  2011).  In  other  words,  there  is  a  separation  of  Tcf-dependent  β-catenin 
transcriptional activities from Tcf-independent β-catenin targets. Supporting evidence for Tcf-
independent mechanism also came from evidence that mESCs over-expressing a β-catenin-ΔC 
mutant,  incapable  of  co-activator  activity  but  capable  of  Tcf  interaction,  can  stimulate  self-
renewal by inhibiting Tcf3 repressor activity (Wray et al., 2011; Yi et al., 2011). However, it was 
also proposed that Oct4 was not capable to bring β-catenin to chromatin, and Tcf factors might 
be  required  for  β-catenin  chromatin  binding.  Our  model  is  consistent  with  the  view  that  β-
catenin is closed associated with core pluripotency factor Oct4. We further proposed that Tcf 
factor(s) are required for β-catenin chromatin binding via the Sox2 recognition component of a 
Oct4/Sox2 composite DNA-binding motif. In this, the Sox2 component of the DNA recognition 
site accounts for CHIR-mediated active input. The Oct4/β-catenin/Tcf-dependent pluripotency 
gene  regulation  is  a  separate,  though  closely  intertwined,  mechanism  compared  with  the 
traditional Oct4/Sox2/Nanog core pluripotency network. 
 
Shh and neural patterning 
In early neural decision-making we proposed that the SoxB1 family member, Sox2, acts as a 
neuronal  lineage-priming  factor  essential  for  a  neural-specific  Shh  response.  In  this,  Gli 
transcriptional effectors are proposed to regulate a number of VNT cell type determinants (Class 
II target genes). In the first step towards testing this model, we systematically recovered and 
validated CRMs for all Class II genes, and demonstrated Sox2 binding at these sites in neural 
progenitors. Further, Gli action was dependent on Sox2 binding for at least some of these genes. 	 ﾠ 164	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Future experimental work will involve temporal chromatin binding profiles of Sox2 and Gli1 via 
ChIP-qPCR or ChIP-seq. The prediction is that if indeed Sox2 priming is required prior to Gli1 
binding, we expect to see a temporal order of Sox2 binding precedence of Gli1. 
We  also  observed  extensive  overlap  of  cis-regulatory  elements  utilized  by  ventral 
determinants activated through Gli-dependent processes: Nkx2.2, Nkx6.1, and Olig2. The system 
level characterization of common cis-elements deepens our understanding of cross-repression-
mediated ventral progenitor cell layer patterning. Furthermore, by in silico characterization of 
bHLH family chromatin binding motif, E-box motif, we proposed a model of cell fate choice 
from neuronal progenitor cells to motor neuron (MN) or oligodendrocyte progenitor (OLP) cell 
fate difference via DNA binding sequence recognition site specificity. 
More specifically, the model proposes Olig2 heterodimers promotes OLP cell fate by 
preferentially binding to CATCTG sequences activating target gene transcription in glial cells 
whereas Olig2::Olig2 homodimers have a preference for CATATG inhibiting gene activity in 
MN  progenitors.  Future  experimental  work  to  test  this  model  will  involve,  first  of  all,  the 
identification of Olig2 heterodimer species, and Ascl1 as well as NeuroD1/NeuroD4/Neurog2 
are strong candidates for OLP and MN lineages, respectively. Secondly, the validation of site 
specificity by the proposed Olig2 heterodimers and the identification of functional Olig2 dimer 
species.  This  will  be  performed  utilizing  protein  binding  microarray  technology  for  in vitro 
biochemical validation and ChIP-seq against tethered dimers by the in vitro neural embryoid 
body differentiation culture system. Thirdly, functional validation will be performed by ectopic 
expression of tethered dimers using chick electroporation. Fourthly, a quick method to validate 
the activating versus repressive roles of Olig2 dimers can be tested by luciferase assay. 	 ﾠ 165	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While  the  general  model  may  be  correct,  the  model  is  likely  to  oversimplify  these 
regulatory processes. For example, although Ascl1 expression correlates well with the generation 
of OLPs generation, and there is substantial decrease of OLPs in Ascl1-/- mutants, there is a 
recovery of OLPs in later stages. This suggests other bHLH factors may compensate for loss of 
Ascl1, such as Ascl3 and Ascl5 (Sugimori et al., 2008). Further, the generation of MN and OLP 
are under combinatorial actions of patterning factors including Nkx2.2, Olig2, and Pax6, and 
proneural bHLH factors, like Ascl1 and Neurogenin2. While we focus mostly on Olig2 and 
OLPs generated from within the pMN pool, OLPs can be generated from other progenitor cells 
(Sugimori et al., 2008). 
An interesting question is whether multi-potent progenitors first commit to neuron- and 
glia-restricted  progenitors,  which  later  differentiate  into  astrocytes  and  oligodendrocytes,  or 
alternatively,  neuron-oligodendrocyte  progenitors  dominate,  together  with  separate  astrocyte 
progenitors (Anderson et al., 2002; Gabay et al., 2003; Lu et al., 2002; Pringle et al., 2003). 
Some evidence argues for different domains in the VNT that generate different cell types in a 
distinct progression, with a pool of undifferentiated progenitors persisting throughout the course 
of neuro/gliogenesis (Sugimori et al., 2007). 
In  the  future,  with  the  time  course  RNA-seq  data  in  hand,  we  could  extend  our 
investigation  of  Shh-responsive  genes  to  the  potential  actions  of  regulatory  RNAs  in  Shh-
mediated  neural  patterning,  such  as  long  inter-genic  non-coding  (linc)  RNA  and  microRNA 
(miRNA)  transcripts.  Non-coding  miRNAs  and  lincRNAs  play  important  regulatory  roles  in 
gene networks during development (Guttman et al., 2009; Guttman et al., 2011). While many 
functions  have  been  ascribed  to  miRNAs,  and  miRNA  gene  organization  is  well  described, 
lincRNAs are less well understood. So far the mammalian genome is predicted to encode ~3500 	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lincRNAs. lincRNAs have roles in a broad spectrum of activities, such as chromatin structure 
modification, transcriptional regulation by recruiting TFs, post-transcriptional RNA processing, 
and translational controls (Qureshi et al., 2010). Guttman et al. (2011) performed a systematic 
functional study on all known ESC-expressed lincRNAs by knockdown experiments, and found 
dozens of lincRNAs that are essential for ESCs to remain pluripotent or to repress lineage-
specific gene expressions (Guttman et al., 2011). In the neural system, lincRNAs have been 
found to be involved in mediating cognitive and behavioral processes (Qureshi and Mehler, 
2011). A potential intersection between Shh-Gli regulation and miRNA and lincRNA encoding 
targets has not been addressed and would complete our general analysis of regulatory strategies. 
From preliminary analysis, my colleagues have shown that regulatory RNAs, miRNAs 
and lincRNAs, also intersect with our primary data; 14 GBRs lie next to a gene encoding a 
miRNA, while 142 have a lincRNA gene as a nearest 5’ or 3’ neighbor (Figure 4.2A). Thus, both 
classes  of  regulatory  RNAs  are  potential  downstream  regulators  of  Shh  action.  However, 
determining whether this may be the case requires a specific analysis of regulatory RNAs in our 
model. As an example of the approach in identifying Shh-responsive lincRNA (Figure 4.2B), this 
lincRNA has very strong signal in the Shh-positive sample, and has strong ventral TF binding in 
the vicinity. By in situ hybridization, this transcript shows nice expression in the progenitor 
regions of the VNT (Figure 4.2C). In the future, functional assays, including ectopic expression 
and knock down of regulatory RNAs in mESC system or conditional mutation in mouse models 
can be utilized to assist in the discovery and experimental analysis of Shh-responsive regulatory 
RNA in early embryonic NT patterning. 
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Figure 4.2 (Continued) 
Examples of Shh-responsive lincRNA from RNA-seq data (Courtesy of Dr. Nishi, Dr. 
Xu, Rinn Lab) 
(A) CisGenome browser view of Gli1-FLAG binding associated with a predicted linc RNA 
encoding gene following SAG treatment of neuralized EBs . A strong GBS (lowest track) is 
located ~ 50 kb downstream of NR_015481, a predicted lincRNA-encoding gene. The GBR 
shows an elevated me2 and polII signature and the predicted lincRNA gene displays a strong 
H3K4me2 signature at the promoter region. An Affymetrix probe-set just 3’ to lincRNA gene 
structure prediction shows a two-fold enhanced expression on SAG-mediated Shh pathway 
activation (orange + SAG and brown – SAG). LincRNA dataset was provided by Dr. J. Rinn 
Laboratory. 
(B) CisGenome browser example of a novel predicted Shh-responsive lincRNA. Chromatin 
binding signals from Gli1 and ventral progenitor determinants are also shown to demonstrate 
potential regulation of lincRNA transcription by Shh network genes. 
(C) Whole mount and cross-sectional in situ hybridization of the transcript in (B) showing 
strong expression in the progenitor domains of VNT, fulfilling the spatial requirement of Shh-
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 ﾠ 169	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Future challenges and directions for studying gene regulation on system level 
All sequencing technologies have some biases and artifacts. For example, there is bias towards 
GC-rich content in fragment selection. Sequencing errors are almost always present, although 
advance in technology has largely reduced this factor. How many reads need to be sequenced in 
order  to  have  a  reasonable  coverage  of  the  genome  is  always  a  heated  debate  in  the  field 
(Kharchenko et al., 2008), which is especially crucial for histone modification ChIP-seq that 
requires  a  large  number  of  short  reads  sequencing.  Finally,  bioinformatics-wise,  data 
management, such as storage, sharing, and processing is a unique challenge for next generation 
sequencing (NGS) data, and luckily, large public database, such as Gene Expression Omnibus 
(Edgar  et  al.,  2002),  is  gradually  building  up  and  standardizing  data  from  various  labs  and 
consortiums. 
For ChIP-seq, relatively large amounts of starting material are needed, which can be 
prohibitive  for  some  experiments.  Further,  antibody  quality  determines  the  feasibility  and 
specificity of the experiment. Although epitope tags can always be one solution, the availability 
of  epitope-tagged  protein  of  interest  proposes  another  major  challenge.  One  inherent 
disadvantage is that the profiles identified represent an average binding status for a given factor 
in the whole cell population. While this is not a major problem for TF ChIP-seq, for histone 
modification ChIP-seq and TFs with broad expression domains, conclusions on co-binding of 
multiple factors need to be drawn with caution. In addition, many TF binding cis-elements are 
located in intergenic regions that are more than 10kb from transcription start site (TSS) of target 
genes. For example, only 12% of GBRs occurred within 10 kb of a TSS, suggesting that long-
range interactions are a common feature of the Gli1 regulatory program. Similarly, only 5.3% of 	 ﾠ 170	 ﾠ
the Nkx2.2+Nkx6.1+Olig2+ cis-regulatory elements are within 10 kb of a TSS. Associating a 
binding region with its target genes has been a tough problem for all peak-calling algorithms. 
Traditionally, binding sites are assigned to the nearest genes, but research has shown that 
such simplified association introduces a strong bias for genes in large gene dessert. Moreover, 
several  enhancer  elements  located  >0.5  Mb  from  target  gene  TSS  have  been  reported.  For 
example, a Gli1 binding site located 540 kb upstream of Nkx6.1 TSS has been validated by 
transgenic assay. One mechanism for bringing these long-range enhancers to specific promoters 
have been assigned to insulators, which can bring together sequences located far apart in the 
linear genome (Yang and Corces, 2012). 
Complications  of  bioinformatics  analyses  can  also  come  from  3-dimentional  (3D) 
chromatin  structures  variations,  such  as  looping.  Recent  advances  in  Chromosomal 
Conformation Capture (3C)-based techniques, such as 4C, Hi-C, and 5C, have unveiled the 3D 
architecture  of  the  genome  and  the  compartmentalization  of  the  nucleus,  as  well  as  the 
phenomenon that enhancers far apart and even on different chromosomes can be folded into 
proximity  (Lieberman-Aiden  et  al.,  2009).  Therefore  various  efforts  have  been  devoted  to 
establish a rule for assigning cis-regulatory elements to the real target promoters. For example, 
GREAT algorithm associates cis-elements with target genes by defining a ‘regulatory domain’ 
for each gene in the genome, ranging from 5 kb upstream and 1 kb downstream of gene TSS, and 
an extension up to the basal regulatory domain of the nearest upstream and downstream genes 
within  1  Mb  as  default  (McLean  et  al.,  2010).  When  computing  for  gene  ontology  term 
enrichments, a binomial test is further performed to adjust biases introduced by variability in 
gene  regulatory  domain  sizes.  In  another  study,  Tang  et  al.  (2011)  empirically  defined  the 
‘regulatory potential’ of a TF for a given gene by taking into account of the number of TF 	 ﾠ 171	 ﾠ
binding peaks, weighted by the distance from each site to the TSS, within a certain distance 
(default,  100  kb),  without  considering  actual  binding  peak  strength  (Tang  et  al.,  2011). 
Distinguishing functional binding from non-functional binding simply by chance, or affinity, is 
labor-intensive. 
For RNA-seq, sensitivity of transcriptome and variations among samples is a significant 
issue  biological  replicates  are  important.  Current  sample  processing  protocols  have  several 
variation, such as whether to fragment RNA (RNA hydrolysis or nebulization) or cDNA (DNase 
I treatment or sonication), whether to enrich mRNA by poly(A)+ or by ribosomal depletion. 
Bioinformatics-wise,  the  complexity  of  eukaryote  transcriptomes  and  the  variation  in  RNA 
splicing makes the subsequent data processing challenging, such as the assembly of the short 
reads into contigs and the alignment of contigs with genomic sequences. As a final stage, the 
validation of in silico discovered transcript, especially low abundance ones, is also a challenge in 
reducing false positive hits. 
As powerful as NGS technique is, the complexity of genomics data poses considerable 
challenges to biologists who are not familiar with system level type of data. This points to the 
increasing importance in cross-disciplinary communication and collaboration among biologists 
with  statistician,  mathematician,  and  computer  scientists.  In  addition,  while  the  plethora  of 
bioinformatics algorithm, pipelines, and workflows provide users with ample selections for data 
analysis, there is no golden standard as to which method is the best for which data set. So the 
reproducibility of bioinformatics analysis can be a severe hurdle for communications in the field. 
Thus the open source sharing platform for NGS data as well as the standardization of NGS data 
analysis platform are at least as important as generating data in the long run.   	 ﾠ 172	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